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Abstract
The cell membrane provides a barrier and maintains the equilibrium between the 
intracellular and extracellular spaces. It regulate the flux of ions, metabolites and cellular 
components, and also acts to regulate the communication between the cells. However, any 
change in the cell membrane, as a result of mechanical, biological or chemical damage, 
may significantly alter the structure and function of the cell.
Various protein toxins, such as lipolytic enzymes and pore-forming bacterial toxins, have 
developed means to circumvent this barrier to gain access to resources. The interaction 
between the toxins and the cell membrane is of interest to understand the mechanisms 
involved in a range of toxin-related disorders such as cholera, prion diseases, and snake 
envenomation.
Surface Plasmon Resonance (SPR) provides a technique to simultaneously measure the 
change in mass density at a surface as a consequence of the adsorption and/or desorption 
events with a means of exciting fluorescent dye molecules at the surface. The combination 
of SPR and Surface Plasmon field enhanced Fluorescence Spectroscopy (SPFS) provides a 
surface sensitive technique with an ability to quantitatively and qualitatively determine 
small changes in mass and fluorescence in real-time and without the need for labelled 
molecules, as a result of the toxin-membrane interactions.
Biomimetic membrane phospholipid vesicles were constructed as a model cell membranes 
and provides a means of monitoring the initial interaction events and the subsequent 
actions the toxins trigger in relation to the membranes. The biomimetic membranes 
provide a simple and reliable model to study these events.
Direct membrane lysis, caused by lipolytic enzymes such as phospholipase A2 (PLA2) can 
be observed, and the affinity between the enzyme and the membrane determined. The 
binding between cholera enterotoxin and the biomimetic membrane can be monitored, and 
changes in the membrane permeability determined. One of the pathogenic hallmarks of 
Alzheimer’s disease is the accumulation of insoluble P-amyloid deposits on the surface of 
neurons. The biomimetic membrane system provides a means to monitor the initial stages 
involved in amyloid aggregation and the subsequent toxic events.
Understanding the mechanisms involved between the analyte-ligand interactions provides 
insight into possible therapeutic targets against these events. Direct membrane lysis due to 
PLA2 activity was shown to be inhibited by manoalide and eicosadienoic acid, whereas 
cholera toxin and P-amyloid binding were inhibited by lanthanide trivalent compounds. 
Therefore, the biomimetic membrane system provides a novel method to study toxin 
antagonists.
1.0 Introduction
Bacterial toxins, neurodegenerative peptides and lipolytic enzymes may be seen to share 
very little in common. However, as detailed in this thesis, they do consequently share a 
common connection; their interaction with the cell membrane. The application of optical 
methodologies, such as Surface Plasmon Resonance and Fluorescence Spectroscopy, 
allows for the monitoring of the interactions between a constructed artificial model 
membrane with the membrane binding peptides associated with the diseases and toxins 
mentioned above.
1.1 The Cell
The cell (Figure 1.1) is the basic structural and functional unit of all living organisms, and 
was so called because it resembled a small compartment. The term was coined by Robert 
Hooke in 1667 to describe what he saw when looking at a section of cork under a 
microscope. He observed it to be “perforated and porous, much like a Honey-comb” and 
had “very little solid substance, in comparison of the empty cavity that was contained
between Next, in that these pores, or cells, were not very deep, but consisted of a great
many boxes, separated out of one continued long pore, by a certain diaphragm” [1]. This 
later led to the development of the cell theory in 1839 by Schleiden and Schwann, to 
conclude that:
• Cells are the basic fundamental unit of structure, physiology and organization of 
living organisms.
• All living organisms are composed of these fundamental units (cells), either as a 
single cell, such as a bacterium, or aggregates of cells, such as plants and animals.
• All cells originate from pre-existing cells through cellular division.
• Cells contain the hereditary information, which is passed from generation to 
generation.
• All cells share a similar chemical composition, and all energy flow (metabolism 
and biochemistry) occurs within cells.
• Two exceptions exist, viruses are viewed (by some) to be alive but are not 
composed of cells, and the first cell did not originate from a pre-existing cell.
These observations still remain as the foundations of modem biology.
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Figure 1.1 Diagram o f  a typical eukaryotic cell, consisting o f  the basic membrane-bound 
organelles suspended in the cell cytoplasm, self-contained within a plasma membrane.
A living cell is composed o f four general classes o f macromolecules: nucleic acids, 
proteins, polysaccharides and lipids. Although subtle differences exist between cell types, 
they generally contain a comparable proportion o f each macromolecule, (Figure 1.2).
Approximate Chemical Composition of a Rapidly Dividing Prokaryotic Cell
Material % Total Wet Weight % Total Dry Weight
Water 70 -
Proteins 15 50
Nucleic acids 7 23
Polysaccharides 3 10
Lipids 2 7
Others (e.g. inorganic ions) 3 10
Total 1 0 0 1 00
Figure 1.2 Chemical composition o f  a unicellular prokaryote, which bares a close 
similarity to the chemical composition o f  eukaryotic cell [2, 57-
All the cellular components are bathed in water, which comprises -70%  of the total weight 
o f each cell. The polar properties o f water make it an ideal solvent because many cellular 
molecules are themselves polar, therefore they readily dissolve in water and promote the 
formation o f hydrogen bonds.
1.1.1 Proteins
Proteins are linear amino acid polymers, formed between the carboxyl terminus o f one 
amino acid linked via a peptide bond to the amino group o f another amino acid. Each 
peptide has a unique sequence o f amino acids produced from the twenty standard amino
2
acids. These basic units polymerise into short peptides (Figure 1.3) or into longer 
polypeptides or proteins. The protein sequence is determined during protein biosynthesis 
specified within the genetic code of an mRNA molecule.
H
Figure 1.3 The condensation o f  two generic amino acids into a dipeptide via a peptide 
bond.
Proteins are hugely diverse, both structurally and functionally, with between 2000-3000 
different types o f protein molecules in each cell. There are two classes o f proteins; globular 
proteins which are soluble in aqueous solutions and fibrous proteins which are relatively 
insoluble. Each protein is unique in its participation in processes that characterize the 
individuality of the containing cells, tissues, organs and organ systems. Many proteins are 
enzymes that catalyze biochemical reactions vital for metabolism. Other proteins act as 
transporters or function as messenger molecules, such as hormones. Some act as storage 
proteins, such as the binding o f oxygen by myoglobin in muscle cells, whereas others act 
as defence proteins in the blood and on the surface o f cells as antigens. Proteins can 
function as structural elements, such as collagen which provide strength and elasticity to 
skin.
1.1.2 Nucleic acids
The nucleic acids, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) are 
nucleotide polymers, which carry the genetic information o f the cell and acts as an 
intermediary molecule to convert the genetic blueprint into a defined amino acid sequence 
respectively.
Each nucleotide comprises a five-carbon sugar (either deoxyribose in DNA or ribose in 
RNA), a nitrogen base, and a phosphate group, (Figure 1.4). Nucleic acids are composed o f 
nucleotides covalently linked by a phosphodiester bond to one another via the phosphate 
from carbon 3 (3’) o f one nucleotide and the carbon 5 (5’) o f the adjacent nucleotide, 





role within the cell, and contain all the necessary information to reproduce an identical 
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Figure 1.4. Nucleotides, (a) o f  DNA. (b) o f  RNA.
Deoxyribonucleic acid (DNA) is a double stranded molecule composed o f the nucleotides 
adenine triphosphate (ATP), guanine triphosphate (GTP), cytosine triphosphate (CTP) and 
thymine triphosphate (TTP). The two stands associate into a helix conformation by 
hydrogen bonds, ensuring specific base pairing between adenine and thymine, and between 
guanine and cytosine. This ensures the two strands are complementary in base sequence.
Ribonucleic acid (RNA) is typically a single stranded molecule, with an ability to fold 
back on itself in regions where complementary base pairing can occur to form a secondary 
structure. Three forms o f RNA occur within a cell, messenger RNA (mRNA), which 
contains the genetic information o f DNA in a single stranded complementary form, 
transfer RNA (tRNA), which carries the amino acids to the ribosomes during translation of 
the mRNA molecule and ribosomal RNA (rRNA), which serve as structural and catalytic 
components o f the ribosome during the initiation and translation.
1.1.3 Polysaccharides
Polysaccharides are polymers o f  simple sugars containing carbon, hydrogen and oxygen in 
a ratio o f 1:2:1 joined together via glycosidic linkages. The most biologically relevant 
carbohydrates are those containing between 4-7 carbon atoms, such as pentose (5-carbon 
sugars) which are the structural backbone o f nucleic acids (see 1.1.2), and hexoses (6- 
carbon sugars), which are the monomeric constituents o f cell wall polymers and provide an 
energy source.
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The polymerization o f the monosaccharides into carbohydrates can also be combined with 
other classes o f macromolecules, such as proteins and lipids to from complex 
glycoproteins and glycolipids respectively. These compounds play pivotal roles in cell 
membranes as cell surface receptors, and glycolipids have additional roles as a major 
constituent o f the cell wall o f gram-negative bacteria. Polysaccharides often occur as 
structural components o f cells such as cellulose in the plant cell wall or as storage forms of 
energy such as glycogen.
1.1.4 Lipids
Fatty acids are the primary constituents o f lipids, and show the unusual chemical properties 
o f being soluble in non-polar solvents such as chloroform but are relatively insoluble in 
water. This is because they contain long hydrocarbon tails which are highly hydrophobic 
and a head group which is hydrophilic. They serve a wide range of functions within the 
cell including as energy reserves, hormones, protective barriers and as the major 
constituent o f the cell membrane. They are structurally polymorphic and difficult to define, 
and are either classified as amphipathic (possessing both polar and non-polar qualities) or 
as hydrophobic (possessing only non-polar qualities). They are a major class o f 
biomolecule and are a hugely varied group both structurally and functionally (Figure 1.5) 
adding to their essential nature in all living cells.
Lipids
Fatty Acids Steroids




















Figure 1.5 Major classes o f  lipids. Many lipids are composed o f  the basic units o f  the fatty 
acids. [4]
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The simplest class of lipid are the fatty acids, which are also the precursors for most other 
lipid classes, including the sphingolipids, eicosanoids, waxes and the tricylglycerols. They 
are long-chain hydrocarbons containing a carboxylic acid moiety at one end, which at 
physiological pH is readily ionized and renders a negative charge onto the fatty acids.
Glyceride-based molecules are the major constituent of biological membranes. These 
phospholipids contain a glycerol backbone esterified to two fatty acid hydrocarbon chains, 
and their amphipathic physical nature causes the lipids to spontaneously aggregate so that 
the hydrophobic portion is shielded from the aqueous environment and the hydrophilic 
portion aggregate towards the aqueous environment. This compartmentalizes the cell into 
functional components and maintains the structural integrity of the cell.
The diversity observed among the lipids is the result of the length of the hydrocarbon 
chain, the degree of hydrocarbon chain unsaturation (mono, di, tri-unsaturation) and the 
position of unsaturation within the chain. The presence of a double bond within the fatty 
acid significantly lowers the melting point when compared to a saturated fatty acid, 
because the double bond causes a pronounced kink in the hydrocarbon chain, therefore, 
impeding the rotation of the chain and decreases the van der Waals interactions amongst 
the hydrocarbon chains.
1.1.5 The Origin o f  the Cell Membrane
Potential membrane components emerged from the polymerisation of simple organic 
compounds into more complex chemicals and then into macromolecules such as proteins 
and lipids. An energy source would have been needed for this event to occur, and has been 
suggested that lightening, volcanic energy, hydrothermal vents and intense UV radiation 
that penetrated the atmosphere prior to the formation of ozone provided sufficient energy 
[5]. It has been tentatively demonstrated from fossil records that simple 5-carbon mono­
alcohols (terpenoids) were a likely starting point for the evolution of the first membrane. 
The polymerization of these terpenoids could have anchored to a solid surface through a 
phosphate group within the polar head group and at a critical chain length and 
concentration, the polymer peeled off from the solid surface in a manner similar to phase 
transition [6 ]. This subsequently enclosed the surrounding materials within its path to form 
a primitive vesicle [6 , 7]. The simple lipids would be highly diluted in the environment, but
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a process of condensation caused the concentration o f the lipids because o f the 
hydrophobic effect would cause aggregation to shield the hydrophobic portion of the 
molecule and self assemble either into a basic bilayer, micellar or monolayer system.
1.1.5.1 The Composition o f  the Cell Membrane
The compartmentalization o f cell was first documented by Hooke in Micrographia in 1667. 
It was stated that cells were “separated out o f one continued pore, by certain diaphragms” 
and that these walls were very thin in comparison to the cells [1]. It was Carl Nageli in 
1885 who introduced the concept and term, plasma membrane, when he observed that the 
rates o f pigment penetration between damaged and undamaged plant cells was different, 
and this was due to a dense and viscous outer layer distinguishable from the cytoplasm [8]. 
However, it was not until Groter and Grendel in 1924, that it was determined that these 
diaphragms consisted o f a lipid layer two molecules thick [9]. The thickness o f the lipid 
bilayer was determined to be between 40-50A by various methods including neutron 
scattering [10-12]. The lipid bilayer performs many functions, but is primarily a barrier. 
The lipid membrane is composed of two opposing layers o f phospholipids self-assembled 
so that the hydrocarbon chains face one another, while the polar head groups orientate 
towards the aqueous environment (Figure 1.6).
Extracellular fluid
N on-polar hydrocarbon chains
Intercellular cytoplasmPolar head groups
Figure 1.6 Schematic cross section through a lipid bilayer. The polar head groups face the 
aqueous environment, while shielding the hydrophobic hydrocarbon chains.
The plasma membrane o f mammalian cells contains four major phospholipids; 
phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin. A 
phospholipid is a class o f lipid formed from two fatty acid chains, a glycerol backbone, a 
negatively-charged phosphate group and an amine group (Figure 1.7). The phospholipids 
interact mainly be non-covalent interactions. Hydrophobic interactions are responsible for 
the sequestering o f the non-polar hydrocarbon chains away from water, and hydrophilic 
interactions for the orientation o f the polar head groups towards the aqueous environment. 
Dipole-dipole interactions also contribute to the stabilization o f the bilayer structure
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between the ion pairs o f zwitterionic phospholipids such as phosphatidylcholine. 
Maximization o f these interactions ensures that the system has the lowest free energy 
possible. Other noncovalant interactions, such as hydrogen bonding and electrostatic 
attraction, can also contribute to the stabilization o f the system. However, these 
interactions contribute very little to the overall stability o f the energy state compared to the 
hydrophobic and hydrophilic interactions.
Phosphate
Glycerol C ^ >
H y d ro p h o b ic  T ills 
(N on P o lar)
Figure 1.7 Generic phospholipid molecule composed o f  two fatty  acid chains and a 
phosphate group linked to a glycerol backbone, which in turn is attached to a nitrogen 
containing head group.
The phase transition temperature (Tc) o f a lipid is the temperature at which the lipid 
changes from the ordered gel phase, where the hydrocarbon chains are fully extended and 
closely packed, to a disordered liquid crystalline phase, where the hydrocarbon chains are 
randomly orientated and fluid. In the gel state, the phospholipid hydrocarbon chains are 
fully extended and in the trans conformation with the polar head groups remaining 
relatively immobile. Above the phase transition temperature for a particular lipid, the polar 
head group increases in mobility and the hydrocarbon chains change from the trans to 
more unstable gauche conformation [13]. The phase transition temperature is directly 
affected by hydrocarbon length, unsaturation and head group species [14]:
• With increasing hydrocarbon chain length; the phase transition temperature 
increases.
• With increasing unsaturation o f the hydrocarbon chain; the phase transition 
temperature decreases.
• Position of the unsaturated bound; lower phase transition temperature observed 
with double bonds situated in the middle of the hydrocarbon chain.
• Nature of the head group; Phosphatidylethanolamine cause the highest phase 
transition temperature, followed by phosphotidylserine, then phosphatidylcholine, 
and then phosphotidylglyerol.
• Increasing the pH of the medium lowers the phase transition temperature.
Moreover, high phase transition lipids increase the stability of a membrane system by 
ensuring the system is in the gel-phase and membrane leakage is reduced. When a 
membrane system is subjected to an increase in temperature, the rotational freedom of the 
hydrocarbon chains also increases. So when the system enters phase transition, there is an 
abrupt decrease in packing density [15].
The two leaflets of the plasma membrane show an asymmetry in phospholipid distribution. 
The endoplasmic reticulum is the principal site of membrane assembly in eukaryotic cells, 
and the distribution of asymmetry between the leaflets is maintained and controlled by 
slow transbilayer diffusion, protein-lipid interactions, and protein-mediated transport. 
Glycosphingolipids and phosphatidylcholine are concentrated in the exoplasmic leaflet, 
while aminophospholipids, phosphotidylserine and phosphatidylethanolamine are 
concentrated on the cytoplasmic face of the lipid bilayer. This asymmetrical 
transmembrane distribution is not random and has an important role in determining the 
physical properties of the membrane, as demonstrated by the concentrated distribution of 
phosphatidylserine in the cytoplasmic leaflet of human erythrocytes, which interacts with 
the cytoskeleton proteins to maintain membrane integrity [16]. This asymmetry is 
maintained by spontaneous transbilayer movement, “flip-flop”, and is dependant on the 
charge of the phospholipid head group, as movement of lipids with polar head groups is 
slower compared to lipids comprising a non-polar head group [17]. The movement of 
phosphatidylcholine and sphingomyelin from the exoplasmic to the cytoplasmic leaflet is a 
slow, non-mediated process in comparison to the aminophospholipids, which are rapidly 
transported from the exoplasmic to the cytoplasmic leaflet by an active ATP dependent and 
protein mediated process. A thermodynamic barrier exists to prevent rapid spontaneous 
transbilayer diffusion of phospholipids.
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The non-random lipid distribution across the bilayer is important for cell functions. Any 
significant change in the distribution o f phospholipid species generally triggers a 
physiological event or a signalling event, as shown during the exposure of 
phosphatidylserine and phosphatidylethanolamine on the exoplasmic leaflet, which signals 
for the removal of the expressing cells via the apoptotic pathway [18], and this mechanism 
is phylogenetically conserved [19].
1.1.5.2 The Role o f  Cholesterol in the Cell Membrane
Sterols are amphipathic lipids, which comprise between 5-30% of the eukaryotic 
membrane, depending on the cell type. Cholesterol is present in higher concentrations in 
cells which have more densely-packed membranes, such as the liver, spinal cord and brain 
cells. However, sterols are absent from the majority o f prokaryotic cell membranes, and in 
its place contain a peptidoglycan to provide structure and support. They are rigid and 
planar molecules, and share four common rings (Figure 1.9).
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Figure 1.9 (a) The general structure o f  a sterol, all containing the same four rings A,B,C 
and D. (b) The structure o f  cholesterol.
Cholesterol is abundant in the eukaryotic cell membrane, and ensures the fluidity over a 
wide range o f temperatures and reduces the permeability o f membranes to cations. 
Cholesterol eliminates the sharp thermal transition between the gel and liquid phases [20], 
therefore, giving the membrane properties intermediate between the two phases. However, 
the lack o f sterols within prokaryotes, the endoplasmic reticulum and the inner 
mitochondrial membrane suggests they are not solely responsible for membrane integrity. 
Cholesterol has been demonstrated to inhibit the flow o f water through membrane bilayers, 
and reduces the passive water permeability in direct proportion to the amount of 
cholesterol in the membrane [21]. This has been speculated to be because the fused ring
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domain of the cholesterol molecule orientates between the head group and the carbon-9 of 
the lipid chains, which presumably squeezes out the water [22], The constraints placed 
upon the motion of the hydrocarbon chains suggests that the sterol induces a tight lateral 
packing between membrane components, as defects due to bad packing make membranes 
more permeable to ions. The formation of hydrogen bonds between the OH-group of the 
cholesterol and the carbonyl group of the fatty acyl ester bonds of the phospholipids have 
been proposed to add to the stability of the membrane [23], but has no effect on the 
thickness of the membrane [24].
The distribution of cholesterol between the two monolayers of the membrane is 
experimentally difficult to determine because transbilayer movement of the sterol between 
leaflets is very rapid in comparison to the “flip-flop” of phospholipids. The preferential 
distribution of cholesterol in the outer membrane was claimed because the sterol has a 
preference for saturated and monounsaturated phospholipids compared to polyunsaturated 
phospholipids [25].
It has been suggested that cholesterol acts as a spacer molecule within the exoplasmic face 
of the bilayer, aiding the assembly of lipid rafts, which function to segregate and 
concentrate membrane proteins [26]. Lipid rafts constitute cholesterol and sphingolipids in 
the exoplasmic leaflet of the plasma membrane, with the cholesterol acting to condense the 
sphingolipids by occupying the spaces between the saturated hydrocarbon chains. 
Glycosphingolipids on the exoplasmic leaflet can interdigitate with the cytoplasmic leaflet 
to couple the two leaflets [27, 28]. These lipid rafts can then incorporate distinct classes of 
proteins involved in the various cellular functions including signalling and transport.
1.1. 6  SelfAssembly
Self-assembly is an intrinsic property of certain molecules, which have the capacity to 
generate structural organizations without input from an external source, thereby 
maximizing the benefit of the individual [29-31]. Self-assembly is a reversible process in 
which pre-existing components of a system form patterned structures. The capacity of 
individual components to self-assemble reflects the information regarding shape, surface 
properties, charge and mass, coded within these individual components to determine the 
interactions among them. There must be freedom for the components to move in respect to 
one another, therefore, the process usually occurs in fluid phases or on smooth surfaces.
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The process of self-assembly is reversible as it involves non-covalent or weak covalent 
interactions, such as van der Waals, electrostatic and hydrophobic interactions [32],
Self-assembly offers some advantages over systems maintained entirely by covalent bonds, 
including a reduction in structural errors in the final product by rejection of defective 
subunits during assembly [33], No system is finite because the assembly is via reversible 
non-covalent interactions, and results in the formation of an energetically and 
economically viable structure. If certain systems, such as the cell, were held together by 
covalent bonds, there would be inherent difficulties associated with this because there 
would be a need for an excessive amount of time required to effect the synthesis of the end 
product, and the synthetic steps would proceed with absolute commitment, since one error 
could risk the functionality of the system [34].
1.1.7 Fluid Mosaic Model
Biological membranes can be viewed as two-dimensional, fluid, asymmetric lipid bilayers, 
which provides a matrix for transmembrane proteins to act as channels for the transport of 
molecules from the cytoplasm to the extracellular medium or visa versa. This concept of 
the fluid mosaic model was established by Singer and Nicolson in 1972, describing the 
lateral and rotational freedom and random distribution of the molecular components in the 
membrane [35]. It was named accordingly because of the fluid nature of the phospholipids 
within the bilayer plane, because the membrane is composed of a heterogeneous array of 
phospholipids, proteins and glycoproteins give the membrane a mosaic structure (Figure 
1.10). The model states that globular proteins alternate with sections of the phospholipid 












(Picture source vwvv. sun. menloschool. org/~cweaver/cells/c/cell_membrane/)
Figure 1.10 Fluid Mosaic Model o f  the cytoplasmic membrane. The matrix o f  the unit 
membrane is composed o f phospholipids, with the hydrophobic hydrocarbon tails directed 
inwards and the hydrophilic groups towards the aqueous medium. Proteins and 
carbohydrates are embedded within the matrix.
Moreover, there have been refinements to the fluid mosaic model since its first proposal 
over the past thirty years, when it became apparent that proteins are not generally floating 
freely in the lipid matrix even when the lipids are in a liquid state. This is because the 
hydrocarbon chains o f lipids near proteins have different configurations to those in the rest 
o f the bilayer. This is to ensure no void regions are formed (Figure 1.11), therefore, the 
packing of the hydrocarbon chains adapts to fill voids, usually by causing membrane 
curvature.
Lipid bilayer >tesral P*°tem
Void region
Figure 1.11 Alterations to the original Fluid Mosaic Model suggest proteins are not free  
floating, since packing constraints impose structural coupling between proteins and 
neighbouring lipids.
Moreover, the Singer-Nicolson model has been substantially revised to include:
• The mobility o f the cell-surface proteins are restricted by lipid-anchored or other 
lipid domains, with the aim to segregate.
• Membrane proteins may co-localize with each other.
13
• Membrane proteins may cluster and are accommodated by lipid rafts organized by 
weak non-covalent interactions.
• Proteins are likely to have an equal importance in determining the constituents, 
structure, and dynamics of membrane domains.
• Free diffusion can occur within domain boarders where molecular interactions do 
not hinder.
The Fluid Mosaic Model developed to classify the membrane as a structure that is heavily 
compartmentalized, quasi-two-dimensional, mosaic and partially fluid [36].
1.2 Poisons, Toxins and Venoms
Living organisms are designed to pass on their hereditary material and reproduce. To do 
this they must be able to defend themselves from predation and assimilate nutrients for 
their own survival and growth. Many living organisms have evolved and developed an 
arsenal of weapons in a bid for survival, whether it be body armour, homs or chemical 
weapons. Many prokaryotes and eukaryotes produce proteins that have toxic properties 
that act towards other living organisms either intentionally or inadvertently. The toxicity 
effects observed from the actions of a particular toxic protein can have an effect on the 
whole organism or a localized action on a particular substructure such as an organ.
The route of delivery into a system distinguishes poisons, toxins and venoms from each 
other. A toxin is a poisonous substance that is injected in some way into the system, and 
venoms are usually defined as biologic toxins that are injected by a bite or sting. Poisons 
are genetically defined as a substance which is ingested or absorbed through epithelial 
linings such as the skin or gut. The Swiss toxicologist Paracelsus, stated that all things are 
poisonous if administered at a toxic dose. Toxins are mainly proteins that are capable of 
producing a detrimental effect on contact or adsorption with cells by interacting with 
biological macromolecules or cellular receptors. The toxicity o f a particular substance 
varies in their mode of action and their severity depending on dose and tolerance to the 
toxin. They vary tremendously in structural complexity, from venoms that contain a range 
of lytic peptides that each target a specific receptor, to relatively simple proteins such as 
the phospholipase groups.
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Biotoxins are substances produced by living organisms, and have two primary functions:
• Predation: snake, spider, scorpion venoms
• Defence: bee, deadly nightshade, poison dart frog venoms
These biotoxins have diverse actions including haemotoxicity that targets red blood cells, 
necrotoxicity that causes necrosis in all tissue types and neurotoxicity that primarily affects 
the nervous system. Toxins are believed to increase the chance of survival and/or 
proliferation and/or spreading of a particular organism in its environment [37], Naturally 
occurring toxins are the product of a long term co-evolution of species sharing the same 
habitat. The evolution of envenomation is believed to have arose in squamates about 200 
million years ago [38]. Moreover, these toxins have developed to selectively hit key 
molecular targets such as the machinery controlling protein synthesis and the cell 
membrane.
1.2.1 Factors Affecting Toxic Response
The fate of a toxin within a biological system is dependant on the dose-response 
relationship, which is defined as the change in effect on an organism caused by differing 
levels of exposure to a particular toxic compound. For a toxin to exert its effects on a 
system it must gain access and circumvent any host defence systems. The first step in the 
toxin action cascade (Figure 1.12) is it must come into contact with the biological system. 
The absorption of the foreign molecule may exert a local effect at the initial site of contact, 
but must gain entry into the organism to insure a systemic effect. The most common access 
route for a toxin is via the gastroinstinal tract, the respiratory tract, and to a lesser extent, 
absorption through the skin. Whatever the initial point of contact for the toxin, it must 
cross the cell membranes, therefore, for the successful penetration of a biological system 
there must be physicochemical constraints imposed, such as size/shape of the toxin, 
structural similarity to endogenous molecules and the charge on the toxin.
Absorption-----------------Distribution -^----------► Metabolism
Excretion
Figure 1.12 Disposition o f a toxin molecule in a biological system can be divided into four 
phases.
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1.2.2 Toxic Response to Foreign Compounds
The stages following the exposure of a cell to a toxin can be divided into primary, 
secondary and tertiary events. Primary events are the result o f the initial damage caused by 
the toxin, such as enzyme inhibition and pore formation. Secondary events result in 
biochemical and/or structural cellular changes observed following the initial damage, such 
as changes in membrane structure, nucleic acid damage and stimulation of apoptosis. The 
final state o f toxicity is the observable manifestations, which can include necrosis and 
apoptosis [39].
1.2.3 Animal Toxins
Toxins produced by animals have evolved for defensive and predatory purposes to ensure 
their survival and reproduction. A common feature o f animal toxins is that most target the 
systems homeostasis and directed towards cell surface proteins involved in essential cell 
functions. They tend to be ligands o f ion channels which are inactivated upon toxin 
binding and interfere with neuronal and/or muscular function, ensuring the immobilization 
o f the predator or prey (Figure 1.13). They are targeted towards receptors and ion channels 
because they are common to the animal kingdom, therefore, the toxins act against a range 
o f animal species. Unlike many of the toxins developed by plant species, animal toxins are 
designed for rapid effect and action, therefore, they have evolved to act at the cell surface.
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Venomous animals can be grouped into non-biting/non-stinging and biting/stinging 
animals depending on their route of venom administration. A range of taxonomic phyla 
possess venom that is not administered via biting and stinging, including invertebrates, 
amphibians, and fish.
The injection of venom by means of a sting or a bite are common amongst the reptiles and 
invertebrate. A bite is described by venom injection via structures associated with the 
mouth, such as fangs or mandibles, and stings signify the injection of venom via a 
posterior structure. Venom associated with feeding organs have developed for handling 
prey and designed to instigate paralysis, tissue destruction and death of the victim. 
Defensive use of these oral structures are only secondary [41]. Moreover, posterior stings 
have evolved primarily for defence, and intended to cause immediate pain.
The invertebrates that have developed the means of biting and stinging to deliver venom 
are widespread. The hymenoptera, which include the honeybee, wasp and hornet, have 
been shown to administer a venomous sting that include phospholipase A2, melittin, and a 
complex range of allergic proteins, active antigens and peptides. These toxins tend to 
stimulate histamine release from mast cells, causing an inflammatory response, including 
vasodilatation and lowering of blood pressure. If histamine is released into the skin, it can 
cause itching and reddening of the area. These localized reactions are self-limiting, and 
spontaneously resolve within a short time.
Snakes primarily use two methods for prey capture, those that constrict their prey and 
those that envenomate. Only around 7% of snakes use venom as their means of prey 
capture [40], and these are taxonomically classified in the families, Elapids, Viperids, 
Colubrids and Hydrohilldae. These snakes use modified saliva, delivered through fangs to 
immobilize or kill its prey (Figure 1.14). Venom serves three primary functions; 1) 
prey/predator immobilization, 2) initiate digestion, and 3) as a lubricant during swallowing. 
Moreover, venom has also been suggested to possess antibacterial properties [42] to ensure 
the upkeep and cleansing of the oral surfaces [43]. The snake venom gland evolved 60-80 
million years ago, and has undergone extensive modifications with the development of the 
front-fanged delivery system [44]. It has been shown that the genes for the various venom 
constituents have been recruited from a range of sources, including from the pancreas and
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from ancestral salivary tissue [45]. It has been proposed, using amino-acid sequences, that 
the ancestral proteins of snake venoms were phospholipases and ribonucleases [46].






(Picture source :/www. searo. who. int/en/Section 10/Section 17/Sect ion 53/Sect ion1024_3895. htm)
Figure 1.14 Diagrammatic representation o f  the venom apparatus
The major constituents (>95% of dry weight) o f snake venom are polypeptides, which 
include enzymes, toxins, and small peptides. More than twenty enzymes have been isolated 
from various species, with 12 common enzymes found in the majority o f venoms [40]. 
Hyaluronidase is present in all snake venoms to facilitate the distribution o f the other 
venom components around the tissues of the predator/prey. Other components present in 
snake venoms include procoagulant enzymes, that stimulate blood clotting factors and the 
formation o f fibrin, thereby depleting their levels leading to un-clottable blood [47]. 
Haemorrhagins, such as zinc metalloproteinases, cause damage to the endothelial lining of 
the blood vessel walls, resulting in haemorrhage. A range o f toxins, including necrotic 
toxins and myolytic toxins cause an increase in membrane permeability and substantial 
damage to cells respectively. The most potent snake venom known is that from the Inland 
tipan [48], which causes systemic neurotoxicity that often results in respiratory paralysis. 
The venom causes the breakdown of skeletal muscle tissues, which leads to acute renal 
failure [49] and cause the hydrolysis o f the cell membranes.
1.2.4 Bacterial Toxins
Animals and plants have developed strategies, through co-evolution with microbes, to 
attempt to defend and ward off the attack from a pathogen. These defences include simple 
physical barriers like the dead cell layers o f skin, waxy cuticles o f  plants, mucus-covered 
epithelia, antimicrobial peptides and the immune response [50]. However, bacterial 
pathogens have also evolved strategies to circumvent these defences through the 
development and acquisition o f virulence factors. Bacteria have developed a range o f
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strategies to ensure their survival and modification of the host physiology to promote their 
multiplication and spread (Figure 1.15). Only around 10% o f bacterial species are 
pathogenic to humans and animals, and not every species in a genus is pathogenic and not 
every strain o f each pathogen causes disease [51]. Some virulence factors employed by 
certain pathogens include factors that neutralize host defences and factors that cause the 
destruction o f the host cells. Toxins produced by bacteria act differently to those produced 
by animals, and do not need such a rapid action. Bacterial toxins are not a defensive 
mechanism employed by bacteria, but are virulence determinants engaged to gain access to 
environments to sequester nutrients, to multiply, and for transmission to new environments 
when resources are expended.
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Figure 1.15 Fitness factors found in pathogenic bacteria. (LPS = lipopolysaccharide) [50].
The development of bacterial toxins is believed to have occurred during the co-evolution 
between bacteria and unicellular eukaryotes during the past 1 billion years. This is 
supported by the fact that numerous virulence factors attack host cell proteins, molecules 
and structures present in all eukaryotic cells [50]. Moreover, it is probable that these 
virulence factors served to paralyze unicellular eukaryotes and were later adopted by 
pathogenic bacteria. Certain human restricted pathogens, such as Streptococcus pyogenes, 
must have adapted to their hosts in the 1 million years during the emergence o f humans. 
The bacterial genome consists o f the core genes that encode fundamental pathways and 
essential structural features such as cell wall components and ribosomal RNAs. The other 
part o f the bacterial genome is the flexible genetic elements, which encode variable 
determinants that provide some type o f selective advantage under specific conditions, such 
as infection and growth in specific niches. These housekeeping genes frequently consist o f 
various mobile genetic elements, such as plasmids, bacteriophages, insertion sequence 
elements and transposons [52] coding for antibiotic resistances and toxins. Horizontal gene 
transfer allows for the transfer o f genetic material between two unrelated organisms and 
therefore, the exchange o f virulence factors between unrelated species.
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Bacterial toxins alter the normal metabolism of the host cells with deleterious effects to the 
host [53], and are often responsible for the symptoms associated with the bacterial 
infection. Toxins are categorized according to their site of action, and are broadly grouped 
as exotoxins that modulate intracellular targets and the endotoxins and membrane- 
damaging toxins that act on the cell surface. However, all bacterial protein toxins must first 
interact with the cell membranes.
1.2.4.1 Bacterial A-B Subunit Enterotoxins
Enterotoxins are soluble proteins secreted into the surrounding medium by the bacterium, 
where it circulates around the host and attaches to receptors on the surface of sensitive 
cells. Bound enterotoxins can become internalized into the host cells where they are 
capable of modifying the intracellular target through covalent mechanisms. Bacterial 
enterotoxins vary in specificity, and can either act on a wide range of cells and tissues or 
only act on specific cells. These toxins share a common structural feature of consisting of 
two distinct non-identical protein moieties or subunits, the A domain and B domain. The 
fundamental property of these enterotoxins is for the B domain to bind to the cell 
membrane and specifically deliver their A subunit into the cytosol of the target cell. The 
internalization of the toxin occurs by receptor-mediated endocytosis, whereby the B 
domain binds to the receptor on the cell membrane and utilizes the host cells endocytotic 
pathway to become enclosed in an endocytic vesicle generated by the invagination of the 
cell membrane. The internalized toxin within the endocytic vesicle matures and acidifies, 
causing a conformational change in the B domain, which inserts into the endosome 
membrane to generate a pore that is involved in the translocation of the A domain into the 
cytosol [54]. The A domain possesses the enzymatic activity specific for each toxin, 




Figure 1.16 Bacterial toxins that modify intracellular host proteins. Exotoxins bind to 
receptors (R) on the surface o f  host cells and are endocytozed. After it matures, the 
endosome acidifies, causing a conformational change in the B domain, which inserts into 
the endosome membranes to generate a pore fo r  the translocation o f  the A domain into the 
cytosol [53].
Many bacterial species have evolved subunit toxins to cause pathogenicity, including 
Corynebacterium diphtheriae, Pseudomonas aeruginosa and Vibrio cholerae (which will 
be described in chapter 5).
1.2.4.2 Bacterial Cytolytic & Membrane-Permeating Toxins
Surface-acting toxins exert their actions by binding to the cell membrane and modify the 
host cell physiology without having to be endocytosed and enter the intracellular space of 
the host cells. The membrane permeating toxins are largely grouped into two classes: the 
lipases and the pore-forming toxins. The modulation o f the host cell physiology can affect 
host cell signalling or directly damage the cell membrane. Any non-selective fluxes o f 
ions, fluid and small molecules, disrupts the cells equilibrium and will generally induce 
cell death. Most of the toxins are produced and stored as an inactive form (protoxins). 
These protoxins are activated by a chemical modification step, such as the cleavage of a 
terminal site, and this increases the affinity for the membrane [37].
Pore-forming toxins (PFT) represent more than one third o f all bacterial toxins, and are 
believed to act extracellularly to release nutrients useful for the pathogens growth and 
reproduction [54]. Toxins that generate defects, channels, or pores in the cell membrane 
provide a route for the unregulated flux o f small solute molecules and fluids. Therefore, the 
toxins must be amphipathic in nature because the lumen o f the channel is in contact with 
the water, and the other domain is in contact with the non-polar lipid domains. For the
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cytotoxicity of a toxin to be satisfied, the toxin must bind to sensitive cells with high 
affinity. At this stage, conformational changes take place so that the toxin can reoriented 
and penetrate into the membrane. This is governed by the cell membranes physical 
properties, and is dependant on phospholipid species, sterol content, and membrane 
defects. The bound toxin molecules laterally diffuse, oligomerize to ensure that the non­
polar domains of the cell membrane are shielded from the medium, and to generate a 
channel from the extracellular membrane through to the cytoplasmic face of the cell 
membrane (Figure 1.17). Pore-forming toxins make membranes more permeable to water, 
and if excessive influx occurs, the cells swell and lyze. If flux is not excessive, cellular 
damage occurs by perturbation of the permeability barrier that causes the leakage of ions 
needed for cell viability. This means of non-enzymatic damage uses a mechanism similar 
to that of the membrane attack complex of the complement system to neutralize the threat 
from invading pathogenic bacteria during the immune response [53].
Binding to the host cell surface often involves a receptor-toxin association because the 
toxins are generally secreted at low concentrations into an environment that is rapidly 
cleared of foreign materials. Therefore, many pore-forming toxins rely on ubiquitous or 
widely distributed receptors as their targets for binding, such as phosphatidylcholine and 
cholesterol, both of which are the major constituents of animal cell membranes. Receptor 
preference ensures toxins bind to host cells and avoid self-interactions by binding to 
receptors uncommon in their own cell membranes [55]. The small hydrophobic sequence 
that each toxin monomer contains is not large enough to form a channel. Oligomeric 
complexes ensure enough hydrophobicity to insert into the target membrane to begin to 
form a stable structure. Lipid domains, in which the receptors for the binding of the p-PFT 
monomers facilitates oligomerization by concentrating the receptors in specific areas.
22
Monomer




Figure 1.17 Steps leading to the formation o f a pore by a f3-pore forming toxin, such as 
Staphylococcus aureus a-hemolysin. Soluble monomers bind to the cell membrane and 
oligomerize on the cell surface forming a non-lytic heptamer. The oligomer inserts the 
stem into the lipid bilayer, generating a transmembrane channel, allowing the flux o f  ions 
and small molecules (-1000 molecular weight).
1.2.5 Endogenous Cytotoxic Peptides and Their Role in Disease
Some proteins and peptides found naturally in the body can cause detrimental effects as a 
result o f improper regulation, misfolding and accumulation to toxic levels. Proteins or 
peptides which usually perform necessary functions can become toxic if  improperly 
controlled or not recognized as “se lf ’.
1.2.5.1 Diseases Caused by the Folding and Misfolding o f Proteins
Protein folding is strictly regulated, because abnormal proteins are extremely harmful to
cells. Such proteins can originate from mutations, unbalanced subunit synthesis, and
damaging conditions such as oxidation. Folding o f proteins can take place in the cell
cytosol, but the vast majority takes place in the endoplasmic reticulum (ER). This
organelle also performs pivotal quality control to ensure proteins are correctly folded, and
any misfolded proteins can be re-routed for degradation. The quality control o f protein
folding is not error free because having some flexibility allows for protein evolution [56].
Other proteins or fragments o f proteins can cause toxicity by converting from their 
normally soluble forms to insoluble fibrils, which accumulate in a variety o f organs 
including the brain, liver and spleen [57]. These insoluble fibrils act as seeds for the 
formation o f amyloid plaques, as misfolded/abnormal proteins aggregate via hydrophobic 
interactions [58], and causes clinical conditions termed amyloidosis. This group o f diseases
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include Alzheimer’s (as detailed in chapter 6 ) and Parkinson’s disease, Prion diseases such 
as Creutzfeldt-Jakob disease, and type II diabetes (non-insulin dependant). It has been 
shown that pancreatic amyloid deposits composed of the islet amyloid polypeptide (LAPP) 
are found in nearly all type II diabetes patients [59], and their cytotoxic actions are 
associated with the progression of pancreatic p cells death. It has been suggested that IAPP 
is normally produced by the islet cells in the pancreas to oppose the actions of insulin in 
the peripheral tissues [60], but its polymerization into amyloid deposits causes the 
cytotoxic destruction of the islet cells leading to disrupted glucose and hormone passage 
from the islet cells.
Protein aggregation is a consistent feature of many neurodegenerative disorders, including 
Parkinson’s, motor neuron, and Creutzfeldt-Jakob diseases. These disorders are 
characterized by the accumulation of high-ordered insoluble fibrils, and the species of 
protein aggregate determines which neurones are pathologically affected and what clinical 
symptoms arise form each protein. It is not known whether protein aggregates are 
themselves toxic to cells or whether they are the result of an underlying molecular factor. 
These late-onset, slow-progression disorders result in a gain-of-function associated with 
abnormally folded forms of the proteins formed under conditions that stabilize a partially 
folded structure [61]. Progressive neuronal dysfunction is followed by eventual neuronal 
loss. Protein fibril formation is either believed to be a contributory factor in cell death or is 
an inseparable epiphenomenon [62]. However, very little information is known regarding 
what makes certain proteins prone to aggregate. In vivo, the cell uses chaperone proteins to 
assist in protein folding under physiological and stress conditions. Chaperones associate 
with the nascent polypeptides as they emerge from the ribosome, promoting correct folding 
[63]. However, protein folding is not error free. Chaperones are also enrolled in the 
translocation of proteins across the membranes, helping protein complex assembly and 
disassembly, and suppress protein aggregation [64]. Unfolded or misfolded proteins tend to 
have exposed hydrophobic domains that render them prone to aggregate, and it is assumed 
to be the passive process of self-assembly that drives mass-action [63]. Therefore, the cell 
has developed a mechanism to avoid protein aggregation by ensuring proteins are kept 
soluble by molecular chaperones or are quickly degraded by the covalent attachment to 
ubiquitin, which earmarks the abnormal protein for proteolysis by the proteasomes [65]. 
During the pathological aggregation of proteins, the levels of abnormal proteins is believed 
to exceed the cells ability to maintain them in soluble form [64], Protein aggregation
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directly impairs the function of the ubiquitin-proteasome system [6 6 ], thereby further 
limiting the cell’s ability to dispose of protein aggregates and allowing their continued 
pathogenicity. The late on-set o f diseases associated with protein aggregation suggests that 
the gradual decrease in the efficiency of the ubiquitin-proteasome system is associated with 
aging [61]. In vivo studies to determine whether protein aggregates are directly pathogenic 
to cells or the result of an underlying mechanism is unclear, but one study by Bence et al 
reported that protein aggregation directly impairs the function of the ubiquitin-proteasome 
system (UPS), thus leading to the accumulation of ubiquitin conjugates and cell cycle 
arrest [6 6 ]. The commitment of the proteasome to the ubiquitylated aggregates without 
being able to unfold or degrade it would ensure the proteasome is unavailable for 
degrading other abnormal proteins. As a result of a decline in UPS activity, aggregated 
proteins continue to accumulate, slowly leading to the characteristic progression of many 
neurodegenerative diseases.
1.2.5.2 Diseases Caused by Inflammation
Inflammation is the non-specific biological response of vascular tissues to any noxious 
stimulus, such as pathogens, physical damage or chemical irritants. It is a protective 
response designed to initiate healing by attempting to remove the foreign stimulus from the 
organism. A single finite event, such as a bee sting, causes a self-limiting and localized 
response. Whereas, a complex sustained response involving the whole organism is initiated 
when the foreign stimulus can not be removed, is not recognized as truly foreign, or is 
perceived as foreign but is in fact “self’, such as the development of rheumatoid arthritis. 
An inflammatory response is a cascade that follows an essentially uniform course of 
events, with different types of injury and varying degrees of damage leading to variations 
in the intensity and duration of a particular aspect of the cascade.
Two forms of inflammation exist; acute and chronic inflammation. An accute 
inflammatory response cascade is triggered involving the local vascular system, the 
immune system and various cells within the injured tissues (Figure 1.18). The initiation of 
the inflammatory response by a stimulus causes the blood vessels at the site to exude 
plasma proteins and leukocytes into the surrounding tissue, causing the characteristic 
swelling associated with inflammation. The microcirculation responds to the injury by 
increased blood flow to the site of inflammation, causing reddening and heat. Histamine is 
the first inflammatory mediator to be released after injury, causing increased vascular
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permeability. Polymorphonuclear leukocytes accumulate at the site o f inflammation to 
phagocytoze the stimulus. They also release enzymes that cause damage to the tissues. 
Down regulation of the inflammatory response is achieved after the injurious stimuli have 
been removed.
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Figure 1.18 The acute inflammatory cascade, when the stimulus is removed and 
inflammation response is down regulated.
Chronic inflammation may develop as a progression from acute inflammation if the 
original stimulus persists or after repeated episodes o f acute inflammation. The purpose o f 
chronic inflammation is to clear necrotic debris produced during the acute inflammatory 
processes, to provide defence against persistent infections, and to heal and repair the 
damage to the tissues [67]. It is characterized by infiltration o f mononuclear immune cells, 
such as macrophages and lymphocytes, tissue destruction and attempts at healing, which 
include fibrosis. Chronic inflammation may also occur if  the host tissue is modified and 
new antigenic determinants are produced following the release o f lysosomal enzymes by 
phagocytic cells. This causes the endogenous antigen production, and thereby initiates 
chronic inflammation and an auto-immune response against self-antigens. The introduction 
o f a foreign antigen initiates a cascade whereby T-lymphocytes begin by recognizing the 
antigen. The activated T-lymphocyte begins to produce lymphokines to direct the immune 
system response by signalling between its cells and attracting other immune cells. The 
monocytes phagocytoze the foreign stimulus and damaged tissues so that new tissue can be 
generated in the area of inflammation for normal function to resume.
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Typically, inflammation is a beneficial response. However, if the inflammatory processes 
are not stringently regulated or failure to eliminate the noxious stimulus, prolonged local 
cell injury and trauma occurs. As chronic inflammation proceeds, additional inflammatory 
cells are recruited to the site of inflammation, resulting in the release of more inflammatory 
mediators.
Phospholipase A2 (PLA2) are lipolytic enzymes which play an extensive role in the 
cascade of many acute and chronic inflammatory diseases (as discussed in chapter 4). They 
liberate important precursors o f inflammatory mediators, secondary messengers and 
membrane remodellers [6 8 ], from the hydrolysis of phospholipids to free fatty acids and 
lysophospholipids.
Elevated levels of PLA2 have been extracted from various tissues suffering from 
inflammation, including the body fluids of patients suffering from acute pancreatitis and 
the synovial fluid from arthritic joints [69]. Patients suffering from severe necrotizing 
acute pancreatitis show increased levels of serum PLA2-II and highly disturbed renal 
function [70]. The role of PLA2 in arthritis has long been established. Considerable PLA2 
catalytic activity has been observed in the synovial fluids that acts to reduce friction 
between the articular cartilage and other tissues in joints, from patients suffering from 
rheumatoid arthritis [71]. Rheumatoid arthritis is considered a chronic, inflammatory auto­
immune disorder that causes the immune system to attack the joints. It is a disabling and 
painful inflammatory condition, which can lead to substantial loss of mobility due to pain 
and joint destruction. Elevated levels of circulating PLA2-II have been shown to correlate 
with disease activity in adults and juvenile rheumatoid arthritis [72].
1.3 Monitoring Molecular Interactions
The need to monitor molecular interactions, both quantitatively and qualitatively, between 
an analyte and a ligand is high priority in both understanding the mechanism of biological 
interactions and to facilitate the discovery of novel methods and materials for therapeutics 
and diagnostics. The commercial applications of monitoring molecular interactions extends 
from health care through to applications in vetinary, agricultural and industrial analysis, 
and pollution monitoring [73].
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The monitoring of biological interactions uses a combination o f a recognition step and a 
transducer step (Figure 1.19). The recognition step involves a biological element, such as 
an antibody or enzyme receptor, on the surface that can recognize biological or chemical 
analytes in solution or in the atmosphere. The biological element can either catalyze a 
chemical reaction, such as an enzyme, or specifically bind the analyte, such as an antibody. 
It is possible to use various biological components as receptors, therefore providing many 
different applications. The major types o f biological molecules and systems used as 
receptors include antibodies, enzymes and whole cells [74]. The receptor is connected to or 
integrated into a transducing element that converts the analyte-receptor reaction into a 
quantitative electrical or optical signal. Various transducers can be used to construct the 
receptor-analyte monitor, including optical (fluorescence, absorbance), electrochemical 
(potentiometric, conductimetric), calorimetric, acoustic, and mechanical [74]. Therefore, 
with an increasing number o f receptor and transducer options, there is increased flexibility 
in the type o f monitor and their applications. The high level o f specific biological 
recognitions between binding partners and a high degree o f sensitivity are critical 
parameters sought-after in the development o f these devices. The specificity o f the devices 
is emphasized, and allows it to be used in complex media such as blood, serum, 













Figure 1.19 Principle o f  operation o f  a typical biological spectrometer.
1.3.1 Monitoring Molecular Interactions Using Optical Techniques
Optical spectrometry devices involve determining changes in light absorption or reflection
between the reactants and products, or measuring the light output by a luminescent
process. This analytical method is becoming increasingly widespread and described in over
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4,000 publications (data obtained from SciFinder Scholar 02/05/2007). The use of optics in 
spectroscopic techniques including, absorption and reflection spectroscopy, chemi- and 
bio-luminescence, fluorescence spectroscopy and evanescent wave techniques.
The sensitivity of these techniques, relates to the smallest concentration o f analyte that can 
be detected or the degree of discrimination between the desired analyte and potential 
contaminants [76]. Optics provide a means of constructing a device with high sensitivity, 
while the specificity is determined by the biochemistry of the receptor/ligand interactions. 
Therefore, an optical spectroscopic device provides a means of sensitive quantitative 
analysis of molecular interactions.
1.3.2 Using Evanescent Waves as a Means o f Monitoring Molecular Interactions
The use of the evanescent wave in optics allows for monitoring of molecular interactions
and events at the surface. An evanescent wave is formed when sine waves are internally 
reflected off an interface (internal reflection element) at an angle greater than the critical 
angle, causing total internal reflection (see section 2.1 Surface Plasmon Resonance 
Spectroscopy). Therefore, receptor-ligand events can be monitored as changes in the light 
intensity caused by complex formation. The evanescent wave technique can be used to 
directly monitor the interactions between receptors and their analytes at the surface in real­
time. This system is employed in attenuated total reflection (ATR) and surface plasmon 
resonance spectroscopy. The evanescent wave can also be used to indirectly monitor 
interactions at the surface by employing the wave to excite fluorescently labelled 
molecules.
The use of the evanescent wave technique in spectrometry design has become widespread, 
and has been adapted for various monitoring and sensing needs. This technique has been 
employed to detect small variations in the sequence of nucleic acids [77], where a capture 
probe is immobilized on the surface, and the hybridization with a fluorescently-labelled 
complementary strand can be monitored by fluorescence detection. The commercial 
significance of this development allows for the detection of point mutations for the 
diagnosis of genetic diseases and for the detection of specific genomic sequences of an 
infectious disease. In line with the health-care benefits, the application of the evanescent 
wave has been used for pesticide detection, where high toxicity of pesticides and their 
widespread use in agriculture represents a general danger for environmental welfare.
29
Screening for pesticide residues in drinking water is stringent, and the optical evanescent 
wave technique allows for the sensitive and specific monitoring of pesticide concentration 
[78]. The detection of pathogenic bacterial using conventional biochemical diagnostics and 
molecular screen can be laborious and potentially dangerous to the patient if treatment is 
not provided quickly. Therefore, the development of a real-time monitor would improve 
the speed with which the patient can be treated. Moreover, the detection of bacterial toxins 
could also be beneficial for screening of food-borne toxins such as Clostridium botulinum 
toxin. Fluorescently labelled antibodies specific for C. botulinum have been covalently 
attached to the surface and the botulinum toxin detected in real-time and at concentrations 
as low as 5ng/ml. The reaction showed high specificity and no response was observed 
against tetanus toxin [79].
Covering an internal reflection element with a thin metal layer causes the evanescent field 
wave to excite the quasi-free electron gas in the metal film. Exciting the plasmons in the 
metal film by a laser causes amplification of the surface wave by -50 fold compared to 
ATR. This amplification of the surface wave is dependant on the metal and thickness of the 
film. The sensitivity of reflectance change decreases when a thick chromium film or a thin 
gold film is employed, and the linear range becomes narrower as the thickness of the metal 
films increases. The sensitivity and linear range of the resonance angle shift are not 
affected by the thickness variation of the metal films [80]. The enhancement field effect 
increases the sensitivity of the IRE since the angular position of the resonance minimum 
becomes more sensitive to changes in the refractive index of the metal/dielectric interface. 
Given that the resonance energy only propagates a few hundred nanometres from the metal 
surface into the dielectric, it is susceptible to the thickness of the films absorbed on the 
surface. Therefore, depositing a metal film at an optimal thickness (~50nm) ensures good 
amplification of the surface wave, good sensitivity to reflectance change, and maximising 
the penetration depth of the resonance energy into the dielectric. The use of this enhanced 
evanescent wave technique for quantitative and qualitative observations at the surface has 
been employed in Surface Plasmon Resonance Spectroscopy (SPS), and its theoretical 
background is described in chapter 2 .
The first optical spectrometer based on Surface Plasmon Resonance (SPR) was described 
in 1982 [81], to monitor the change in refractive index caused by the adsorption of human 
y-globulin IgG on a silver surface and its resultant interactions with the y-globulin IgG
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antiserum in a concentration dependant manner. This led to increased interest in the use of 
SPR as the basis of biosensors and monitors for analyzing processes occurring at or near 
the surface. SPS can be used to determine physical parameters including organic vapour 
concentration gradients to monitor air density and ammonia concentration [82]. The 
kinetics of adsorption and structure of bio-adhesive films has been monitored using this 
technique [83], and could be beneficial for determining the efficiency and reliability of bio­
adhesives for use in wound healing and tissue repair. An interest in the construction and 
monitoring of organized organic mono- and bilayers on metal surfaces by self-assembly 
using SPS have grown considerably. These layers show marked stability to chemical 
conditions and give uniform, controllable and known thickness dielectric films. Tailoring 
the surfaces of these devices by processes of self-assembly to form organized systems 
allows the economical development of sophisticated detection systems and ensuring a 
native and non-denaturing environment for receptors, proteins and ligands at the surface.
An inherent problem with SPR-based devices is their cost, large dimensions and 
complexity [84]. Miniaturization using nanotechnology and microelectronics is an 
attractive objective to produce a portable and cost-effective device. Commercially 
available portable SPR devices have been developed to detect Escherichia coli 0157:H7 
for use in the food industry [85], Staphylococcus aureus enterotoxin [8 6 ] and 
environmental pollutants [87].
1.3.3 Using Evanescent Wave Enhanced Fluorescence as a Means to Monitor Molecular 
Interactions
One of the key advantages of SPS is it allows for label-free detection of binding events, 
whereby the presence of bound analyte at the interface generates a change in the optical 
properties of the surface. However, a major disadvantage of using SPR for bio-analytical 
applications is that low concentrations of the analyte cannot be detected, with a 
detectability of approximately l-10nmol.dm*3 for a 20kDa molecule [8 8 , 89]. Sensitivity 
and detection problems also arise if the analyte has a very low molecular mass. Therefore, 
the development of strategies for improving the detection limit and sensitivity of SPR must 
be considered.
The first device to use the evanescent wave to excite a fluorophore was employed in 1975 
to determine the concentrations of phenyl arsenic acid and morphine [90]. Totally
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internally reflected light was used to excite fluorescein labelled antibodies which had 
become bound to a hapten-protein conjugate adsorbed on a quartz-plate in an antibody 
solution. The evanescent field excited fluorescent molecules close to the surface, and this 
excitation can be enhanced if the fluorescent molecule is placed near to a metal film. The 
metal causes an enhancement o f several orders o f magnitude because the local field at the 
molecule is increased by the dipole field of the resonant plasmon [91]. Metal-enhanced 
fluorescence is caused by the metal concentrating the local electromagnetic field and 
subsequently increasing the rate o f excitation [92]. Moreover, the nearby metal can 
increase the intrinsic radiative decay rate o f the fluorophore, thereby, modifying the rate at 
which the fluorophore emits photons [93]. The prospect o f combining the best features of 
the direct SPR device and indirect fluorescence techniques, led to the development o f an 
indirect SPR fluoroimmunoassay (SPRF) technique [94], and its enhanced sensitivity was 
demonstrated by assaying for human Chorionic Gonadotrophin (hCG) in serum.
The excitation o f fluorophores in the evanescent field o f the plasmons is distance 
dependant, and an optimal distance to the metal exists at which maximal fluorescence 
excitation is observed. The direct interaction between the metal film and an adsorbed dye 
molecule can result in an enhancement o f fluorescence intensity depending upon the metal 
film thickness, which was determined to be in the range o f between 45-70A depending on 
the fluorescent species (Figure 1.20). On metal films above 200A quenching o f the 
fluorophore occurs via energy transfer to the metal surface, and the excitation energy is 
dissipated in the metal.
NILE BLUE ON A« 
(VERT SCALE « 1 0 )
g 0008
£ 0000 > NILE BLUE ON Au 
(VERT SCALE ■ 1 )
NILE BLUE ON Cu 
(VERT SCALE * 0
Q002
100 ISO 20050
MASS THICKNESS OF FILM A
Figure 1.20 Luminescence intensity o f  various dye molecules on varying thicknesses o f  
silver metal films [91 J.
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The desired situation for fluorescence enhancement is achieved when the chromophores 
are located close enough to the metal to be excited by the evanescent wave, but are 
decoupled to ensure no loss of fluorescence intensity by quenching processes is observed.
To ensure bound fluorescent analytes are within the exponentially decaying evanescent 
fields, it was proposed to develop specific interfacial supamolecular structures to maintain 
optimal fluorescence enhancement working distances [95]. Self-assembled support layers 
on the metal surfaces have been used [96] to fimctionalize the surface.
SPFS has recently been employed to detect various cardiac markers, such as myoglobin, 
for the early detection of acute myocardial infraction [97]. This immunoassay enabled 
enhanced fluorescence detection of myoglobin over a range of concentrations from 
subnormal to elevated levels of the cardiac marker.
The combination of the surface-sensitive technique, SPR and fluorescence detection 
enables a highly sensitive analytical tool to probe molecular interaction close to the 
surface.
1.4 Constructing an Artificial Cell Membrane and its Uses
Various strategies have been employed to immobilize biological molecules onto a surface.
The direct physisorption encounters inherent problems with lack of orientational control of 
the adhering molecules, and a decrease in biological activity. Non-specific binding of a 
protein can become a major problem leading to large background signals. Therefore, more 
sophisticated strategies using support layers and scaffolds have been used in an attempt to 
have better control over the immobilization procedures. Poly-L-lysine provides a simple 
and convenient method for adhering negatively charged macromolecules and biological 
entities. Poly-L-lysine (PLL) coated surfaces provide a positively charged surface [98], and 
has been extensively employed in the attachment of mammalian cells to surfaces. It has 
recently been used for the development of bacterial-based micro-scale medical diagnostic 
tool [99], whereby, Escherichia coli and Pseudomonas sp. have been selectively attached 
to the solid surface using PLL. A direct covalent attachment between proteins and a 
surface using poly(ethylene glycol) linkers has been reported. It is well-known for its 
ability to prevent non-specific interactions and also act as hydrophilic spacers minimizing 
any detrimental interaction between the attached protein and the solid surface [1 0 0 ].
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Control over the orientation of the attachment requires two unique and mutually reactive 
groups on the protein and the support surface. Surface hydrolysis of polyester scaffolds 
was developed as a convenient technique to promote protein adsorption for improving cell 
attachment. Hydrolyzed or spontaneously hydrolyzable surfaces display a pronounced 
fibrous structure, ensuring greater protein absorption compared to the smooth non­
hydrolyzed polyester surfaces [101]. Recently, open-pore mesoporous TiCVNafion® film 
have been shown to provide a surface which allows fast diffusional access into the porous 
structure and could be employed as a host to study proteins and enzymes [1 0 2 ].
1.4.1 Self-Assembled Monolayers
The use of functionalized Self-Assembled Monolayers (SAM) provides an attractive 
alternative for the deposition of biological molecules onto surfaces. An organic thin film 
can be deposited on a solid substrate by various techniques such as thermal evaporation, 
sputtering, electro-deposition, molecular beam epitaxy, adsorption from solution, 
Langmuir-Blodgett (LB) technique, and self-assembly. The two most widely used methods 
for molecular layer deposition on solid surfaces are Langmuir-Blodgett and self-assembly, 
which both provide a means of producing an ultrathin organic film onto a surface as a 
support layer.
Certain characteristics are desirable for the adsorption of biological entities to surfaces, and 
include; a high surface-density of active molecules, the absence of non-specific binding, 
and stability and durability of the support layer [103]. Langmuir-Blodgett films (LB films) 
are constructions of high-density monolayers and multilayer transferred from the water-air 
interface onto a solid surface. LB films produce ultrathin layers of uniform thickness with 
specific internal structure, and allow for the arrangement of molecules in a fixed 
configuration which would not spontaneously come about. The process of LB film 
formation occurs in two distinct steps (Figure 1.21). The initial stage of film formation is 
the creation of a single layer of molecules, or monolayer, on a water surface. Reduction of 
the area of the water surface ensures the molecules are forced together to form a densely 
packed homogenous layer and eliminate any voids. The uniform monolayer is then 
deposited onto the substrate, which can be repeated any number of times to build up a film 
of accurately defined thickness, or constructing superlattice structures by depositing 
monolayers of different materials [104]. A constant surface pressure is maintained on the
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film as the glass is raised through the surface, and the surface pressure causes surfactants to 
transfer from the water and onto the glass [105].
LB films do show drawbacks in their production, including limited high temperature range 
and a slow rate o f deposition which is easily perturbed by small levels o f contaminating 
materials. In spite o f their limitations, these films have been extensively used in nano­
electronics for the construction o f miniaturized components, the construction o f artificial 
cell membranes and in semiconductor devices such as sensors because o f their insulating 
properties [106].
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Figure 1.21 Steps in the Langmuir-Blodgett technique: (a) spreading (b) compression (c) 
transfer o f  primary monolayer (d) subsequent down stroke (e) subsequent upstroke [104].
SAMs form by the spontaneous and reversible absorption of amphiphilic molecules in an 
organic solvent onto a substrate [103, 107] forming a 2D arrangement on the surface. The 
initial driving force for the self-assembly of surfactants is the chemical affinity between the 
absorbents and the surface. A molecule capable o f forming a SAM comprises a head group 
that ensures the chemisorption o f the surfactant onto the substrate surface. The pinning o f 
the head group to a specific site on the surface occurs through a chemical bond resulting in 
a very strong molecular-substrate interaction. This bond formation can be covalent in 
nature, such as the Au-S bond in the case between alkanethiols on gold, or ionic in nature, 
such as between -CC>2*Ag+ bond between carboxylic acids on AgO/Ag. This chemisorption 
results in an exothermic interaction, whereby the molecules try to occupy every available 
binding site on the surface by compacting the existing bound absorbents. This suggests that 
the amphiphiles retain a level o f mobility prior to the final pinning to the surface. The alkyl
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chain comprises the second molecular part o f the surfactant. The formation of ordered and 
closely assembled layers occurs, resulting in the formation o f van der Waals interactions 
between the alkyl chains. The tail-to-tail interactions creates lateral interchain interactions 
causing the alignment o f the molecules parallel on the surface and creating a crystalline 
film. The final molecular part o f the surfactant is the terminal functionality (Figure 1.22), 
and can vary in complexity, such as simple methyl groups, simple hydroxyl groups and 
complex biotin moieties. The tail group exerts the most direct influence on the interfacial 
properties o f the films, therefore, provides an attractive route for tailoring the structure of 
the interface by introducing additional steric and electrostatic interactions.
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Figure 1.22 Schematic o f  the constituent parts o f  a surfactant that forms a self-assembled 
monolayer, and the forces involved in forming a stable and organised structure.
Commonly paired substrate-absorbents used to generate SAMs include: (/) carboxylic 
acids on aluminium oxide or silver, (if) alcohols, amines, and isonitriles on platinum, (iii) 
alkylsilane derivatives on hydroxylated surfaces, (iv) dialkyl sulfides and dialkyl disulfides 
on gold, and (v) alkanethiols on metals such as gold, silver and copper, and non-metals 
such as gallium arsenide and indium-tin oxide [108]. This provides an attractive system 
because o f the ability to form a flexible structure, with the capacity to incorporate various 
groups whether in the alkyl chains or in the terminal group, ensuring a variety o f surfaces 
capable o f specific interactions. An attractive feature o f SAMs are their ease o f preparation 
either from solution or the gas phase, they are precisely orientated, densely pack structures, 
and show an ability to tune the thickness and surface properties o f  the films using standard 
organic synthetic techniques [108].
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The most studied system using SAMs is that of an alkanethiolate monolayer on an Au 
( 1 1 1 ) surface, because the gold is particularly chemically inert and permits the formation 
of reproducibly well defined SAMs. Gold also forms no stable oxides under ambient 
conditions and can form highly specific interactions with sulphur atoms. Gold is also the 
standard because it is easy to prepare thin films by physical vapour disposition, sputtering, 
or electro-deposition. It is also compatible with cells and biological macromolecules 
without causing any evidence of toxicity. Voltammic studies have shown that thiol groups 
are de-protonated upon adsorption to the gold surface [109], as depicted in equation 1.1, 
however, this system is dynamic, therefore, the chemisorption is reversible and must reach 
an equilibrium to maximise the packing density of the thiols.
RSH + Au(s) ^  RS-Au(s) + e + H*
(1.1)
A well packed monolayer of alkanethiols on gold has been reported to allow approximately 
8.3x10'10mol.cm‘2 total organic material to absorb [110]. The formation of a SAM at 
temperatures above 25°C improves the kinetics of formation and reduces the number of 
defects observed in the SAM. The incubation period between the surfactant solution and 
the surface is typically allowed to proceed until equilibrium is reached. It has been shown 
that the kinetics of the monolayer formation occur in a relatively short time scale, but the 
subsequent ordering process is much slower. The initial rapid adsorption is completed 
within 1 min at thiol concentrations below 1 mmol.dm ' 3 to ensure a 80-90% maximum 
coverage [111], and is described by diffusion controlled Langmuir adsorption. The effect 
of temperature has been shown to be particularly relevant during the initial rapid 
absorption phase to ensure minimum defect formation in the monolayer [112]. The 
chemisorption of the thiol to the gold surface requires the activation of the S-H bond of the 
thiol via a dissociative mechanism [113]. The S-Au bond formed is very strong (-40 
kcal.mol’1) and has been proposed to occur via oxidative addition [114], followed by a 
reductive elimination of the hydrogen by the mechanism:
R -  S  -  H  + Au°„ => R -  S ~ A u +  • A u l  + ' A H i
(1.2)
The sulphur atoms of the bound thiols form a symmetrical hexagonal coverage (Figure 
1.23a), whereby the sulphur atoms have a S—S spacing of 4.97A, and a calculated area of
21.4 A per molecule [107]. This ensures a central bonding habit between the thiol and the 
gold to form a (V3xV3)R30° overlayer , where R = rotation (Figure 1.23b). The tilt of the
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alkyl chains acts to minimize their spacing between neighboring chains, ensuring optimum 
surface coverage.
Au(Ul)
Figure 1.23 (a) Structure o f  a SAM o f thiols on Au(l l l ) ,  arranged in a hexagonal close- 
packed arrangement with the thiol hexagonal ( V3xV3)R30° overlayer structure, and (b) 
side view, where the absorbents are packed 5A apart with their alkyl chains tilted 30° from  
the surface normal in a trans-extended conformation.
The subsequent step in SAM formation is the surface crystallization process, where the 
alkyl chains move from a disordered state to form a two-dimensional crystal. The slower 
process o f additional adsorption and consolidation involves the displacement of 
contaminants, expulsion o f included solvent from the monolayer which alters the 
interactions between the hydrophobic surface and the surfactant by changing the wetting 
properties o f the surface [115], and lateral diffusion on the surface to reduce defects and 
enhance packing. The final ordered film is reached within 16 hours [116]. The kinetics of 
the second step are governed by chain-chain interactions (van der Waals and dipole-dipole) 
and the surface mobility o f the chains. The kinetics o f the second step in SAM formation is 
faster for longer alkyl chains (chain length «>10) because of the increased van der Waals 
interactions [116]. Moreover, the kinetics o f absorption are strongly dependant the 
introduction o f large functional groups within the alkyl chains. Molecules that have their 
longer alkyl-chain portions above the functional group (i.e., closer to the monolayer-air 
interface) form monolayers faster than those that have them below [117]. It can therefore 
be suggested that the length o f the upper alkyl chain provides a strong driving force for 
monolayer formation by maximizing the van der Waals interactions. The defects and 
variability within a SAM can arise from the presence o f contaminants, either absorbed 
from solution or pre-absorbed onto the substrate, and can influence the absorption kinetics 
since the thiols must ultimately displace the contaminants to chemisorb [118].
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1.4.2 Supported Lipid Bilayers & Hybrid Lipid Bilayers
Phospholipid bilayer vesicles can adsorb on SAMs and yield either supported bilayers 
(Figure 1.24a) or hybrid bilayers (Figure 1.24b). The determining organization o f the 
adsorbed vesicles depends on the functional groups presented at the exposed surface. 
SAMs terminated with hydrophilic groups, such as alcohols, promote the formation of 
bilayers supported by the underlying SAM, while hydrophobic SAMs formed from n- 







Figure 1.24 (a) Schematic o f  phospholipid vesicles adsorbed onto a hydrophilic SAM to 
produce a supported bilayer, and (b) a hybrid bilayer form ed due to the hydrophobicity o f  
the SAM layer.
Supported bilayers have been characterized by Atomic Force Microscopy and 
electrochemistry [120], and have been shown to be complex and contain a number of 
defects. The formation o f supported bilayers is a slow process independent o f vesicle 
concentration, due to the need for vesicle rupture and fusion, however, this process can be 
accelerated by using fusogenic agents such as polyethylene glycol [121, 122]. The 
fundamental process o f supported bilayer formation is vesicular fusion and their 
subsequent rupture to from a supported bilayer. Bilayer vesicles introduced to a surface 
begin to inter-vesicle mix to form larger vesicles. At a critical size, the adsorbed vesicles 
rupture to form bilayer disks, causing the loss o f the vesicle interior content. The adsorbed 
disks merge to form a continuous bilayer on the SAM support. The early steps o f supported 
bilayer formation were determined using two-colour fluorescence labelled vesicles, and 
visualized using fluorescence microscopy [123].
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The process of hybrid bilayer formation is governed by the effects of interfacial free 
energy on molecular reorganization at a surface. Phospholipids have a small partition 
coefficient, therefore in solution, they exist primarily as vesicles. The exposure of lipid 
vesicles to a hydrophobic SAM causes the spontaneous addition of a single molecular layer 
to the surface [124]. The driving force for bilayer formation is the free energy of the 
hydrophobic surface in contact with water. Lowering the free energy of the hydrophobic 
surface by bilayer formation may be accompanied by a free energy penalty associated with 
vesicle disruption. The activation energy barrier associated with the delamination of the 
lipid vesicles, which are thermodynamically stable structures, must be substantial. Hybrid 
bilayers have shown the ability to be good dielectric barriers with few pinhole defects. The 
fluidity of hybrid lipid bilayers is less than those seen in supported lipid bilayers, but 
hybrid bilayers do show improved stability [125]. The decreased fluidity on the bilayer is 
the result of one of the bilayer leaflets being chemisorbed to the surface, therefore, the 
fluidity of that particular leaflet is altered, which in turn effects the hybrid leaflet [126]. 
Hybrid bilayers have significantly more mechanical stability than supported lipid bilayers, 
because there is hydrophobic coupling between the two leaflets, thereby excluding solvent 
from the bilayer [127]. The formation of a hybrid bilayer is dependant on the ionic strength 
of the buffer, and increasing the concentration of Na+ and Cl' ions promotes faster 
absorption and fusion of the phospholipid vesicles to the SAM. The advantages of creating 
a hybrid lipid bilayer over a supported lipid bilayer is the relatively small amounts of lipid 
vesicles needed for bilayer formation. The proposed mechanism by which a hybrid bilayer 
forms from stable vesicles is by a delamination process.
The construction of a mechanically stable bilayer tethered to a surface permits the use of 
techniques that were not generally applied to biological membranes before. The use of a 
metal support, such as gold, also allows for the application of electrochemical techniques 
to examine the insulating capacity of lipid bilayers, and for assessing ion channel activity
[128]. The application of surface sensitive techniques, such as Surface Plasmon 
Resonance, allows for the monitoring of the formation of these biomimetic bilayers and 
events that occur at the surface of the biomimetic membrane.
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1.4.3 Supramolecular Complexes using Biotin-Streptavidin
Bio-specific recognition between biotin and streptavidin is well established, and has 
become a model system for protein-ligand binding studies. Biotin (vitamin K) is a water 
soluble B-complex vitamin and is used in cell growth, the production of fatty acids, 
metabolism of fats and amino acids. Streptavidin is a 60KDalton tetrameric protein 
secreted from Streptomyces avidinii, and has the approximate dimensions 54 x 58 x 48A
[129]. It has been suggested that the production of streptavidin is a defence mechanism of 
S.avidinii to sequester biotinylated enzymes away from competitor bacterial species that 
require these biotinylated enzymes for growth [130]. Each streptavidin can bind up to four 
biotin molecules with very high affinity (K^ = lO^mol"1) [131]. This high affinity 
interaction has been extensively exploited to improve the sensitivity of immunoassays, 
immunocytochemical techniques and DNA probe diagnostics.
The multi-valency shown between streptavidin and biotin enables the linkage between two 
or more biotinylated molecules in a ‘bridge’ or ‘sandwich’ mode. The carboxy-terminus of 
biotin, which is not involved in the binding process to avidin/streptavidin, can be linked to 
structural elements [132]. Linkage to lipids and thiols allows for the preparation of 
molecular layer architectures at the water/air interface. This multi-valency can be exploited 
if streptavidin is bound to a biotinylated thiol or lipid at the air-water interface, causing the 
molecules to form a two-dimensional crystalline domain [133]. The crystalline 
fimctionalized monolayer provides an ordered, planar surface for the ligand binding, 
thereby producing a functional binding matrix for the construction of self-assembled 
multilayer films [134].
The mole fraction of the biotinylated-thiol/lipid in the fimctionalized surface has been 
shown to influence the streptavidin surface density. High mole fractions of biotin present 
in the fimctionalized surface causes steric hindrance and a reduction in streptavidin binding 
efficiency [135]. SPR has shown that low biotin surface coverage provides optimal 
accessibility for streptavidin to bind quickly via diffusion controlled adsorption.
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1.4.4 Artificial Lipid Bilayers
It was not until 1962 that the first experimental bilayer lipid membrane was pioneered 
[136] to study their electrical properties and controlled chemical investigations. It was 
shown that an in vitro bilayer lipid membrane (BLM) could be formed from solubilized 
membrane lipids in the absence of all other cell components and show the cellular function 
of electrical excitability. Bilayer mixtures of lipids, membrane proteins and glycoproteins 
have been used by many research groups as an alternative chemically simple model for 
biological membranes. The cellular lipidome comprises over 1000 different lipids [137], 
and each of their functionalities is determined by their local concentration, which varies 
between organelles, between the two leaflets and within the lateral plane of the membrane. 
Therefore, the non-random mixing of components and compositional heterogeneity reflects 
the complexity of directly observing and characterizing bio-specific interactions.
The experimental and theoretical difficulties faced when observing the cell membrane 
makes model BLMs comprised of only simple mixtures of three or four components 
attractive because it gives the opportunities to monitor these components rigorously. 
Despite the vast array of lipid species found in cellular membranes, there is an asymmetric 
distribution of lipid species and predominant lipid components observed [17, 138, 139]. 
Therefore, by ensuring major membrane components are included in the BLM model a 
relationship to in vivo cell membranes can be ensured.
Artificial bilayer membranes can take numerous forms. Planar BLMs can be formed on 
various substrates including metal and hydrogels. They show great diversity and versatility 
and have been used in a number of applications ranging from basic membrane biophysics 
including transport and microchip studies, the conversion of solar energy via water 
photolysis, biosensor development using supported bilayer lipid membranes (s-BLMs), and 
photobiology comprising apoptosis and photodynamic therapy [140]. Spherical BLMs 
(liposomes) are vesicles which form spontaneously via self-assembly when amphipathic 
phospholipids are agitated in solution, and were first described in 1965 [141]. Liposomes 
consist of one or more phospholipid bilayers surrounding an aqueous cavity (Figure 1.25). 
The bilayer vesicles can range in size and lamellar number; single unilamellar vesicles 
(SUV) contain a single lipid bilayer with a diameter generally below lOOnm, large 
unilamellar vesicles (LUV) contain a single lipid bilayer with a diameter between lOOnm 
to several microns, oligolamellar vesicles (OLV) contain about five concentric lipid 
bilayers and a diameter usually below lOOOnm, multilamellar vesicles (MLV) generally
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contain between five and twenty concentric lipid bilayers and a diameter below lOOOnm, 
and multivesicular vesicles (M W ) contain multi-compartment structures and a diameter in 
the micrometer range [142],
Figure 1.25 Schematic o f  the five  types o f  liposomes: small unilamellar vesicles (SUV), 
large unilamellar vesicles (LUV), oligolamellar vesicles (OLV), multilamellar vesicles 
(MLV) and multivesicular vesicles (MMV) [142].
The composition o f the BLMs determine the physical and chemical properties o f the 
vesicles. Altering the composition can result in aggregation, disruption and fusion between 
the vesicles [15]. The preparation o f biomimetic membrane vesicles is generally performed 
either via replacement o f the organic solvent or detergent or via a mechanical method. The 
amphiphile mixture dissolved in an organic solvent is placed under reduced pressure to 
remove the solvent, resulting in a dry film. The film is rehydrated by addition o f a buffer to 
yield a heterogeneously sized population o f MLVs. The vesicle population can be 
homogenized by either probe sonication or forced through a polycarbonate membrane via 
the extrusion method until the required vesicular size is achieved.
The inclusion o f a small mole fraction (-1%  total lipid concentration) of a biotinylated 
phospholipid into the vesicles composition has been extensively used to immobilize bilayer 
membranes to surfaces using a streptavidin-biotin supramolecular architecture to generate 
high-yield artificial membrane immobilization with good stability [143]. It has been 
reported that avidin-biotin immobilized SUVs show excellent stability with a low leakage 
o f entrapped reporter molecule after storage at 4°C for seven months, while covalently 
immobilized SUVs showed poor membrane integrity with 30-50% o f the encapsulated 
reporter molecule diffusing out under the same storage conditions [144]. Non-specifically 
bound vesicles have been reported not to produce a significant problem during 
experimental analysis because they are likely to leak their contents by rupturing on the 
surface and be carried away by diffusion [145].
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The rationale design of the supamolecular architecture and the simultaneous monitoring of 
the surface optical properties and fluorescent signal was subsequently used in this work to 
optimise the maximal binding capacity of the tethered artificial cell membranes. Prevention 
of the steric effects of the tethered membranes by engineering the ratio of the anchor 
molecules in the support layer was performed and SPFS was further employed to develop a 
surface for interfacial agents of the cell membrane to interact. The determination of 
binding constants for the receptor-analyte interactions and efficiency of inhibitors of 
interfacially active agent were performed.
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2.0 Theoretical Introduction
This chapter details the theoretical background associated with the experimental 
methodologies employed in this thesis. An introduction to the theory behind Surface 
Plasmon Resonance (SPR), and its applications in monitoring the changes in refractive 
index associated with adsorption and desorption events at the surface will be described. 
The employment of this technique will be detailed along with the background relating to 
the modification of the spectrometer to include for fluorescence detection using Surface 
Plasmon field enhanced Fluorescence Spectrometry (SPFS). The concept of molecular 
adsorption at the surface will also be described in relation to the Langmuir isotherm model 
and mass transfer effects.
2.1 Surface Plasmon Resonance Spectroscopy
Surface Plasmon Resonance (SPR) is a phenomenon which occurs in thin metal films at 
the interface between two media of different refractive indices. At a critical angle, incident 
light travelling through the medium of higher refractive index is totally internally reflected 
at the interface with the medium of lower refractive index. The electromagnetic field 
component of the incident light penetrates into the medium of lower refractive index and 
creates an exponentially decaying evanescent field wave. Surface Plasmon Resonance 
Spectroscopy (SPS) measures changes in reflectivity as a result of changes in the refractive 
index at the air/dielectric interface. This subsequently equates to monitoring changes as a 
result of the adsorption and/or desorption of analytes at the interface.
2.1.1 Refractive index
The refractive index (rj) of a material is the factor by which the rate of the electromagnetic 
radiation phase velocity is slowed compared to its velocity in a vacuum. It is dependant on 
the wavelength of light, and to some extent, the temperature and pressure at which the 





Where c is the speed of light, and vphase is phase velocity.
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A material with a high refractive index means light passes through more slowly compared 
to a material with a lower refractive index. The refractive index can be used to determine 
the identity o f an unknown material (Figure 2.1), and can also be used to determine purity 
or concentration, i.e. determining the glucose concentration in bodily fluid.
Material Refractive index (n)
at L = 589.3 nm
Vacuum 1





Planar Lipid Bilayer 1.45 [2]
Cell membrane 1.45 [11
Lipid 1.48 [3]
Crown glass (Quartz) 1.50- 1.54 [4]
Flint glass (High refractive index glass) 1.60-1 .62
LaSFN9 glass 1.85
Refractive index fo r  various materials
2.1.2 Surface Plasmons
A plasmon is a quasiparticle (a quantum o f energy) assembled from an electron plasma and 
a photon to produce collective oscillations. The plasma is a dense gas o f charged particles, 
which is formed from mobile delocalized valence electrons in the metal. Surface plasmons 
are electromagnetic transversal waves that propagate along the surface o f a conductor or 
semi-conductor, and possesses both longitudinal and transverse wave components. Surface 
plasmons interact strongly with light, and are confined to the surface o f the interface 
between the negative dielectric (conductor) and the positive dielectric (Figure 2.2). The 
incident electromagnetic radiation passing through the optically dense material reflects off 
the boundary between the optically dense medium and the metallic film. This causes the 
evanescent field to extend from this interface and propels the electrons, causing the 
production o f a surface plasmon.
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dielectric
e ’ >  0
e' < 0
Figure 2.2 Schematic o f  the propagating plasmon wave along the surface o f  the 
dielectric/metal interface in the x direction, and the decaying evanescent wave (----)
An evanescent wave exhibits exponential decay away from the metal/dielectric interface, 
and is produced when sine waves are reflected off the dielectric/metal interface at an angle 
greater than the critical angle, therefore, causing total internal reflection.
Plasmons give rise to some o f the physical and optical properties associated with metals. 
Light o f a frequency below that o f the plasma wave frequency is reflected because the 
electrons in the metal shield the electric field from the light. Conversely, light o f a 
frequency above that o f the plasma wave frequency is transmitted, because the electrons in 
the metal cannot shield the electric field rapidly enough. Surface plasmons have been 
employed in a range o f applications including in electrochemistry [5], biosensing [6], and 
in surface plasmon resonance spectroscopy [7].
2.1.3 Excitation o f  Surface Plasmons
Incident transversal magnetic light, which has an electric field component perpendicular to 
the magnetic field, causes the excitation o f surface plasmons. The frequency o f the photon 
propagating in the dielectric material must be smaller than the frequency of the surface 
plasmon propagating along the metal/dielectic interface for the excitation o f  a surface 
plasmon to occur. The dispersion relation (relation between the energy o f a system and its 
corresponding momentum) for an electromagnetic wave shows that the energy is 
proportional to the frequency o f  the wave and the momentum to the wavenumber (Figure 
2.3). The dispersion relation for surface plasmons is not linear, and reaches a maximum 
frequency (comax), because it has a lower energy compared to the incident light. Therefore,
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the surface plasmon wave vector propagating along the metal/dielectric interface is greater 
than the wave vector o f the free photon in the dielectric [8]. This means that incident light 
in a vacuum can not directly excited surface plasmons, as there is no intersect between the 
incident light wavevector (a) and the surface plasmon wavevector (P I+2) (Figure 2.3).
<i)” ck
Possibility of achieving 
resonance at the intersection
Wavevector
Figure 2.3 Dispersion relation offree photons in a dielectric (a), free  photons propagating 
in a coupling prism (b). With the dispersion relation fo r  surface plasmons at the 
metal/dielectric interface before(Pl) and after adsorption o f  an additional dielectric layer 
(P2). Where co=frequency, c=  speed o f  light and k= wavevector.
To excite the surface plasmons at the metal/dielectric interface, the wavevector o f the 
incident light must be adapted to match the wavevector o f the plasmons. This can be 
achieved by increasing the wavevector by passing the incident light though a material with 
a higher refractive index compared to the dielectric, such as a prism. This causes attenuated 
total reflection (ATR), and is known as prism coupling. Altering the incident light 
wavevector can also be achieved using grating couplers, whereby the metal/dielectric 
interface is periodically distorted. The incident wave is diffracted causing a series o f beams 
to be directed away from the interface at a variety o f angles, and if the diffracted 
wavevector is equal to the surface plasmon wavevector then coupling occurs [9].
Prism coupling is achieved by reflecting the incident light on to the base plane o f a high 
refractive index prism, either in the Otto or Kretschmann configurations (Figure 2.4). In 
the Otto configuration, the incident light passes through the high refractive index prism, 
and at a critical angle, total internal reflection is achieved, resulting in the creation o f an 
evanescent field. This evanescent field propagates into the air dielectric, to a penetration
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depth o f around 200nm. However, this setup is not experimentally preferred, due to its 









Otto Configuration Kretschmann Configuration
Figure 2.4 Schematic o f the Otto configuration and Kretschmann configuration 
respectively, used to achieve photon excitation o f  the surface plasmons in the metal film.
Experimentally, the Kretschmann configuration is the preferred method o f prism coupling, 
whereby, a thin metal film (~50nm) is either evaporated directly onto the base plane o f the 
prism or onto a high refractive index glass slide that is optically matched to the prism. The 
metal film has a limiting thickness, since thick films cause damping o f the evanescent field 
and prevents the excitation o f the plasmons on the opposite side o f the film. Moreover, 
metal films that are too thin cause a loss in the excited plasmon field because the field 
reaches back into the prism. Therefore, the optimum thickness is in the range o f 50nm for a 
gold film, when excited with a Helium-Neon (HeNe) laser at 632.8nm [10].
The excitation o f the surface plasmons is only possible when the system enters resonance. 
This is achieved when the plasmon wavevector and incident photon wavevector couple. 
This situation occurs at the intersection shown in Figure 2.3, where the resonance coupling 
happens at a given combination of defined frequency and incident angles. Once resonance 
is achieved, the surface plasmons are excited by the energy o f incident light, resulting in a 
decrease o f the reflected intensity because part o f the incident energy is coupled into a 
surface plasmon wave. Therefore, this loss o f energy is observed as a resonance minimum 
when reflected light intensity is plotted against incident light angle (Figure 2.5)
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Figure 2.5 Resonance curve obtained during the adsorption o f  an analyte to the metal 
surface using the Kretschmann configuration.
If  the reflectivity is monitored, a maximum intensity is observed, 0C, which can be 
determined as follows:
sin 9c = —  
m
(2.2)
This is determined according to the laws o f total internal reflection (TIR), whereby, the 
incident light passing through a material with refractive index, «i, will be reflected when 
passing through to a material with a lower refractive index, «2 -
In accordance with Snell’s law (2.3), increasing the angle o f incidence, 0j, causes the 
transmission angle 02 to increase until a maximum value o f 02 = 90° is reached. Therefore, 
0i is called the critical angle 0C, as given in 2.2.
ms\n6\ =m.sin# 2
(2.3)
Increasing the incidence angle 0i further, can not change the transmission angle 02 passed 
90°, since transmitted light can not enter back into the optically dense material (Figure 
2.6). Since all incident light is reflected at angles greater than the critical angle 0C, the 





Figure 2.6 Schematic representation o f  the reflected and transmitted light at an interface 
between two optical media o f  different refractive index (m and nf). The reflection angle 
equals the incident angle, and the transmission angle is determined by Snell’s law.
Above the critical angle, resonance is achieved, resulting in a decrease in the measured 
reflectivity to a minimum value of 0a (Figure 2.5). This is the resonance angle at which 
maximal energy transfer occurs, and is determined as follows:
Where £j = permittivity o f  metal film  
£2 = permittivity o f dielectric 
£p = permittivity o f prism
2.1.4 Sensitivity o f  Surface Plasmons to Optical Changes
Biomolecular interactions taking place in the immediate proximity o f the evanescent field 
causes a change in the optical properties o f the wave by altering the conditions at which the 
excitation o f the surface plasmons occurs. Adsorption or desorption o f a dielectric layer at 
the interface can be observed by the excited plasmon field and monitored as a result o f the 
change in the angle o f resonance for minimum energy transfer (resonance minimum).
The addition o f subsequent layers to the prism/gold/dielectric interface causes the 
refractive index to change in the area within the evanescent field. This results in the 





2.1.5 Surface Plasmon Field Distribution
The evanescent field decays away from the interface exponentially, resulting in a certain 
penetration depth into the dielectric medium. However, the electromagnetic field o f a 
surface plasmon wave is distributed in an asymmetrical manner, and the majority o f the 
field is concentrated in the dielectric. This penetration depth is a function o f the 
wavelength used to excite the surface plasmons. Moreover, it is influenced by the choice of 
metal used at the interface, and therefore, determines the detection sensitivity o f changes in 
refractive index at the surface (Figure 2.7).
Gold is used to increase the field enhancement o f the evanescent wave by a factor of 
sixteen compared to the intensity o f the incident electromagnetic field. In comparison, 
silver causes the field enhancement o f the evanescent wave to increase by a factor of 
-fifty , and gives a narrower resonance minimum compared to gold. This is because 
evaporated gold causes surface roughness, which broadens the resonance curve [11]. The 
greater field enhancement seen at the silver/dielectric interface compared to that o f the 
gold/dielectric is the result o f  less attenuation o f the evanescent signal and higher 
localization o f the evanescent field in the dielectric. This is due to an energy loss through 
enhanced scattering at the gold interface because o f the roughness o f the gold surface [12]. 
Moreover, silver shows increased field enhancement because coupling o f the incident light 
with the surface plasmons in the silver film is achieved via a two photon process, whereas, 
a three photon process is required to cause the coupling o f the incident light with the 
surface plasmons in gold, aluminium and copper films [13]. A two photon process is a 
photophysical event triggered by a two photon excitation.
M etal Layer Supporting Surface 
Plasmon Waves
Silver Gold
Wavelength X-630nm X—850nm X=630nm X=850nm
Propagation length (pm) 19 57 3 24
Penetration depth into metal (nm) 24 23 29 25
Penetration depth into dielectric 
(nm)
219 443 162 440
Figure 2 .7 Major characteristics o f  surface plasmon waves at the metal/dielectric interface 
(optical constants taken from [14]).
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2.2 Fluorescence
Fluorescence is an included term under the heading of luminescence, which describes any 
process in which energy is emitted from a material at a different wavelength from that at 
which it is absorbed.
2.2.1 Excitation o f Fluorophore
Fluorescence occurs when photons of light are absorbed by a fluorophore, fluorochrome or 
fluorescent probe when in its ground electronic state. The molecule is elevated to an 
excited state due to the transfer of the electron to a higher energy orbit. The excess energy 
is dissipated when the electron returns to the original electronic ground state, and thereby 
releasing a quantum of light [15]. This fluorescence emission has a lifetime of
Q
approximately 10‘ seconds, and was first described by Sir David Brewster in 1838. 
However, the term was not coined until 1852 by Stokes, who stated that the refrangibility 
of light is always lowered by internal dispersion [16]. Stokes also dispelled the idea that 
the colour dependence seen was not because of coloured particles in suspension as 
suggested by Brewster nor because of the colour of the incident light, but was the direct 
result of the refrangibility.
A fluorophore is the functional group of a molecule, usually a polyaromatic hydrocarbon 
or heterocyclic group, that absorbs energy at a specific wavelength and re-emits energy at a 
specific yet different wavelength. There are many natural and synthetic compounds that 
exhibit fluorescence and they have been used in various applications, such as fluorescent 
strip lights which employ mercury atoms to emit light in the ultraviolet range of the 
spectrum. But the field of immunoassays and diagnostics employs the greatest range of 
fluorescent probes and fluorophores. Automated sequencing of DNA uses labelled 
fluorescent tags to identify the DNA sequence and antibodies can be modified to include a 
fluorescent functional group to observe analyte binding quantitatively in immunoassays.
The process of fluorescence is a three stage process, as diagrammatized by Jablonski 
(Figure 2.8) to describe the adsorption and emission of light.
Stage 1: Excitation
A photon of energy supplied by an external source such as a laser is absorbed by die 
fluorophore. This causes the electrons in the ground state (So) to become excited and move
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to one o f the many higher electronic singlet states (S i’). This occurs within approximately 
10'15 seconds.
Stage 2: Excited State Lifetime
The excited state is maintained for a finite period o f time, and the fluorophore undergoes 
conformational changes and may also interact with its molecular environment. This causes 
the partial dissipation o f some o f  the energy it possesses as the electron moves from the 
higher electronic singlet state (S i’) to a relaxed singlet state (Si), by a process o f internal 
conversion. This takes approximately 10'12 seconds. Some o f the excited molecules do not 
return to the original ground state (So) by fluorescence emission, but rather by other 
processes such as collisional quenching and fluorescence energy transfer (FRET).
Stage 3: Fluorescence Emission
A photon o f energy is emitted as the excited molecule in the relaxed singlet state (Si) 
returns to the ground state (So), taking approximately 10'8 seconds. However, due to the 
dissipation o f some o f the energy, the energy o f the photon is lower, therefore, o f a longer 
wavelength than the excitation photon. The energy difference between the excitation 




Figure 2.8 Jablonski diagram depicting the excitation (Stage I) o f  a fluorophore from its 
ground singlet state (So) to the excited electronic state (Sj ’)  by a specific photon (hvex), and 
subsequent emission o f  fluorescence (Stage 3) by the dissipation o f  energy (hvem) from the 
relaxed singlet state (Si) back to the ground state (So).
The process o f fluorescence is cyclic, therefore, the fluorophores can be repeatedly excited, 
unless the fluorophore is irreversibly inactivated by photobleaching. The fact that each 
fluorophore can be continually excited provides a highly desirable property o f sensitivity. 
Molecules with short excited state lifetimes permit the greatest sensitivity since multiple 
excitations can be achieved if  the molecule is quickly returned from the excited state to the
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ground state [15]. Fluorophores demonstrate environmental sensitivity to exogenous 
factors such as solvent polarity and the pH of the aqueous medium, therefore, the choice of 
fluorophore for each application must be carefully considered.
The recording of an emission spectrum for a particular molecule is achieved by detecting 
the fluorescence intensity over a range of emission wavelengths at a constant excitation 
wavelength. The fluorescence excitation spectrum of a single fluorophore species is 
generally identical to its adsorption spectrum. For fluorescence detection to be possible, 
four basic elements are required; an excitation source, the fluorophore, wavelength filters 
to isolate the emission photons from the excitation photons and a detector to register the 
output.
2.2.2 Fluorescence Quenching
The fluorescence intensity of a fluorescent molecule can be decreased by a variety of 
processes, and requires the molecular contact between the fluorophore and the quencher. 
This contact can be due to diffusive encounters (dynamic quenching) or through complex 
formation (static quenching). In dynamic quenching, the fluorophore comes into contact 
with the quenching species during the excited fluorescence lifetime and causes the excited 
molecule to return to the ground state without emitting a photon. Collisional quenching 
provides a nonradiative pathway from the excited state back to the ground state. In static 
quenching, the formation of a complex between the fluorophore and the quencher is non- 
fluorescent. The process of quenching is sensitive to the molecular environment that 
affects the rate and probability o f the fluorophore coming into contact with the quencher, 
such as steric shielding and charge-charge interactions [17].
The decrease in fluorescence intensity caused by dynamic quenching can be described by 
the Stem-Volmer equation:
y  =  l + ^ ro [e ] = l + X c[g ]
(2.5)
Where Io and I  are the fluorescence intensities in the absence and presence of a quencher 
respectively, kq is the bimolecular quenching constant, To is the unquenched lifetime, Kd is 
the Stem-Volmer dynamic quenching constant, and [Q] is the quencher concentration. The 
Stem-Volmer plot of Iq/I  verses quencher concentration should be linear, and any deviation
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from linearity often indicates multiple populations of fluorophore, which may not be 
accessible to the quencher. In the collisional quenching of fluorophores, the quantum yield 
(the fraction of the excited fluorophores that decay by emission relative to the total decay) 
and the lifetime are reduced because of the additional rate process which depopulates the 
excited state. Fluorophores with longer lifetimes are quenched more than those with 
shorter lifetimes [18].
Static quenching, caused by complex formation between the quencher and the fluorophore, 
is described by:
j  = l  + K[ Q]
(2.6)
Where Ks is the association constant for the complex formation between the quencher and 
the fluorophore.
The combination of the static and dynamic quenching equations for the same fluorophore 
can be produced as the modified Stem-Volmer equation:
y  =  (1 +  K s i Q W  + Ko[Q]) (2.7)
2.2.3 Resonant Energy Transfer
Fluorescence resonance energy transfer (FRET) describes the transfer of energy between 
two fluorescent molecules over a range of l-10nm [19]. Through long range dipole-dipole 
coupling, the energy from an excited fluorescent molecule is nonradiatively transferred to 
an acceptor fluorescent molecule. The donor molecule returns to the ground singlet state 
without the emission of a photon, which provides a non-radiative pathway back to the 
ground state, while the acceptor molecule is excited to a higher singlet state and then 
subsequently emits a photon.
The rate of energy transfer between the donor and the acceptor molecule is given by:
1 ( R o ^




Where td  is the decay time o f the donor molecule in the absence o f  the acceptor molecule, 
and r is the distance between the donor and the acceptor molecule. Ro is the Forster 
distance, at which half o f the donor molecules decay via resonant energy transfer and the 
other half decay via radiative and nonradiative means. The Forster distance depends on the 
overlap o f the donor emission spectrum with the acceptor absorption spectrum and their 
mutual molecular orientation.
The efficiency o f the transfer o f energy between a donor and acceptor fluorophore is 
dependant on whether the rate o f  transfer is faster than the rate o f decay, if  this is so, then 
the transfer o f energy will be feasible and efficient. If not, then little transfer of energy 
between the donor and acceptor molecules will occur during the excited state lifetime.
The efficiency o f the resonant energy transfer between two molecules is given by:
e =^ l_ =_ rL_
Td 1 +  Jct R 6q +  r 6
(2.9)
The FRET efficiency verses the donor-acceptor distance can be plotted (Figure 2.9), from 
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Figure 2.9 Simulation o f  the fluorescence resonant energy transfer (FRET) efficiency for  
the energy transfer between a donor molecule and an acceptor molecule. From which, the 
Forster distance can be calculated from  50% resonant energy transfer (.......... )
It has been shown that quenching o f fluorophores by resonant energy transfer results in 
increased photostability because the fluorophore spends less time in the excited state, 
therefore decreasing its opportunity to partake in photochemical reactions [19].
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The most common application of FRET is to measure the distanced between two sites on a 
macromolecule, such as between two sites on a protein. The macromolecule is covalently 
labelled with a donor and acceptor, and from this, the distance can be determined from the 
efficiency of energy transfer from the extent of donor quenching due to the acceptor [17], 
In fluorescence microscopy, fluorescence confocal laser scanning microscopy and 
molecular biology, FRET is used to quantify molecular dynamics such as protein-protein 
interactions and conformational changes.
2.3 Surface Plasmon Field Enhanced Fluorescence
It has been extensively documented that fluorophores are excited resonantly by the 
plasmon field enhancement effect observed at metal surfaces. This technique has been 
exploited in various applications including, monitor the interfacial binding between 
oligonucliotide probes and their complementary target strands [2 0 ] and observing the 
lateral mobility of lipid molecules in model membrane systems [21]. Increasingly, Surface 
Plasmon field enhanced Fluorescence Spectroscopy (SPFS) is being used for sensing and 
monitoring purposes, such as the detection of the pregnancy hormone, human Chorionic 
Gonadotrophin (hCG) [22].
Surface Plasmon Resonance Spectroscopy (SPS) is renowned for showing a lack of 
sensitivity towards detecting low molecular weight analytes or small numbers of 
molecules, because of the small shift in resonance minimum and refractive index. 
However, the simultaneous measurement of surface plasmon resonance and fluorescence 
provides an improvement in sensitivity. The inclusion of a thin metal film in the 
Kretschmann configuration for SPS also provides a means of exciting the fluorophores. 
The coupling of the surface plasmons in the metal film and incident light produces the 
evanescent field that is capable o f exciting the fluorophores present in the dielectric. 
However, the fluorescence intensity observed for any given fluorophore is highly 
dependant on the proximity to the metal surface, as both collisional quenching and FRET 
provide a nonradiative pathway to the ground state. Quenching and FRET have no 
significant effect on the spontaneous rate at which a fluorophore emits photons (radiative 
decay) [23]. Moreover, an opportunity arises to control the radiative rates of a fluorophore 
from its interactions with nearby metal surfaces, which has been termed Radiative Decay 
Engineering (RDE) by Lakowicz, who described this phenomenon in 2001. Metal surfaces
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in close proximity to oscillating fluorophores can modify the rate of emission and spatial 
distribution of the radiated energy of the fluorophore [23]. Excited fluorophores close to a 
metal surface, 2 0 nm or less, are almost all quenched, because the fluorescence dipole is 
coupled to the surface plasmons causing the damping of this dipole.
Enhancements in fluorescence can be observed of up to 1000 times, depending on the 
distance and the geometry at which the fluorophore and metal surface are orientated [24, 
25]. This enhancement occurs at distances up to 200A, and is partly due to the 
amplification of the evanescent field, which penetrates into the dielectric and causes an 
increase in the local excitation intensity of the fluorophore by increasing the intrinsic 
radiative decay rate [26]. Fluorophores with high radiative decay rates have high quantum 
yields and short lifetimes, and fluorophores in close proximity to the metal surface increase 
their quantum yields. Therefore, this causes the increase in the radiative decay rate and 
intensity of fluorescence. This is because the fluorophore returns to the ground state 
quicker, shortening the fluorescent lifetime and resulting in an increased number of 
photons observed per fluorophore. Moreover, since the fluorophores spend less time in the 
excited state, the extent of photobleaching is also decreased because the fluorophores 
spend less time in the higher singlet states. The combination of increased quantum yield 
through shortened lifetime and decreased photobleaching through shorter excitation times 
results in a substantially increased numbers of detectable photons per fluorophore.
At metal/fluorophore distances greater than 200nm, little fluorescence is observed because 
the fluorophores move beyond the evanescent field. Therefore, they can not be excited and 
are too far from the metal surface to experience any enhancement effects. However, this 
does prove advantageous in some experimental circumstances. By ensuring the 
supamolecular architecture of the surface is specifically designed, it is possible to provide 
binding sites for biorecognition events in the proximity of the fluorescence detection field, 
while excluding the fluorescent probe in the bulk solution that could significantly 
contribute to the fluorescence signal, and cause over reporting.
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2.4 Mass Transfer
The physical process involved is the diffusive and convective transport of molecules within 
a system is termed mass transfer, and is caused by the difference in concentration between 
two areas. This causes the random net movement of molecules from a region of high 
concentration to a region of low concentration. The mass transfer coefficient is a diffusion 
rate constant, defined by:
,  km
K c = --------------
A A ca
(2.10)
Where km is the mass transfer coefficient, A is the effective mass transfer area, and Aca is 
the driving force concentration difference. This coefficient can be used to quantify the 
mass transfer between phases, such as the analyte in the bulk phase of a solution and the 
surface.
With low mass transfer, the diffusion of molecules from the bulk to the surface is slower 
than the rate of binding of the analyte to the ligand, creating a deficit of analyte at the 
surface.
The mass transfer coefficient is small if the flow rates at which the analyte approaches the 
ligand is low or the molecular weight of the diffusing molecule is very high, causing the 
diffusion layer to be large. Therefore, by controlling the flow rate, mass transfer can also 
be controlled. A high flow rate increases the association and dissociation rate constants, 
bringing the analyte from the bulk to the surface faster and avoids the deficit of analyte at 
the surface created by slow diffusion of the analytes.
2.5 Langmuir Adsorption
The adsorption of an analyte in the gaseous phase or in solution to an immobilised receptor 
provides a convenient methodology for monitoring the interaction between the analyte- 
ligand complex. This diffusion-limited reaction can be characterised and modelled using 
the Langmuir adsorption isotherm, and was originally developed by Irving Langmuir in 
1916 to model the adsorption of gases on a plane crystal surface. The theory stated that 
adsorption of gases onto the surface was the result of a time lag between the gas molecules 
impinging on the surface and the time taken for the condensation of the gas, leading to an
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accumulation of these molecules in the surface layer [27]. It was also said that if a gas 
molecule strikes a portion of the surface already covered, it evaporates so quickly that it is 
equivalent to a reflection.
This model was later expanded for the adsorption of liquids to solids. It stated that if the 
liquid molecules contained active groups, it will orientate and pack into the surface layer in 
a way that is dependant upon the number of atoms exposed in the surface of the solid [28].
The assumptions made for this model are that: 1) the adsorption of molecules on the 
surface produces only a homogenous monolayer, 2 ) all binding sites are equivalent and 
there is no bias between the molecule and any of the binding sites, and 3) all occupied 
sites do not interfere with the binding of neighbouring binding sites. The adsorption of 
molecules is limited by the number of available binding sites, until complete surface 
saturation is met and all binding sites are occupied.
The interactions which take place at the surface are expressed by the kon rate constant (mot 
}Ls'J) for the processes of association between the analyte (A) and the ligand (B) to form 
the complex (AB), and the k0jf  rate constant (s'1) for the disassociation of the analyte and 
ligand complex.
kon
A + B< >AB
T T
(2.11)
The rates of association and disassociation between the ligand and analyte will become 
equal in time. When equilibrium is achieved, the concentrations of analyte, ligand and 
complex will be constant, therefore:
M  A ][B \ =  h g [A E \ 
(2.12)
From this, the dissociation equilibrium constant (Kd mol.dm'3) and the association 
equilibrium constant (Ka mol.dm'3) can be resolved:
[A][B] _ k o f f  _  ^  




This simple example interaction between two reactants (Figure 2.10), is not under the 
influence o f exogenous factors such mass transfer. However, in experimental situations 
these have to be taken in to consideration. The movement o f the analyte from the bulk 
solution into the proximity o f the ligand to initiate association is most influential, and is 
determined by the mass transfer rate constant. Therefore;
k.




Where Abuik is the concentration o f the analyte in the bulk solution, Ainterface is the 







Figure 2.10 Schematic depiction o f  the adsorption and desorption process between the 
analyte (A) and ligand (B). The surface coverage is dependant on the rate constants kon 
and k0ff.
The rate o f complex formation between the analyte and the ligand at the surface is equal to:
d[AB]
dt
— fcon^A'Jin/efface^ B'J koff[AB J
(2.15)
However, the number o f free ligand sites (B) will decrease over time as the analyte binds to 
the receptor sites, therefore,
[A], = [ B ] o - [ A
(2.16)
Where [AB]t is the concentration o f the bound complex at time t, and [B]o is the ligand 
concentration at the starting time. This can be integrated with 2.15 to give:
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tAB}  = h » { [B \ [A \  -  [A],[AB],) -  kff[AB], 
d t
(2.17)
Which in turn can be simplified to:
A^B}  = h,»[A\,({B]o -  [AB ],) -  k„e [AB], 
dt
(2.18)
The formation of the AB complex provides the signal response, which in SPS and SPFS, is 
the reflectivity and fluorescence respectively. The maximum response/signal, Rmax, is 
equivalent to [B]o, because all binding sites are occupied, therefore:
dR
—  =  kon[A](R  max- Rt) -  koffRt
d t
(2.19)
When the system is in equilibrium, it is possible to determine the equilibrium constant, Req, 
for the binding between the analyte and the ligand at various analyte concentrations:
D R max[v4]




I \e q  —  ---------------------------------
K d  +  [A]
(2.21)
The graphical plot of Req against the free analyte concentration produces the Langmuir 
adsorption curve (Figure 2.11), where the concentration required to saturate 50% of the 
available ligand sites is R max/2 ,  therefore, the dissociation equilibrium constant, K d, can be 
determined:
[A\R max7? max/2 =
[A] + K d
Therefore,
[A] = K d at equilibrium.
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Figure 2.11 Langmuir adsorption isotherm, allowing the direct determination o f  the 
equilibrium constants (75 nmol, dm 3fo r  the above representation).
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This chapter details the experimental set-ups and methodologies followed during this 
study. The optical instrumentation setup is described with reference to Surface Plasmon 
Resonance (SPR) and Surface Plasmon field enhanced Fluorescence Spectroscopy (SPFS) 
as detailed in chapter 2. The construction of the supamolecular surface is laid out along 
with the preparation of all solutions, bilayer vesicles and membrane binding/peimeablizing 
agents.
3.1 Optical Setup & Methodology
The technique of SPR was applied here to qualitatively and quantitatively study the 
construction of the supamolecular surface and the absorption and desorption of analytes to 
that surface in real time and without the need to label molecules. Moreover, simultaneous 
detection of fluorescence using SPFS facilitated the detection of low molecular weight 
analytes and small numbers of analytes. This provides a highly sensitive analytical tool for 
observing small changes in mass at the metal/dielectric interface.
S. 1.1 Experimental Instrumentation Set-up
The home built spectrometer used in this work is of a common geometrical design in the 
Kretschmann configuration [1], with the modification to include a facility to detect 
fluorescence. As depicted in Figure 3.1, the Surface Plasmon Spectrometer (SPS) consists 
of a Helium-Neon (HeNe) laser (JDS Uniphase, Co, Output power = 5mW, X = 632.8nm) 
that is focused onto the metal/dielectric interface at the base plan of the prism. The laser 
beam passes a fixed frequency precision light chopper (Perkin Elmer, Inc), which cuts the 
incident light at a constant frequency, and the information regarding chopping frequencies 
is fed to the lock-in amplifier (Perkin Elmer, Inc). Light passing through the chopper 
subsequently passes through two polarizers (Melles-Griot, Inc) causing the light to be p- 
polarized. The light is focused onto the back of the thin metal film via a prism. The 
reflected light is detected by a photodiode and amplified by a low power battery amplifier. 
The signal is fed to the lock-in amplifier, which subtracts the received signal when the light 
is chopped (blocked) from that when the light passes through the chopper. Moreover, this 
cleans up the signal by removing any extraneous light, such as that from the laboratory.
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The polarised light is focused on to the base plane o f the high refractive index {n = 
1.84489) LaSFN9 prism (Schott UK, Ltd), which is optically matched to the substrate using 
refractive index liquid (Serie B n  = 1.70, Cargille-Sacher Laboratories Inc). The reflected 
light is focused by a lens (f = 25mm, Ovis) towards the photodiode, which monitors the 
intensity o f the reflected light. As with the chopper, the photo-detector is connected to the 











Shutter Controller Motor-Steering Universel Counter Lock-m Amplifier
Figure 3.1 Surface Plasmon fie ld  enhanced Fluorescence Spectroscopy set-up. With an 
ability to concurrently measure reflectivity andfluorescence.
The addition o f a photomultiplier tube (PMT) (Hamamatsu Photonics UK Ltd) onto the 
goniometer to the rear o f the mounted sample allows for the detection o f light emitted by 
the sample as fluorescence. The emitted fluorescent light is focused by a lens (f  = 50mm, 
Ovis), and then passes through an interference filter, which controls the spectral 
transmission o f the incident light by reflecting one or more spectral bands and transmitting 
others. The filtered incident light strikes the PMT, which is a sensitive device for 
measuring photon count that also amplifies the signal produced by the incident light. The 
PMT is enclosed in a home built protection unit, provided by the Max-Planck Institute, to 
reduce exposure from extrinsic light. A computerized shutter, positioned in front o f the 
HeNe laser beam, cuts the incident light at timed intervals to minimise the exposure o f the 
fluorophore to photobleaching. The PMT is also connected to a photon counter that has an 
automatic shut-off if  the irradiation exceeds a predefined level, preventing damage to the 
fluorescence detection equipment.
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The prism is mounted onto a motorized 2-phase goniometer (Huber GmbH & Co), which 
allows the sample to be rotated to a precise angular position at 0.005° steps in the x and y  
direction. Two x andy tables and two tilting tables allow for optimum control o f movement 
o f the mounted sample. The instrumentation is controlled by a personal computer using 
Windows-plasmon Steuresoftware (Wasplas™) version 2.60 developed by Scheller [2].
The spectrometer is isolated from the external environment by means o f a cushioned 
optical breadboard (Melles Griot, Inc), which aims to minimise interference due to 
vibrations, and a Faraday box to prohibit light infiltration and fluctuations in temperature 
(Figure 3.2).
Figure 3.2 SPR Kretschmann configuration housed within a Faraday box to exclude 
environmental interference.
3.1.2 Flow Cell Set-up
The conventional geometric set-up o f the flow cell used during SPR measurements is 
schematically depicted in Figure 3.3. Initially, a quartz glass flow cell (Herasil, Schott) is 
used in part o f the thesis. However, due to the fragility o f  the glass and general wear over 
time, a Teflon flow cell constructed by the Mechanical Engineering Department o f  the 
University of Bath replaced the quartz flow cell. The Teflon cell is placed onto a quartz 
glass slide o f low florescence (n = 1.46, Schott UK Ltd), with a viton O-ring to seal the 
contact between them. Another O-ring is placed into the rivet on top o f the flow cell, were
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the gold coated high refractive index glass slide (SFL6, n = 1.799, UQG Optics Ltd) is 
placed on top, with the gold layer facing the flow cell. A high refractive index prism 
(LaSFNg, n = 1.845) is optically matched to the base plane o f gold coated slide with Series 
B refractive index liquid ( n = 1.70, Cargille Labs, Ltd). Optical matching between the 
base plane o f the prism and the gold substrate is pivotal to allow unperturbed coupling 
(Figure 3.3)
H eN e Laser
Substrate 
Teflon Flow Cell
Figure 3.3 Schematic o f  the flow  cell set-up
Photodiode-
P r i s m
Gold (Au 111) Film 
Quartz Slide
The flow cell is equipped with an inlet and outlet valve, to which Tygon™ tubing (Cole 
Parmer, UK) with an internal diameter o f 0.76mm is attached (Figure 3.4). The flow cell 
circuit is connected to a peristaltic pump (Rego Analog, Istmatec SA) to ensure the even 
delivery o f the sample. A hypodermic needle (19G 2”, Becton Dickinson UK, Ltd) was 
removed from the luer lock and attached to the each ends o f the tygon tubing. The needle 
ends o f the tygon tubing are inserted into the Eppendorf containing the sample for injection 
into the flow cell. The circulating volume around the flow cell circuit is approximately 
500pl, which circulates at 1.8ml.min_1 (50 RPM, tubing internal diameter = 0.76mm), for 
optimised analyte delivery, while minimising the mass transport effect and the shear force 





Figure 3.4 Schematic o f  the flow  cell circuit.
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3.1.3 Instrumentation Alignment
The alignment of the spectrometer is critical for the accuracy of the measurements 
performed, and must be done before any experimental procedure to ensure the incident 
laser beam is aligned with the centre of the flow cell. Moreover, the reflected laser beam 
must be aligned with the centre of the photodiode, and the emitted fluorescence must be 
aligned with the photomultiplier tube to ensure optimum fluorescence detection.
3.1.3.1 Alignment o f the Surface Plasmon Spectrometer
The alignment of the spectrometer is performed using two iris diaphragm apertures (25mm 
diameter, Ovis). One diaphragm is mounted after the polarizers; to align the incident light. 
With a second diaphragm positioned before the photodiode to align the reflected light.
The detector motor is moved to 180° and the orientation and height of the photodiode is 
adjusted to optimize the position of the reflected light beam into the centre of the 
photodiode. The sample is mounted securely into the holder on the goniometer and the 
sample motor is moved to 45°, while the detector motor moved to 90° (Figure 3.5). In 
accordance with the Laws of Reflection, part of the incident light is reflected as the laser 
strikes the base plane of the prism, and is reflected towards the photodiode through iris 
diaphragm 2 (Figure 3.5). To ensure the incident light and reflected light beams are aligned 
with the centre of the sample flow cell and the photodiode respectively, both iris 
diaphragms 1 and 2 are closed so that only a weak beam of light penetrates the iris’. The 
two tilting tables are manually adjusted to align the height of the reflected laser beam into 
the centre of the iris diaphragms. The tilting table that controls the height of the reflected 
laser beam is aligned to the centre of iris 2 initially. Then, the back reflected beam is 
aligned with iris 1 because the tilting table that controls the height of the reflected beam 
also affects the height of the back reflected beam.
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Figure 3.5 Schematic o f  the practical alignment o f  the spectrometer in accordance o f  the 
laws o f  reflection.
For the accurate alignment o f the system, the incident light at the base plane o f the prism 
and the reflected light at the iris diaphragm 2 should be fixed irrespective o f changes in 
angle o f incidence. The goniometer is adjusted in the z direction until the incident beam 
seen at the base plane o f the prism is fix. The beam can then be adjusted in the x direction 
into the centre o f the sample. The iris apertures are opened when the alignment is 
completed and the measurements are to be started.
3.1.3.2 Alignment o f the Surface Plasmon fie ld  enhanced Fluorescence Spectrometer 
In cases where simultaneous detection o f reflectivity and fluorescence are desired, the
spectrometer must be aligned accordingly. Where dual detection is required, the alignment
o f the SPS is followed as previously reported in section 3.1.3.1, with the additional
alignment o f the photomultiplier tube (PMT). The photosensitive device consists a
photoemissive cathode, which directs the emitted electrons to the photomultiplier. The








Figure 3.6 Schematic o f  the photomultiplier tube
(www. wikipedia. org/wiki/Photomultipliertube)
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The PMT is attached to the backend of the goniometer and can be adjusted in height (y) 
and in the x plane to adjust the orientation and alignment (Figure 3.7). The fluorescence 
collection lens is position in between the sample holder and the PMT. It is placed near to 
the sample to maximize the fluorescence collection area. The centre o f the lens is 
positioned at the same height as the incident laser beam. The optimisation of the 
fluorescence detection unit is achieved by adjusting the position o f the PMT in the x and z 
directions, and performing a fluorescence measurement. The adjustments are repeated until 
a maximum fluorescence value is achieved.
Sample holder
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Figure 3.7 Photograph o f  the Photomultiplier Tube (Hamamatsu) attached to the 
goniometer behind the sample holder.
3.1.4 Measurement Procedure
The measurements performed are recorded as scan curves and resonance kinetic plots. 
After the alignment o f the spectrometer and the loading of the sample onto the goniometer, 
a resonance scan curve is carried out.
3.1.4.1 Surface Plasmon Resonance Spectroscopy Measurement Procedure
The incident light beam focused on to the base plane o f the prism and the reflected light is
monitored at the photodiode, while varying the angle o f incidence. Therefore, the intensity
of the reflected light detected will also vary. This scan curve is a plot o f the normalized
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reflected light intensity verses the incident angle (Figure 3.8). The adsorption o f analyte to 
the surface causes a change in the optical properties o f the metal interface resulting in a 
shift in the resonance scan curve along the x axis (as depicted in Figure 3.8) A scan curve 
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Figure 3.8 Example o f  a resonant scan curve, pre- (blue curve) and post- (red curve) 
analyte binding.
The experiments are followed and monitored by recording the change in reflected light 
intensity detected at the photodiode, and any change in the optical properties o f the 
functionalized surface caused by the adsorption or desorption o f analytes can be visualized 
in real-time. The change in intensity of reflected light is achieved by maintaining a fixed 
angle, at around 1.5° lower than the initial angle o f minimum on the scan curve (usually, 
30% Reflectivity), such that the change in the angle o f resonance gives a linear change in 
the measured reflectivity.
As the optical properties of the functionalized surface change, either through adsorption or 
desorption o f analytes, the reflectivity at the fixed incidence angle also increases or 
decreases respectively (Figure 3.9). In the example in Figures 3.8 and 3.9, the adsorption 
o f the analyte to the surface causes an increase in reflectivity from 30 % to ~ 63% at the 
fixed angle o f incidence, as shown with the shift in scan curves (Figure 3.8) and as 





















Figure 3.9 Resonance kinetic p lot o f  adsorption o f  analyte to the surface. Measured at a fix  
angle o f  incidence, the adsorption o f  analyte to the surface is visualized as an increase in 
reflectivity [R]%.
3.1.4.2 Surface Plasmon fie ld  enhanced Fluorescence Spectroscopy Measurement 
Procedure
The inclusion o f fluorescence measurements along with the standard resonance 
measurements is performed to increase the sensitivity o f detection o f low molecular weight 
analytes or small numbers of analytes, when little or no change is observed with surface 
plasmon resonance spectroscopy. Therefore, this optimizes the signal sensitivity by dual 
detection o f reflectivity and fluorescence.
Much in the same way as with resonance scan curves, measurements o f the intensity o f the 
reflected light at varying angles o f incidence is performed, as well as photon count 
produced by the fluorescent sample detected by the PMT and lock-in amplifier (Figure 
3.10). A background fluorescence o f -5000 counts per second (cps) is detected at angles 
below the critical angle because of the intrinsic fluorescent properties o f the prism. At 
angles above the critical angle, when total internal reflection occurs, the strong evanescent 
field excites the fluorescent molecules which are then detected.
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Figure 3.10 Dual Resonance scan curve, showing the change in reflectivity with varying 
angle o f  incidence (Red plot), and the change in photon count with varying angle o f  
incidence (Blue plot).
The fluorescence kinetics measurement is performed at a fixed angle o f incidence (-30%  
reflectivity), within the linear range of the reflectivity scan curve. This is in order for the 
fluorophores to be under constant excitation conditions and any change in fluorescence is 
due to adsorption or desorption of the molecule and not changes in the angle o f incidence. 
Kinetics measurements involving fluorescence are executed under non-continuous light 
illumination to prevent the photo-bleaching o f the fluorophore. Fluorescence is used in this 
study to provide a means o f observing small changes at the surface that are not easily 
visualized using conventional Surface Plasmon Spectroscopy (Figure 3.11), and shows the 
sensitivity o f this methodology.
100-, Resonance Kenetics Measurement 
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Figure 3.11 Fluorescence Kinetics Measurements, showing an observable change in 
fluorescence over time as a result o f  membrane-pore formation (Blue plot), but little 
observable change in reflectivity (Red plot).
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3.1.4.3 Measurement Sequence
The generalized sequence for the measurement o f adsorption and desorption remains fairly 
consistent, however, the reagents, experimental conditions and analytes usually vary 
between experiments.
The functionalized surface is constructed and monitored with the adsorption of each layer 
being followed by SPR. The analyte components of each layer are dissolved and injected 
into the flow cell after a stable baseline is observed. Running buffer is passed across the 
surface between the addition of each layer to remove any unbound or non-specifically 
adsorbed analytes.
After the adsorption of each layer, a scan curve is performed. The adsorption of the bilayer 
vesicles marks the complete construction of the functionalized surface, and any non­
encapsulated fluorophore can be rinsed away from the flow cell with buffer. Following the 
construction and rinsing of the surface, a fluorescence scan curve is performed to quantify 
the fluorescence intensity.
The monitoring of the adsorption or desorption to/from the model cell membrane (bilayer 
vesicles) is performed either using SPR or combined SPR/SPFS. After the adsorption or 
desorption process, the flow cell is rinsed with buffer, and another scan curve is performed, 
which can be used as a comparison with the previous scan curve to monitor any change in 
the optical properties of the surface, and therefore, any changes in thickness, reflectivity 
and fluorescence.
The sequence of events is repeated for each experimental procedure, unless otherwise 
stated.
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3.2 Surface Preparation & Modification Procedure
In the following section, the preparation and modification techniques used throughout this 
work are explained and described, from the initial cleaning procedure of the glass up to the 
self assembly of the monolayers ready for the tethering of bilayer vesicles.
3.2.1 Substrate Preparation
High refractive index glass (SFL6 , n = 1.7988, UQG Optics Ltd) is used as the substrate, 
onto which the gold is thermally evaporated and the subsequent supramolecular layers are 
attached. Before any modification of the substrate, it is carefully cleaned to remove any 
contaminants. The glass is sonicated in a 2% Hellmanex® II solution (Hellma GmbH & 
Co.KG) for fifteen minutes, and then repeatly washed ten times with Milli-Q® ultrapure 
water (Millipore UK, Ltd) to remove any trace of detergent and contaminants. The glass 
wafers are then sonicated twice for fifteen minutes in absolute ethanol (Fisher Scientific 
UK). The cleaned glass slides are then dried in a stream of nitrogen and immediately 
placed into the UV TipCleaner (BioForce Nanosciences, Inc) for ten minutes, which 
removes debris and organic contaminants by a combination of UV and ozone. The clean 
wafers are then placed immediately into the evaporator for further processing.
When used gold substrates are to be cleaned, the metal films are removed by sonicating the 
gold-glass wavers in a potassium iodide/iodine solution (0.6mmol.dm' 3 KI and 
0.098mmol.dm'3 U, Sigma Aldrich) for fifteen minutes. The glass wavers are then 
repeatedly rinsed ten times with Milli-Q® water, and then cleaned as above.
3.2.2 Thermal Evaporation o f Metal onto Clean Substrate
Clean glass wavers (25mm x 25mm) are placed onto the carrier in the thermal evaporator 
(K975x Turbo Evaporator, Emitech Ltd) and centred over the tungsten basket. 
Approximately 125mg (±lmg) of gold 99.99% (Advent Research Materials Ltd) is rinsed 
with absolute ethanol and placed into the tungsten basket. The evaporator is brought down 
to a vacuum of 3x1 O' 6 mbar, and then a current of 3-4 amps is passed through the tungsten 
element for ten minutes to evaporate the gold onto the glass wavers below. The resulting 
layer of 50nm thermally evaporated gold on high refractive index glass is annealed in a 
furnace at 500°C for ninety seconds, and then allowed to cool to room temperature before 
storing in a holder in a nitrogen atmosphere at +5°C.
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3.2.3 Self-Assembly Procedure fo r  Construction o f  Hybrid Lipid Bilayer
As mentioned in section 1.4.1, self-assembly is based on the spontaneous formation o f
ordered films from solution directly onto a substrate, in this case, gold. This process
provides a means o f producing highly structured systems, with functional group flexibility
which are easy to produce and analyze.
The foundation layer o f the Hybrid Lipid Bilayer (HLB) is produced from the 
cheinisorption o f a sulphur bearing thiol to the substrate. The gold slides are immersed in 
a 1 mmol.dm'3 solution o f l,2-Dipalmitoyl-sw-Glycero-3-phosphothioethanol (DPPTE, 
Avanti Polar Lipid, Inc) (See Figure 3.12) in chloroform for over 16hours at room 
temperature, to ensure the formation of a densely packed and highly ordered monolayer. 
The strong specific interaction between the sulphur-bearing thiol and the gold induces 
spontaneous assembly at the interface. Experimentally, it has been shown that the 
monolayer reaches its equilibrium at around lOOOminutes [3].
Figure 3.12 Schematic o f  DPPTE (16:0), which chemisorbs to the gold substrate
The monolayer coated slides are rinsed with absolute ethanol to remove any non- 
specifically adsorbed thiol molecules and then dried under a stream o f nitrogen before 
being assembled into the flow cell set-up (Figure 3.3), and mounted into the spectrometer 
to follow the subsequent layer formations.
The upper leaflet o f the HLB is composed o f a biotinylated lipid mixed with a natural 
lecithin. OAmg.mL'1 egg lecithin Grade I (Egg PC, Avanti Polar Lipid, Inc) dissolved in 
2:1 (v/v) chloroform.methanol is mixed with l%mol l,2-Dipalmitoyl-s/?-Glycero-3- 
phosphoethanolamine-N-(cap Biotinyl) (DPPE-biotin, Avanti Polar Lipid, Inc). The 
solvent is removed from the dissolved lipid mixture with a stream o f nitrogen, and put 
under vacuum over night to ensure all traces o f solvent have been evaporated and to 
prevent oxidative damage to the phospholipids. After removal o f the solvent, the lipid film 
is rehydrated in HEPES pH7.4 buffer (10 mmol.dm'3 HEPES 99%, 150 mmol.dm'3 sodium 
chloride 99.5%, 2 mmol.dm'3 calcium chloride dihydrate 99%, all reagents from Sigma
o
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Aldrich, in MilliQ water), to give a final Egg PC concentration o f O^mg.mL"1. The 
hydrated suspension is vortexed vigorously for 10 minutes to produce multilamellar 
vesicles. These vesicles are extruded eleven times using a manual LiposoFast extruder 
(Avestin Europe GmbH) and a lOOnm pore diameter polycarbonate membrane to shape 
the multilamellar vesicles into uniformly spherical small unilamellar vesicles (SUV) of 
lOOnm diameter. The vesicles are then allowed to sit for thirty minutes before use to allow 
the vesicles to stabilize. The Egg PC vesicles are introduced into the flow cell and the 
binding o f the vesicles is monitored with SPS overnight to allow the binding, fusion and 
reorientation o f the vesicles to the foundation monolayer (Figure 3.13). This ensures that 
the head groups are orientated towards the aqueous environment. The flow cell is 
subsequently rinsed with fresh buffer to displace any non-specifically bound analyte from 
the surface.





Figure 3.13 Schematic o f  the Hybrid Lipid Bilayer (HLB) attached to the gold  substrate, 
in preparation fo r  the attachment o f  bilayer vesicles via biotin/streptavidin conjugation.
3.2.4 Self-Assembly Procedure fo r  Construction o f  Biotinylated-Thiol. Thiol-Alcohol 
Monolayer
The second procedure for the modification o f the gold substrate for the tethering o f bilayer 
vesicles is the construction o f a biotinylated-thiol SAM. 1 l-mercaptoundecanoic-(8- 
biotinoylamido-3,6-dioxaoctyl)amide (Figure 3.14), known throughout this thesis as 
biotin-thiol, is custom synthesized at the University o f Bath, using a modification o f the 
procedure published by Bushby et al [4].
Figure 3.14 1 l-mercaptoundecanoic-(8-biotinoylamido-3,6-dioxaoctyl)amide
The biotin-thiol is dissolved in absolute ethanol to a 1 mmol.dm'3 stock solution, where it is 
stored at -20°C until use. A 1 mmol.dm'3 stock solution o f 11-mercapto-l-unadecanol 
(Figure 3.15) in absolute ethanol is also prepared and store at -20°C until use.
Figure 3.15 Hydroxyl spacer, 11-mercapto-l-unadecanol, used to control the proportion 
o f  biotin-thiol linker molecule expressed on the surface o f  the gold substrate.
The gold slides are immersed in a mixed ethanolic solution of 0.05mmol.dm'3 biotin-thiol 
and 0.95mmol.dm'3 11-mercapto-l-unadecanol, and allowed to self-assemble onto the gold 
substrate for over 16 hours to ensure maximum surface coverage and optimum orientation 
o f the thiols (Figure 3.16). The excess thiols and non-specifically adsorbed thiols are rinsed 
away with absolute ethanol and dried under nitrogen before being assembled as part o f the 
flow cell.
The self assembled thiol monolayer can then be used to tether bilayer vesicles via 
biotin/streptavidin conjugation
Biotin-Thiol'
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OH spacer
Figure 3.16 Schematic o f  the self-assembly o f  0.05mmol.dm3 1 l-mercaptoundecanoic-(8- 
biotinoylamido-3,6-dioxaoctyl) amide and 0.95mmol.dm3 11-mercapto-l-unadecanol 
hydroxyl spacer.
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3.3 Preparation of Bilayer Vesicles
The use of bilayer vesicles as model membrane systems provides an attractive model 
system because they allow a means of stringently controlling the composition of the 
bilayer vesicles and the extrinsic environment used to study their behaviour. They can 
have a very simple composition to study specific events or can be more complex to mimic 
the composition of cell membranes. Small unilamellar vesicles are usually produced in one 
of two ways: either by sonication or extrusion of the phospholipid suspension.
3.3.1 Preparation o f l,2-Dimyristoyl-sn-Glycero-3-Phosphocholine vesicles
A 4mg.mL' 1 stock solution of l,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC,
Avanti Polar Lipid, Inc) dissolved in 2:1 (v/v) chloroform:methanol is prepared, and kept 
at -20°C until use. lOOpL of the 4mg.mL1 DMPC stock solution is mixed with l%mol 1,2- 
Dipalmitoyl-s«-Glycero-3-phosphoethanolamine-N-(cap Biotinyl) (DPPE-biotin, Avanti 
Polar Lipid, Inc) in a glass vial, and vortexed briefly. The solvent is removed from the 
dissolved lipid mixture with a stream of nitrogen, and put under vacuum over night to 
ensure all traces of solvent have been removed and to prevent the oxidative damage of the 
phospholipids. After removal of the solvent, the lipid film is rehydrated in HEPES pH7.4 
buffer (lOmmol.dm' 3 HEPES 99%, 150mmol.dm'3 sodium chloride 99.5%, 2mmol.dm ' 3 
calcium chloride dihydrate 99%, all reagents from Sigma Aldrich, in MilliQ water), to give 
a final DMPC concentration of 0.4mg.mL‘1. The hydrated suspension is vortexed 
vigorously for lOminutes to produce multilamellar vesicles. These vesicles are extruded 
eleven times using a manual LiposoFast extruder (Avestin Europe GmbH) and a lOOnm 
pore diameter polycarbonate membrane to shape the multilamellar vesicles into uniformly 
spherical small unilamellar vesicles (SUV) of lOOnm diameter. The vesicles are then 
allowed to stand at room temperature for thirty minutes before use to allow the vesicles to 
stabilize.
3.3.2 Preparation o f l,2-Dimyristoyl-sn-Glycero-3-Phosphocholine: Cholesterol vesicles 
A 4mg.mL' 1 stock solution of cholesterol (95%, Sigma Aldrich) in 2:1 (v/v)
chloroform:methanol is prepared and kept at -20°C until use. The DMPC vesicles are
prepared as above in section 3.3.1, with the addition of 30mol% cholesterol to the glass
vial before the removal of the solvent. The inclusion of 30mol% cholesterol into the
bilayer vesicles is determined experimentally in results section 4.7.3.1.
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3.3.3 Preparation o f High Transition Phospholipid Bilayer Vesicles
DMPC has a phase transition temperature of 23°C, meaning the physical state of the lipid
is in the disordered liquid crystalline phase at room temperature (20-25°C). Therefore, the
hydrocarbon chains are randomly oriented and fluid. l,2-Dipalmitoyl-s«-glcero-3-
phosphocholine (DPPC, 99%, Sigma Aldrich) has a phase transition temperature of 41°C,
therefore, will be in the ordered gel state at room temperature where the hydrocarbon
chains are closely packed.
The phospholipid l,2-Distearoyl-s«-glycero-3-Phosphocholine (DSPC, 99%, Sigma 
Aldrich) has a phase transition temperature of 45°C, therefore, is also in the ordered gel 
phase at room temperature. Stock solutions of 4mg.mL' 1 DPPC and DSPC dissolved in 
2:1 (v/v) chloroformimethanol are prepared and stored at -20°C until use. In a 2mL glass 
vial, (Mmg.mL' 1 (lOOpL) of either DSPC or DPPC stock solution is pipetted, with lmol% 
biotin. The solution is vortexed briefly, and the solvent removed using a stream of 
nitrogen. The vial is then placed under vacuum for around 16 hours to remove all traces of 
solvent. The lipid film is rehydrated in HEPES pH7.4 buffer to give a final lipid 
concentration of (Mmg.mL'1. The hydrated suspension is vortexed vigorously for 
lOminutes to produce multilamellar vesicles. The vesicles are extruded eleven times using 
a manual LiposoFast extruder (Avestin Europe GmbH) and a lOOnm pore diameter 
polycarbonate membrane. The vesicles are then allowed to stand at room temperature for 
thirty minutes before use to allow the vesicles to stabilize.
High phase transition temperature vesicles with 48mol% cholesterol are prepared by the 
addition of 0.192mg.mL'1 of either DSPC or DPPC stock solution into a glass vial with
0.192mg.mL'1 cholesterol stock solution and 0.04mg.mL'1 biotin stock solution. The 
solution is vortexed briefly, and the solvent removed using a stream of nitrogen. The vial is 
then placed under vacuum for around 16 hours to remove all traces of solvent. The lipid 
film was then hydrated and processed as above.
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3.3.4 Preparation o f  Ganglioside (GM1) Bilayer Vesicles
Gangliosides such as GM1 (Figure 3.17) are cell membrane glycosphingolipids, which 
modulate cell signal transduction events, and are involved in neuronal plasticity and cell 
membrane repair mechanisms. However, the GM1 cell surface receptor has also been 
exploited by adventitious prokaryotic species such as Vibrio cholerae and Escherichia coli 






Figure 3.17 Monosialoganglioside GM1.
A stock solution o f 4mg.mL‘1 G M 1 ammonium salt from ovine brain (Avanti Polar Lipid, 
Inc) is prepared in 2:1 (v/v) chloroformimethanol, and stored at -20°C until use. A mixed 
solution o f 2mol% GM1, lmol%  Biotin, 30mol% Cholesterol and 67mol% DMPC is 
pipetted from the 4m g.mL'1 stock solutions into a 2mL glass vial and vortexed briefly. The 
solvent is evaporated off using a stream o f nitrogen and place under vacuum for over 16 
hours to remove any residual solvent. The lipid film is hydrated with HEPES buffer pH 7.4 
to a final lipid concentration o f 0.4mg.mL'] and extruded as detailed previously, and stored 
at room temperature for thirty minutes before use.
3.3.5 Preparation o f  Mixed Phospholipid Bilayer Vesicles
A 4m g.ml'1 stock solution o f l,2-Dimyristoyl-s«-Glycero-3-Phosphotidylcholine (DMPC),
l,2-Dimyristoyl-5'«-Glycero-3-Phosphotidylethanolamine (DMPE), 1,2- Dimyristoyl -sn- 
Glycero-3-[Phospho- rac-{\ -glycerol)] (DMPG) and l,2-Dimyristoyl-sn-Glycero-3- 
[Phospho-L-Serine] (DMPS) (All from Avanti Polar Lipid, Inc) are dissolved in 2:1 (v/v) 
chloroformimethanol, and kept at -20°C until use. A mixed lipid solution is prepared from 
the phospholipid stock solutions in the proportions 75% (DMPC) + 20% (DMPE) + 2.5% 
(DMPG) + 2.5% (DMPS). The lipids are vortexed to ensure a homogenous mixture. In a 
small glass vial, the mixed phospholipids are mixed with lmol%  biotin, 30mol% 
cholesterol, and 2mol% GM1 ganglioside. The mixture is vortexed briefly, then prepared 
as in section 3.3.1.
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3.4 Preparation of Protein Solutions and Membrane Binding Agents
All protein solutions are prepared in lOmmol.dm' 3 HEPES (99%), 150mmol.dm'3 sodium
chloride (99.5%), 2mmol.dm' 3 calcium chloride dihydrate (99%) in MilliQ water adjusted 
to pH 7.4, and referred to HEPES 7.4, unless otherwise stated. HEPES is a zwitterionic 
buffer, used for many biological studies because it has been shown to be relatively free 
from side effects [5] and it does not collate metal ions [6 ]. HEPES has also been shown to 
protect lipids against peroxidation [7]. The incorporation of sodium chloride into the 
buffer aids with vesicle stability, but also promotes the adsorption and fusion of the hybrid 
lipid bilayer [8 ]. The inclusion of CaCh into the buffer promotes tethered vesicle stability, 
and has been suggested to prevent tethered vesicles from fusing [8 ].
3.4.1 Streptavidin
A 5pmol.dm ' 3 stock solution of streptavidin from Streptomyces avidinii is prepared in 
HEPES 7.4 and stored at +5°C until use. A 500nmol.dm'3 solution is prepared and 
injected onto the functionalized surface, which binds with great affinity to the biotinylated 
layer.
3.4.2 Phospholipase A2
A 3.3x10' mol.dm' 3 (39Units/mL - one Unit liberates lpmol of acid from soybean lecithin 
per minute at 25°, pH8.9 ) stock solution of phospholipase A2 from Crotalus adamanteus 
(PLA2, Worthington Biochemical. Co) is prepared in HEPES 7.4 and stored at +5°C until 
use. Dilutions of PLA2 are made from the stock solution to give final concentrations in 
the range of 3.3x10'8mol.dm' 3 to 3.3xl0'9mol.dm ' 3 in HEPES 7.4.
3.4.3 Crotalus adamanteus venom
Crotalus adamanteus (Eastern Diamondback Rattle snake, Sigma Aldrich) venom is 




A 5.745nmol.dm' stock solution of Cholera ap-toxin (95%, Sigma Aldrich) from Vibrio 
cholerae in HEPES 7.4 is prepared, and stored at -20°C until use. Working solutions 
ranging between 0.01149pmol.dm'3 to 1.149nmol.dm'3 are prepared from the stock 
solution in HEPES 7.4.
A 21 nmol.dm ' 3 stock solution of Cholera P-subunit (95%, Sigma Aldrich) from Vibrio 
cholerae in HEPES 7.4 is prepared and stored at -20°C until use. Working solutions 
ranging between 42pmol.dm' - 4.2nmol.dm* are prepared from the stock solution in 
HEPES 7.4.
3.4.5 fi-amyloid 1-42
A 2mmol.dm ' 3 stock solution of P-amyloid 1-42 (Ultra pure, TFA, rPeptide) in DMSO is 
prepared, sonicated for thirty minutes and stored at -20°C until use. Working 
concentrations ranging between 0 .1- 1 0 pmol.dm ' 3 are prepared from the stock solution in 
HEPES 7.4
3.5 Preparation of fluorophores
Fluorophores are highly photosensitive and prone to photobleaching, therefore, prepared 
fluorophores are kept at -20°C in the dark.
3.5.1 BODIPY 650/665-XSTP ester
A 1 mmol.dm' stock solution of 6-(((4,4-difluoro- 5-(2-pyrrolyl) -4-bora-3a,4a- diaza-s- 
indacene- 3-yl)styryloxy) acetyl) aminohexanoic acid, sulfotetrafluorophenyl ester, 
sodium salt (Molecular Probes, Invitrogen, Co) is prepared in HEPES 7.4 buffer, and 
stored at -20°C in the dark until use. Preliminary experiments use a working fluorophore 
concentration of lOOnM, but is subsequently revised to 5pmol.dm'3.
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3.6 Preparation of inhibitors
Phospholipase A2 inhibitors and cholera toxin antagonists are prepared and stored as 
follows.
3.6.1 Eicosadienoic acid (DEDA)
A 3mmol.dm'3 stock solution o f 7,7 Dimethyl-(5Z,8Z)-eicosadienoic acid (95%, Sigma 
Aldrich) in chloroform is prepared and stored at -20°C  until use. Working concentrations 
of the inhibitor are prepared between 3mmol.dm'3 and 0.3mmol.dm'3. Experiments using 
DEDA (Figure 3.18) as a potential antagonist to PLA2 are prepared by aliquoting the 
inhibitor into a glass vial and removing the chloroform using a stream of nitrogen. The 
film is resuspended to the desired concentration in HEPES 7.4. Experiments using the 
inhibitor as a competitive inhibitor to PLA2 are prepared by aliquoting the inhibitor into 
the vesicle/solvent suspension and removing the solvent using a stream o f nitrogen. The 
film is place under vacuum for over 16 hours to remove all the residual solvent. The lipid 
film is resuspended in HEPES 7.4 to give a final lipid concentration of OAmg.mL'1 with 
the desired concentration o f DEDA. The suspension is vortex vigorously for 10 minutes to 
produce multilamellar vesicles, which is subsequently extruded as describe previously in 
section 3.2.3 to produce small unilamellar vesicles with DEDA incorporated into the 
vesicle bilayer.
Figure 3.18 Schematic o f  7,7-Dimethyl-(5Z,8Z)-eicosadienoic acid  
3.6.2 Manoalide
o n
A 6x10' mol.dm' stock solution of 4-[3,6-Dihydro-6-hydroxy-5-[4-methyl-6-(2,6,6- 
trimethyl- l-cyclohexen-l-yl)-3-hexenyl] -2H-pyran-2-yl]- 5-hydroxy-2- (5H) - furanone 
(Manoalide, 75%, Sigma Aldrich) is dissolved in ethanol and stored at -20°C until use. 
The PLA2 inhibitor, manoalide (Figure 3.19) is aliquoted into glass vials to prepare the 
working concentrations o f 6 x 10*8mol.dm’3 to 2 .4xl0’9mol.dm'3. The solvent is removed 






Figure 3.19 Schematic o f  Manoalide
3.6.3 Europium III chloride
A lOOpmol.dm'3 solution o f europium III chloride anhydrous (99.99%, Sigma Aldrich) in 
HEPES 7.4 is prepared and stored at +5°C until use. Working solutions o f O.lpmol.dm'3 to 
100 jimol.dm'3 europium III chloride (EuCb) are prepared in HEPES 7.4 from the stock 
solution.
3.6.4 Other lanthanide trivalent compounds
lOOpmol.dm'3 solutions o f lanthanum III nitrate, terbium III chloride, erbium III chloride, 
gadolinium III chloride and ytterbium HI chloride (99.99%, Sigma Aldrich) in HEPES 7.4 
are prepared and stored at +5°C until use. Working solutions o f lOpmol.dm'3 the 
lanthanide trivalent compounds are prepared in HEPES 7.4 from the stock solution.
3.7 Preparation o f tethered biom im etic m em brane vesicle slides for 
electron m icroscopy
Lipid vesicle films are rehydrated in HEPES 7.4 to the desired concentration and extruded 
as mentioned previously in this chapter. The unilamellar vesicles are tethered to the solid 
support, and after adsorption, the gold coated substrate is removed from the flow cell set­
up for fixing and staining for examination under the electron microscope. The tethered 
vesicle substrates are immersed in a 2% glutaraldehyde solution (25% EM grade, Agar 
Scientific Ltd) for 30 minutes to fix the specimen. The fixed lipid vesicles are then 
immersed in a 1% osmium tetraoxide solution (2% solution, Agar Scientific Ltd) for 20 
minutes, which acts both as a biological fixative and a stain. After immersion, the 
substrates are rinsed carefully with HEPE 7.4 and then air dried before examination under 
the scanning electron microscope.
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4.0 Solid Supported Lipid Bilayer Vesicles: Method to 
Study Membrane Permeation & Lysis
The immobilization of cell membrane models to a surface provides a means of studying 
simple ligand-analyte interactions involving the cell surfaces using a range of surface 
sensitive techniques that would otherwise be unavailable for their characterization and 
observation. A detailed description of the functionalized surface and its application in 
studying membrane permeation processes caused by lipases is presented. The binding 
constants for the construction of the surface and membrane permeation processes are also 
detailed.
Chapter Synopsis
Biological membranes are very diverse and contain a huge assortment of macromolecules. 
However, it can be difficult to study these membranes and/or events that occur at these 
surfaces in detail. Therefore, a simple and reliable artificial cell membrane model has been 
developed. Preliminary measurements regarding the construction of these biomimetic 
membranes will be discussed. Attention will be focused on the effects that snake venom 
and phospholipase A2 has on these biomimetic membrane models and the determination of 
binding constants. Optimization of the biomimetic membrane vesicles will be performed to 
ensure a stable system to monitor these binding events, and includes the development of a 
simple theoretical model to determine the diffusion constant for the movement of solutes 
from the cytoplasmic face to the extracellular face of the membrane. Finally, the inhibition 
of these lipolytic toxins will be detailed.
4.1 Construction of the Hybrid Lipid Bilayer Surface
l,2-Dipalmitoyl-s«-Glycero-3-Phosphothioethanol (DPPTE) was self-assembled from 
solution onto a thin metal-film. The assembly of this layer was not followed 
spectroscopically because self-assembled monolayer (SAM) coated slides must be rinsed 
and dried thoroughly before the addition of the subsequent biological layers. A small 
amount of solvent can cause defects in the SAM. Therefore, the most reliable method was 
to form the SAM outside of the spectrometry setup and assemble the flow-cell after the 
thorough rinsing and drying of the substrate.
The formation of a monolayer is influenced by a number of factors, including temperature, 
solvent, concentration and chain length of the adsorbent, and the cleanliness of the
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substrate. The use of absolute ethanol as the solvent was preferred because of its high 
purity, low cost, low toxicity and it has a low tendency to incorporate into the monolayer 
[1]. It has been reported that the initial formation of a monolayer is rapid, and a clean gold 
substrate immersed in a 1 mmol.dm' 3 long-chain alkanethiol solution in ethanol is 
autophobic, whereby the solvent peels away to leave a dry surface when the substrate is 
removed from the solvent [1]. Using ellipsometry, it has been proposed that 80-90% of the 
maximum SAM thickness is reached within the initial few minutes. However, it is 
followed by a slower period which lasts several hours, and promotes the formation of an 
organized, well-defined film. The slower phase of additional adsorption and consolidation 
is believed to involve the displacement of contaminants, expulsion of solvent from the 
monolayer, and lateral diffusion on the surface to minimize defects [2]. The limiting 
properties of an alkanethiol SAM are typically reached within 1000 minutes, therefore, the 
SAM was allowed to reach its limiting properties at room temperature. The shift in the 
resonance minimum observed after the chemisorption of the SAM to a bare gold-coated 
substrate (Figure 4.1) was proportional to the layer optical thickness. Providing the 
refractive index of the adsorbent is know, it was possible to determine the thickness of the 
adsorbed material. It was shown that the SPR signal correlates to the absolute surface 
concentration, and a surface concentration correlation (A0/a) for this SPR system was 
equal to 0.1868° (ng.mm' 2) ' 1 [3]. Moreover, the adsorption of biological molecules can 
then be determined from the empirical relationship between the shift in resonance 
minimum, A0, and the surface concentration correlation, A0/cj:
Adsorption (A) = —— —(n g m m 2)
A O la
4.1
The correlation applies for commonly used biological molecules, since they have similar 
refractive indices and do not differ considerably with respect to their SPR response [4], 
The SAM was quantitatively determined from the shift in resonance angle after the 
adsorption of the monolayer to the bare gold substrate (Figure 4.1).
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Figure 4.1 Scan curves fo r  the formation o f  several DPPTE SAM on thin gold-coated 
substrates.
A 0.94° shift in resonance minimum was observed upon the adsorption o f an average 
DPPTE monolayer on the gold substrate, which equated to the adsorption o f 5.04ng.m m 2 
(standard deviation ±0.8) mass to the surface. The subsequent formation o f the 
supramolecular layers was followed spectroscopically using SPR.
5x l0 '4mol.dm3 egg phosphatidylcholine (egg PC) + lmol%  biotin vesicles were added to 
the DPPTE SAM layer and allowed to bind, rupture and fuse for lOOOminutes to form a 
biotinylated hybrid lipid bilayer (HLB) (Figure 4.2) This resulted in the production o f a 
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Figure 4.2 The binding kinetics o f  Egg PC vesicles, forming the upper leaflet o f  the HLB 
on the gold-coated substrate. The Langmuir simulation is highlighted.
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The hydrophobic residues that terminate the DPPTE SAM causes a single egg PC 
monolayer to form via the delamination o f the egg PC bilayer vesicles (as discussed in 
chapter 1.4.2). The formation o f the egg PC SAM followed a typical Langmuir isotherm. 
Here, the upper leaflet formed via a two-step mechanism, with around 90% o f the total 
mass adsorbed during the initial fast step. The remaining adsorption occurred during the 
subsequent slower step, where further lipids adsorb and laterally diffuse to create a well- 
packed upper leaflet. There was an observable overshoot in egg PC binding as the system 
attempts to reach equilibrium. During this time, there was more adsorbent bound to the 
surface than there was at equilibrium because there was a time delay before desorption 
commenced to reach a state o f equilibrium [5]. The association rate constant, kon, and the 
dissociation rate constant, k0jf, were 345.66mol', .Ls' 1 and 0.07827s'1 respectively for the 
addition o f the egg PC vesicles. Further analysis enabled the quantitative determination o f 
the equilibrium binding constant, Kd, to be 2.26x1 O^mol.dm'3, which was relatively weak 
compared to many biological analyte-ligand interactions.
The adsorption o f the egg PC monolayer to the DPPTE lower SAM leaflet showed a 
typical increase in mass at the surface o f around 13.65 ng.mm2, as a result o f a 2.55° shift 
in the resonance minimum (Figure 4.3).
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Figure 4.3 Resonance shift upon the formation o f  a standard HLB o f  egg 
phosphatidylcholine on a DPPTE SAM.
The formation o f the biotinylated support layer allowed for streptavidin-biotin conjugation 
chemistry to be employed to act as a capture for biotinylated biomimetic membrane 
vesicles. The high affinity between streptavidin and biotin ensured a quick and tight
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association. The complex formation between the streptavidin and biotin occurs though a 
series o f non-covalent interactions. The high affinity interaction is the result o f multiple 
van der Waals and hydrogen bonds which causes the ordering o f surface polypeptide loops 
to bury the biotin into the streptavidin interior [6 ]. The mass adsorption o f streptavidin to 
the functionalized surface was calculated to be in the region o f 2.94ng.mm '2 (Figure 4.4). 
This was in good agreement with work carried out by Vareiro, who observed a streptavidin 
adsorption o f 2.54ng.mm ’2 to a mixed thiol SAM [7]. The number of streptavidin 
molecules bound to the biotinylated support system was estimated assuming a mass o f one 
streptavidin molecules was equal to 9.97x10'20grams (i.e. 60000 MW/6.02 x 1023), 
therefore, the number o f streptavidin molecules bound to the surface was 2.95x10 19mm '2 
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Figure 4.4 Adsorption o f  500nmol.dm3 streptavidin to the biotinylated HLB, and scan 
curves before and after streptavidin adsorption.
Biomimetic membrane vesicles, comprising 1% biotin and 99% DMPC were prepared and 
adsorbed to the functionalized surface. The tethering o f the vesicles to the substrate surface 
occurred through the biotin-streptavidin coupling, and was monitored as a change in the 
resonance minimum (Figure 4.5).
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Figure 4.5 Shift in resonance minimum upon biomimetic membrane vesicle adsorption to 
the functionalized surfaces.
The shift in resonance minimum resulted in a 1.07ng.mm'2 increase in mass at the surface. 
The attachment o f the bilayer lipid vesicles completed the construction o f the 
functionalized surface, and is schematized in Figure 4.6. The binding o f specific adlayers 
was quantitatively determined, along with the maximum expected response.
The tethered vesicles were produced by a physical preparatory method that ensured the 
homogeneity o f the vesicle population. Therefore, the dimensions o f the vesicle were; 
outer diameter = lOOnm (determined by the polycarbonate membrane pore diameter), 
internal diameter =90nm, and membrane thickness =5nm [8 ]. Moreover, it was possible to 
determine the total number of lipids comprising a single vesicle, 95000 lipids, vesic le1. The 
weight o f  a single vesicle was 1.07xl0 '16g. The maximum theoretical response for vesicle 
attachment would be 2.95x1020 mm '2 {i.e. the number o f streptavidin molecules bound to 
the biotinylated support system). However, because the vesicles were lOOnm in diameter, 
it was only possible for a maximum o f l x l 0 8vesicles.mm '2 to attach. The observed 
resonance shift for the attachment o f the bilayer vesicles was 0.5°, which equated to the 
adsorption o f 1.07ng.mm'2 mass at the surface. Therefore, the observed number o f vesicles 
which bound to the surface was around lxlO7 vesicles.mm'2.
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Figure 4.6 Schematic representation o f  the HLB solid supported model cell membrane 
vesicles, (a) 50nm thin metal film-coated substrate, (b) 1,2-dipalmitoyl-sn-glycero-3- 
phosphothioethanol (DPPTE) thiol chemisorbed SAM, (c) egg-phosphatidylcholine mixed 
with (d) 1 mol% dipalmitoyl-phosphoethanolamine-N-biotinyl (DPPE-biotin) SAM forming 
the HLB, (e) Streptavidin, (f) 1 mol% DPPE-biotin incorporated into (g) 1,2-dimyristoyl- 
phosphtidylcholine(DMPC) artificial cell membranes.
The results obtained for the binding o f the biological adlayers to the gold substrate are 
summarized in Figure 4.7.




Number o f  molecules adsorbed 
(mm2)
DPPTE 0.94° 5.04 4.17 x 1012 DPPTE molecules
Egg PC 2.55° 13.65 1.14 x 108 vesicles
S treptavidin 0.55° 2.94 2.95 x 10iu streptavidins
Vesicles 0 .2 ° 1.07 1 x 1 0 7 vesicles
Figure 4.7 Mass adsorption o f  the adlayers; DPPTE, Egg PC, streptavidin and biomimetic 
membrane vesicle attachment, with the corresponding number o f  single molecules/vesicles 
adsorbed to the surface.
4.2 Scanning Electron Microscopy of the HLB-Tethered Biomimetic 
Membrane Vesicles
Scanning electron microscopic measurements o f  the tethered vesicles were made to ensure 
the vesicles remained intact and to image the lateral spacing o f the vesicles on the surface. 
Measurements were made on a JEOL JSM6480LV scanning electron microscope (SEM), 
at the Centre for Optical Studies, University o f Bath. The HLB solid supported bilayer
vesicles were fixed with 2 % glutaraldehyde, followed by staining with 1% osmium 
tetraoxide, and viewed under low vacuum (Figure 4.8).
Figure 4.8 Electron micrograph o f  the HLB-tethered biomimetic membrane vesicles 
(bright white/grey circles), under low vacuum (magnification = x5,000).
It can be observed that the bilayer vesicles tethered to solid supports using coupling 
chemistry (vesicles can be seen as lighter spheres on the darker backdrop). The 
visualization o f the tethered vesicles showed intact vesicles on the solid substrate. 
Decoupling the biotinylated lipid vesicles from the solid surface using the biotin- 
streptavidin anchors ensured the vesicles did not come into direct contact with the solid 
surface, and therefore rupture. Observed in the micrograph, are small areas o f black 
colouration in the solid surface (Figure 4.8). These are pin-hole defects caused during the 
thermal evaporation and annealing o f the gold to the glass substrate.
4.3 Preliminary Measurements of the Permeation of Tethered Vesicles 
Using Surface Plasmon Resonance Spectroscopy
The HLB tethered vesicles system allowed for the real-time monitoring of biological 
interactions between a crude lipolytic enzyme and the membrane surface using SPR.
4.3.1 Real-time Monitoring o f  Biomimetic Membrane Vesicle Hydrolysis by Lipolytic 
Toxins
The production o f the stable cell membrane mimic allowed for the real-time monitoring of 
membrane hydrolysis as a result o f toxin-membrane interactions. To ensure permeation 
was observable using SPR, the constructed surface was immediately followed by the 
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Figure 4.9 Construction o f  the functionalized surface, and the subsequent lysis o f  the 
biomimetic membranes using a lytic peptide (C. adamanteus venom), and the resonance 
minimum shift fo r  the desorption o f  mass from the surface as a result o f  membrane lysis.
The desorption o f mass from the surface, as a result o f the lytic toxin, caused a 0.75° shift 
in the resonance minimum, which equated to a 4.0ng.mm '2 mass desorption. Therefore, it 
shows the proof-of-principle that permeation processes were directly observable.
4.3.2 Monitoring Permeation Processes Using SPR and SPFS
The evanescent wave can be used to excite fluorescent molecules within the depth o f its 
field (typically within 200nm of the surface), at the metal/dielectric interface. Therefore, if 
a fluorescently excitable molecule is present at the interface it can be excited by the energy 
wave, and an intense fluorescent signal can be observed. Moreover, both reflected light 
intensity and fluorescence can then be measured simultaneously.
A method to detect permeation processes, as a result o f lytic peptides and toxins, using 
fluorescence was implemented to monitor the flux o f dye molecules from the interior 
aqueous space o f the bilayer vesicles into the bulk solution. The aqueous space o f  the 
vesicles were loaded with 5(imol.dm '3 BODIPY dye, and using the biotin-streptavidin 
supramolecular support surface, were tethered within the evanescent energy field. As a 
result o f permeation processes, the dye molecules were released from the aqueous space of 
the biomimetic membranes and diffuse into solution and out o f the path o f the energy field. 
Therefore, any dye molecules released as a result o f permeation are followed in real-time. 
The HLB support acts to decouple the fluorescent dye molecules from the surface, because 
gold is an efficient fluorescence quencher via Fluorescence Resonance Energy Transfer
106
(FRET). Since FRET is distance dependant, decoupling the dye molecules from the gold 
surface ensures spatial separation [9].
The biotinylated-SAM-streptavidin matrix was employed to exert spatial control over the 
fluorophore distance from the surface ( z direction) and vesicle density (x-y direction).
The introduction o f the lipolytic venom to the tethered vesicles was followed as a change 
in mass density at the surface caused by the hydrolysis o f the phospholipids, and as a 
change in fluorescence (Figure 4.10).
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Figure 4.10 Simultaneous monitoring o f the change in reflected light intensity (SPR) and 
the change in fluorescence (SPFS) on the addition o f  crude PLA2 (C. adamanteus venom) to 
the solid supported biomimetic membrane vesicles.
The injection o f the lipolytic venom at 45 minutes showed a decrease in detected light 
intensity as a result o f a decrease in mass at the membrane surface. This was subsequently 
followed, three minutes after the start o f vesicle hydrolysis, by a 90.7% decrease in 
fluorescence over a 10 minute period, which was observed as a 78704 counts per second 
(cps) decrease in measured fluorescence.
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4.4 M easuring the Dose-Response o f L ipolytic Peptides on Biom im etic  
M em brane Vesicles
Direct membrane lysis can be induced by a range o f lytic peptides and toxins. This 
lipolysis can be provoked by purified phospholipase A2 and crude PLA2 which is found in 
various venoms.
4.4.1 Phospholipase A 2
PLA2 is a lipolytic enzyme that specifically hydrolyzes the sn-2 acyl ester bond of
phospholipids (Figure 4.11). This hydrolysis liberates a lysophospholipid, causing a
change in the membrane fluidity and permeability. However, it can also be converted to a
platelet-activating factor which is involved in signalling pathways. The hydrolysis o f the
phospholipid also liberates a free fatty acid (arachidonate), which modulates ion channels
and is a precursor for the production o f eicosanoids [10]. Both eicosanoids and platelet-
activating factors are key mediators o f inflammation. The proposed hydrolytic mechanism
primarily involves the polar part o f the substrate, i.e. the carbonyl oxygen o f the ester
bond, and occurs through a nucleophilic attack [ 1 1 ].
x1
0
0 = P - 0 ‘
H ?
2h c — c — c h2^ 1 1  *■
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Figure 4.11 The hydrolysis o f  a phospholipid at the sn-2 acyl ester bond to liberate a 
lysophospholipid and a free fatty acid
Phospholipases are found in a variety of forms and in a range o f biological systems. These 
enzymes share a common role in the metabolism o f phospholipids. At present, there are 
fourteen different groups o f phospholipases (Figure 4.12) characterized according to their 
structure, molecular weight and substrate preference [12]. Their locations are either 
grouped as secretory or cytosolic. Type I PLA2 have a physiological and pathological role 
in mammals, and have been shown to be present in pancreatic juice for the digestion o f 
phospholipids in food [13]. Moreover, type I pancreatic enzymes contribute to the 
pathogenic pathway in acute pancreatitis, where it combines with bile salts and contributes
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to the development o f parenchymal necrosis [14]. The other form o f  type I PLA2 is found 
in snake venoms. The type II PLA2 have been shown to be constitutively expressed in 
several tissues, including the spleen, intestine, liver and thymus. This group has been 
linked to organ related inflammatory responses. Group II PLA2 have recently been 
proposed to have a central role in the development of severe acute inflammatory diseases, 
and its levels have been shown to increase in patients suffering from bacterial infections, 
sepsis and multiple organ failure [15]. However, this group o f PLA2 has marked 
antimicrobial properties, and is believed to have a possible role in the innate immune 
response against pathogens such as Staphylococcus aureus [15]. Group II PLA2 enzymes 
are distributed in trace amounts in various mammalian tissues naturally, but are found in 
high levels in inflamed tissues, such as in patients suffering from rheumatoid arthritis and 
septic shock. There is also a significantly higher tissue level o f membrane-associated PLA2 
in breast cancers compared to benign breast tumours or normal breast tissue [16]. The 
85kDa group IV and the 14 kDa group II secretory PLA2 are involved in inflammatory 
diseases through the metabolism of intracellular arachidonic acid. Group IV PLA2 are also 
involved in the development o f the allergic reactions and parturitation [17].




I A Cobra, kraits venom 13-15 secreted mmol.dm'3
B Porcine/human pancreas 13-15 secreted mmol.dm'3
II A Rattlesnake, viper venoms, human 13-15 secreted mmol.dm'3
B
synovia, platelets. 
Gaboon viper 13-15 secreted mmol.dm'3
C Rat/mice testes 15 secreted mmol.dm’3
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VII A Human plasma 45 secreted none
B Bovine brain 40 cytosolic none
VIII A Human brain 26 cytosolic none
B Human brain 26 cytosolic none
IX Snail venom 14 secreted mmol.dm'3
X*
XI A Green rice shoots 12.4 cytosolic none




* Not sufficiently characterized.
Figure 4.12 Classification o f  phospholipase A2 [18, 19].
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PLA2 has been shown to regulate certain functions in the brain, and modulates the levels o f 
secondary messengers, such as arachidonate, eicosanoids and the platelet-activating factor. 
It has been postulated that the enzyme plays a role in neurotransmitter release, long-term 
potentiation (increase in the strength o f a chemical synapse), membrane repair, 
neurodegeneration, apoptosis and ethanol tolerance [20]. PLA2 role in membrane repair 
involves the removal of peroxidized phospholipids by reduction and re-esterification, 
because peroxidized lipids may introduce defects in the membrane and lead to alterations 
in membrane permeability. However, this repair mechanism may also cause areas of 
neuronal degradation, because removal o f  phospholipids from the neurons may lead to loss 
o f essential membrane phospholipids and cause the accumulation o f harmful by-products 
such as free fatty acids. In chronic neurodegenerative disorders, such as Alzheimer’s 
disease, there is abnormal phospholipid metabolism accompanied by elevated activity of 
PLA2 [2 1 ].
Another major source o f PLA2 enzymes are the venoms o f various insects and snakes. As 
mentioned in section 1 .2 , these venoms are typically complex mixtures o f toxins and 
peptides that exert an array o f deleterious effects including neurotoxicity, myotoxicity, 
cardiotoxicity and inflammation. They directly lyze the membranes and cause significant 
necrosis, inflammation and tissue destruction (Figure 4.13). These toxins are typically 
produced as offensive and defensive mechanisms for the capture o f prey, to defend against 
predation and to initiate digestion.
(Picture source: http://sidewnder78.tripod.com/thesidewinderranchenglish/index.html)
Figure 4.13 Tissue damage, necrosis and inflammation o f  the leg and foo t caused by the 
envenomation by the Naja kaouthia (Thai cobra) and in the arm caused by the 
envenomation by the Crotalus atox (Western diamondback rattlesnake) respectively. }
Two basic secretory-PLA2 (S-PLA2) from Vipera russelli and Trimeresurus flavoviridis 
show similar binding affinities and homologies, however, they attack different organs and 
induce different symptoms [22]. This apparent target specificity observed between the
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enzymes and the membrane is better perceived as a specificity for particular phospholipid 
domains compared to actual membrane targets. It has been shown that these enzymes have 
a preference for certain phospholipid species; phosphatidylcholine > phosphatidylserine > 
phosphatidylethanolamine [23]. This preference to phosphatidylcholine probably arose 
because the extracellular face of membranes are typically rich in this lipid species [24], 
compared to the cytoplasmic face of the membranes which are richer in 
aminophospholipids, phosphatidylserine and phosphatidylethanolamine. The specificity 
results from head group preferences due to the difference in their ability to bind to the lipid 
interface [25].
Typical peptides found in snake venoms include proteolytic enzymes, collagenase, 
hyaluronidase, phospholipases, RNase, DNase, phosphodiesterase and acetylcholinesterase 
[26]. The components of the venoms work synergistically with each other, thereby 
increasing the potency of the whole venom compared to the individual fractions. These 
snake venoms tend to be highly stable and resistant to temperature changes, drying and 
drugs. The snake venom S-PLA2 are grouped as type I PLA2 from the Elapidae and 
Hydrophidae groups, and type II PLA2 from Crotalidae and Viperidae group. The S-PLA2 
all have a similar molecular mass in the range of 14 kDa, and have a similar requirement
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for millimolar concentrations of Ca for the effective hydrolysis of the membranes at an 
optimum pH of 8.0-9.0 [27]. The levels of PLA2 in the venoms of the elapine, viprine and 
crotaline subfamilies has been shown to be statistically indistinguishable, but demonstrate 
a difference in enzymatic activity [28]. The Crotalinae (pit vipers), which include the 
rattlesnakes, contain venom that causes increased permeability of the capillary membranes, 
and results in the extravasations of electrolytes, albumin and red cells into the envenomed 
site. Altered permeability of the red-cell membranes may lead to haemolysis and the 
necrosis of skeletal muscle fibres.
The requirement for Ca2+ as a co-factor has been proposed to mediate the enzymatic 
reactions at the lipid-aqueous interface and the binding of the substrate [29]. The ion 
provides two ligation positions, one to lower the activation barrier for hydrolysis and the 
second to aid substrate binding and correct orientation [30], The calcium ion orientates and 
polarizes the carbonyl group of the phospholipid, resulting in a more positive charge on the 
phospholipids, which favours a nucleophilic attack by the PLA2 enzyme. The enzymes are 
capable of hydrolyzing monomeric, micellar and bilayer phase phospholipids, however,
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their catalytic activity is significantly increased (up to 1 0 ,0 0 0 -fold) during aggregate 
hydrolysis [31]. As the substrate o f the enzyme reaches its critical micellar concentration 













Figure 4.14 Interfacial activation o f  PLA2 as a function o f  phospholipid concentration. 
Increase in activity upon reaching and exceeding the Critical Micellar Concentration 
(CMC) [32].
Various models have been proposed concerning the interfacial activation properties of the 
enzyme. These models include the possibility that the enzyme is held at the interface and 
the phospholipids diffuse laterally, increasing the rate o f hydrolysis [33]. Another 
suggested model results from the substrate being confined to a preferential conformation, 
compared to monomeric phospholipids which possess additional conformational and 
rotational freedom [34]. It has also been suggested that the phospholipids alter 
conformation at/above the CMC, and ‘kinks’ appear in the fatty acid chains of the 
phospholipids [35]. This could cause defects in the bilayers and allow for increased PLA2 
enzymatic activity. Many o f these models have be developed using a range o f approaches 
including the application o f molecular dynamics [36] to simulate the behaviour o f the 
enzyme with phospholipids in different states o f aggregation (Figure 4.15).
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Figure 4.15 Molecular dynamic simulation o f  the phospholipase A2 enzyme binding to a 
disordered lipid bilayer [36].
4.4.2 Crotalus adamanteus venom
There are around 8000 venomous snake bites a year in the USA, which lead to around 10- 
15 death per annum, and the rattlesnakes causing around two-thirds o f these bites [37]. The 
C.adamanteus is the largest rattlesnake, and is reputed to be the most venomous snake in 
the United States, injecting between 370-720 mg of venom per envenomation [38]. The 
venom of this snake is particularly toxic, with a calculated lethal dose o f LD50 = 100- 
150 mg for humans [39]. If an envenomed bite remains untreated there is a 10-20% 
lethality rate. Localized effects include pain, severe swelling, bruising and blistering. 
These are typically accompanied by moderate to severe necrosis, myotoxicity and 
coagulopathy [40]. The venom alters blood fibrinogen, causing an anti-coagulating action, 
and has a marked proteolytic and lipolytic action. The lipolytic actions of PLA2 causes an 
inhibition o f blood coagulation because phospholipids typically accelerate clot formation 
by providing a surface on which the clotting factors interact [41]. The proteolytic and 
lipolytic enzymes facilitates the digestion of prey, assists the entry o f the snake’s digestive 
secretions into the prey, inhibits bacterial activity and therefore reduces the putrefaction of 
the prey before it can be digested [42],
4.4.3 Catalysis o f  the Substrate by Phospholipase A2
The catalytic actions exhibited by the lipolytic enzyme occurs at the lipid-aqueous 
interface, and is dependant on the chemical structure o f the phospholipids and the physical 
structure o f the aggregate formed. It has been observed that most S-PLA2 can not readily 
hydrolyze densely packed monolayers and bilayers o f zwitterionic phospholipids, because 
they tend to contain few defects and the fatty acid chains tend to be well aligned and 
packed. Therefore, it is difficult for the enzyme to gain access to the sn-2 acyl bonds of the
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phospholipids for hydrolysis. The kinetics for substrate hydrolysis typically contains a lag 
phase (Figure 4.16). The latency period and the slow activation o f the enzyme is the period 
needed for the enzyme to penetrate the aggregate phospholipids and initiate hydrolysis.
1 6 0 0 - enzyme-substrate complex formation
1 4 0 0 -
1200 -
«5 6 0 0 -
Latency Period
4 0 0 -
2 0 0 -
Time (min)
Figure 4.16 Simulation o f  the latency period during the action o f  PLA2 on aggregate
phospholipids.
The period o f low enzymatic activity is followed by a burst in activity, which is believed to 
be caused by the accumulation o f hydrolysis products (free fatty acid and 
lysophospholipid) [43]. This causes an alteration in the susceptibility o f the phospholipids 
to degeneration. The duration o f  the latency period is determined by a number o f factors, 
including substrate concentration, calcium concentration, and the accumulation o f 
hydrolytic products. Defects in the aggregated phospholipids, lipids in the liquid phase, 
and phospholipids with unequal chain lengths, all promote hydrolysis, and will ultimately 
decrease the latency period. The initial interfacial binding step is represented as:
E + s f _ E * s f _ E * P ^ _ E  + P
4.2
Where E is the PLA2 enzyme, S is the substrate, P  is the product and E* is the bound 
enzyme at the interface. The enzyme in the aqueous phase binds to the phospholipid 
interface to form a Michaelis complex (.E*S). This undergoes catalytic changes to release 
the hydrolytic products and follows the dissociation o f the enzyme from the interface.
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4.4.4 Dose-Response o f  Lipolysis Induced by Purified-PLA2
Phospholipase A2 hydrolyzed the phospholipid vesicles in a concentration dependant 
manner, and this response can be monitored using SPR. PLA2 was added to the tethered 
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Figure 4.17 Monitoring the change in reflectivity [R]%  and fluorescence upon the addition 
o f  3.3 x 10~9 mol.dm'3 PLA2. Initial binding o f  the enzyme is observed before lysis o f  the 
vesicle membranes.
The addition o f PLA2 at 150 minutes, showed an initial increase in reflectivity o f 3.98 
[R]%. This increase in reflectivity equated to the approximate adsorption o f 0.7ng.mm '2 
mass to the membrane surface which was the adsorption o f the enzyme to the membrane 
surface. There was a circa 7 minute latency period from initial enzyme binding to the 
commencement o f vesicle hydrolysis. This was in good agreement with other 
measurements o f vesicle hydrolysis. The Sanchez group observed a circa 8  minute lag 
period before the accelerated phospholipid hydrolysis [44]. They were also able to 
visualize the shrinkage o f giant unilamellar vesicles (GUVs) as a result o f  the phospholipid 
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Figure 4.18 PL A 2-dependent shrinking o f  a DPPC GUV at 53°C, where fluorescence 
intensity images o f  LA URDAN-containing vesicles were collected upon the addition o f  C. 
atrox SPLA2 [44].
The hydrolysis o f the phospholipid vesicles was observed at 157 minutes, where there was 
a huge rise in membrane hydrolysis, leading to a circa 27.9 [R]% decrease in reflectivity 
(Figure 4.17). The change in mass density at the surface was observed as a shift in the 
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Figure 4.19 Resonance shift and fluorescence intensity o f  the tethered vesicle system  
before and after the injection o f  3.3 x Iff9 mol.dm'3 PLA2.
The 0.95° resonance minimum shift equated to the loss o f 5.09ng.mm'2 mass from the 
surface. However, the adsorption of biomimetic vesicles to the support matrix only yielded 
a 3.0ng.mm '2 adsorption o f mass to the surface. Therefore, there was a circa 2ng.mm '2 
mass density deficit in desorbed material, suggesting there was partial hydrolysis o f the 
support matrix. This will be discussed further in section 4.5. The simultaneous monitoring 
o f the fluorescence intensity showed a 73% reduction in fluorescence, with a total decrease
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o f 17738 counts.second' 1 over the course o f vesicular hydrolysis. The remaining 
fluorescent signal was background signal.
The hydrolysis o f the artificial membrane vesicles showed dose dependency. The dose 
response for the PLA2 on the vesicles was performed at varying concentrations between 
1.67x10'’1 and 3 .3xl0 '9 mol.dm'3. The hydrolysis was allowed to reach equilibrium and the 
normalized change in resonance shift was plotted as a function o f enzyme concentration 
(Figure 4.20).
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Figure 4.20 Langmuir isotherm fo r  the normalized equilibrium fo r  the resultant loss o f  
mass from  the surface as a function o f  enzyme concentration.
The plot followed a standard Langmuir equilibrium isotherm, where the maximum rate of 
hydrolysis occurred, Rmax. Langmuir makes several assumptions:
• All surface sites have the same adsorption energy for the adsorbent.
• Adsorption at one site does not affect the availability o f the next site to adsorb.
• Adsorption at one site doesn’t affect the energy o f adsorption o f the neighbouring 
sites.
• The activity o f the adsorbent is directly proportional to its concentration.
The equilibrium dissociation constant, Kd, is an indication o f the strength o f binding 
between a ligand and receptor in terms o f  the ease it takes to separate the complex. K d is an 
inverse measure o f the affinity o f binding between the ligand and its receptor (lower Kd = 
greater affinity between substrate and ligand). The K d can be determined as followed:
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_  Rmax[P]eq
iv e  q —
K D  +  [P ]e q
(4.3)
Where Req is the equilibrium value for each reaction, [ P ] eq is the analyte concentration and 
R max is the maximum equilibrium response. However, it can be calculated directly from the 
Langmuir equilibrium plot, because when Req=Rmax/2 , then [ P ] eq= K D -  Therefore, K d  can be 
directly established from the plot. The calculated Kd was 1.31xlO'10mol.dm'3.
4.4.5 Dose-Response o f  Lipolysis Induced by Crude-PLA2 from Crotalus adamanteus 
The secretory PLA2 found in C. adamanteus venom works in synergy with a range o f  other
toxic peptides, lytic peptides, co-factors and digestive enzymes. The PLA2 enzyme helps to
cause substantial tissue damage and direct membrane lysis to ensure the rapid effect o f the
venom. Unlike the significant observable binding o f the pure-PLA2 to the membrane
surface that occurred in Figure 4.18, there was very little increase in reflectivity observed
upon the addition o f the crude-PLA2 (C.adamanteus venom) to the biomimetic membrane
vesicles (Figure 4.21).
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Figure 4.21 Monitoring the change in reflectivity [RJ% andfluorescence upon the addition 
o f  O.Img.mT1 C.adamanteus venom (crude-PLA2). Initial binding o f  the enzyme is minimal 
before lysis o f  the vesicle membranes.
There was a circa 5-6 minute latency period between the addition o f  the snake venom and 
an observable change in the mass density and fluorescence intensity at the membrane 
surface. There was a very small increase in mass density upon addition o f the venom to the 
membrane surface (A Reflectivity [R]%=0.05), which equated to a 0.0082ng.mm'2 increase 
in mass. This was a significantly lower increase in adsorption at the membrane surface
ion of O.lmg.ml' C adamanteus venom
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compared to that o f the purified-PLA2 , which showed a 0.7ng.mm '2 adsorption (Figure 
4.17).
Hydrolysis was observed at 10 minutes, where there was a circa 8.12 [R]% decrease in 
reflectivity (Figure 4.21). The change in mass density at the surface was observed as a shift 
in the resonance minima (Figure 4.22) upon the injection o f O.lmg.ml' 1 C.adamanteus 
venom.
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Figure 4.22 Resonance minimum shift and fluorescence intensity o f the tethered vesicle 
system before and after the injection o f  O.lmg.ml1 C.adamanteus venom.
The addition o f the C.adamanteus venom caused a 0.25° shift in resonance minimum. The 
shift equated to a 1.338ng.mm'2 loss o f mass from the surface. Moreover, the adsorption of 
biomimetic vesicles to the support matrix yielded a 0 .2 ° shift in the resonance minimum, 
equating to the adsorption of 1.07ng.mm'2 o f mass to the surface. Therefore, there was a 
0.27ng.mm'2 mass density deficit in desorbed material, suggesting there was partial 
removal o f the support matrix as observed with purified- PLA2.
The monitoring o f fluorescence intensity showed a 75% reduction in fluorescence, with a 
total decrease of 23175counts. second"1 over the course o f vesicular hydrolysis. The 
remaining fluorescence signal was background fluorescence.
The hydrolysis o f the artificial membrane vesicles by the crude snake venom showed dose 
dependency. The dose response for the venom was performed at varying concentrations 
between O.lng.ml' 1 to O.lmg.ml'1. The hydrolysis was allowed to reach equilibrium and the
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normalized change in resonance minimum was plotted as a function o f venom 
concentration to produce an equilibrium Langmuir plot (Figure 4.23)
0 .3 0  -I
E










O  0 .0 5
0.00















“ I 1--------1--------1--------1-------- '--------1—
2 0  4 0  6 0  8 0
C.adamanteus venom  (i± )
gm I
4.23 Langmuir isotherm for the normalized shift in resonance minimum as a function o f  
C.adamanteus venom concentration.
The equilibrium dissociation constant, Kd, for the hydrolysis o f the biomimetic membrane
vesicles by C.adamanteus venom was determined directly from the plot to be 3.15pg.ml' .
4.5 Optimization of the Supramolecular Surface: Using a Simplified 
Thiol SAM as the Solid Support System
The desorption deficit observed during the lysis o f the tethered biomimetic membrane 
vesicles (section 4.4.4 and 4.4.5) resulted from the partial hydrolysis o f the HLB support. 
Therefore, an alternative support system was devised to ensure that no hydrolysis o f the 
support occurred.
The partially hydrolyzed HLB support was caused by the presence o f sn-2 ester bonds in 
the DPPTE self-assembled lower leaflet (Figure 4.24a) and in the egg PC upper leaflet 







Figure 4.24 (a) Schematic o f  DPPTE, which chemisorbs to the gold substrate to form the 
lower leaflet, and (b) egg PC, which self-assembled as a single monolayer to form the 
upper leaflet o f  the hybrid lipid bilayer support. (The site o f  hydrolysis is marked with a 
red line).
The addition o f 3.3x10'9mol.dm '3 PLA2 to the biotinylated HLB (no biomimetic membrane 
vesicles attached), showed direct enzyme attachment to the support matrix (Figure 4.25), 
directly followed by the hydrolysis o f the HLB.
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Figure 4.25 Monitoring the change in reflectivity [R]%  upon addition o f  3.3x1 O'9 mol.dm 3 
PLA2. Initial binding o f  the enzyme is observed before hydrolysis o f  the HLB support 
matrix.
On addition o f the lipolytic enzyme, there was an observable increase o f 2.07 [R]% in 
reflectivity at the membrane surface (Figure 4.25). This equated to a mass increase of 
0.62ng.mm‘2. Hydrolysis o f the supramolecular architecture occurred after a three minute 
time lag, during which time the enzyme bound to the support system and penetrated the 
bilayer to gain access to the sn-2 ester bonds o f the lipids. The hydrolysis o f the support 
system did not show the typical membrane lysis o f the biomimetic vesicles (Figure 4.10), 
instead, there was a slower rate o f hydrolysis over a much longer period. The lipolysis of 
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Figure 4.26 Resonance scan curves o f  the supramolecular HLB support system before and 
after the injection o f  3.3 x 1 0 9 m ol.dm3 PLA2.
There was a 0.8° decrease in the resonance minimum after the addition o f the PLA2 to the 
supramolecular support matrix, which equated to the desorption o f 4.28ng.mm‘2 mass at 
the surface. The ability o f the PLA2 enzyme to hydrolyze the supramolecular architecture 
explains the mass density deficit observed between the adsorption o f vesicles and their 
hydrolysis. The atypical hydrolysis kinetics observed (Figure 4.25), suggests that the HLB 
is densely packed and relatively defect free, and the ability o f the lipolytic enzyme to 
penetrate thought the densely packed head-groups of the phospholipids was significantly 
reduced. The slow hydrolysis suggests the enzyme faces a strong barrier against accessing 
the sn-2 ester bonds o f the HLB support.
4.5.1 Formation o f  an Alkanethiol Mixed SAM as an Alternative Support Matrix
The phospholipids containing sn-2 ester linkages were replaced with alkanethiols. Various
groups have used biotinylated thiol systems as anchor systems for forming multilayer films
[7, 45, 46]. Long-chain thiols form well-packed, pseudo-crystalline, oriented monolayers
on gold, in which all the hydrocarbon chains are in the trans conformation and at a 30° tilt
from the normal to the surface [1]. However, inclusion o f high densities o f the anchor thiol
causes steric hindrance and also causes the biotinylated vesicles to tether to close together
causing inter-vesicle fusion. A homogenous monolayer o f a single thiol typically only
produces a limited range o f properties, however, a greater control over the structure o f the
monolayer can be established by the co-adsorption of two or more thiols that differ in the
nature o f the tail group or length of the hydrocarbon chains [47, 48].
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Hydroxyalkanethiols can be utilized as dilution reagents to control the density of reactive 
groups on the surface and to prevent non-specific binding o f analytes to the surface. These 
packing molecules provide hydrophilic regions in between the reactive thiol groups, 
thereby, maintaining the hydrophilic nature of the surface [49]. The distance from the 
hydroxyl group o f the packing molecule to the terminus o f the reactive thiol can be 
adjusted and optimized to ensure space in the x, y  and z planes for either the inclusion of 
integral proteins, receptors or large biological entities. The utilization o f SAMs has found 
many applications, including for electrochemical sensing, where deprotonatable adsorbents 
are self-assembled to form a pH sensor [50]. Another benefit o f using alkanethiols is that 
they interact strongly with the gold surface and form well packed, complete and rugged 
monolayers. In comparison, lipid monolayers tend to weakly associate with the surface, 
causing potential variations [51]. Co-adsorption o f mixed thiols from solution typically 
favours the adsorption o f thiols with longer chain length, and the monolayer is enriched 
with the longer chain thiols [52]. The composition of the mixed monolayer on gold 
parallels, but does not equal the solution composition [53]. Co-adsorption is not random 
and favours certain thiols, but there is no evidence for the formation o f discrete domains of 
specific thiol clusters [53].
Mixed monolayers o f biotin-terminated thiol and 11-mercapto-l-undecanol on gold have 
been shown to resist non-specific binding. 1 l-mercaptoundecanoic-(8-biotinoylamido-3,6- 
dioxaoctyl) amide (Figure 4.27a) does not contain any sn-2 ester bonds within its chain, 
therefore, resists PLA2 induced hydrolysis. 11 -mercapto-1 -undecanol (Figure 4.27b) was 
used as a spacer molecule to dilute the concentration o f the biotin anchor on the gold 
substrate surface.
Figure 4.27 (a) Schematic o f  ll-mercaptoundecanoic-(8-biotinoylamido-2,6-dioxaoctyl) 
amide, and (b) 11-mercapto-l-undecanol, which acts as a diluent to ensure the capture 
anchor is optimally spaced.
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1 mmol.dm '3 stock solutions o f 1 l-mercaptoundecanoic-(8-biotinoylamido-3,6-dioxaoctyl) 
amide, from here known as biotin-thiol, and 1 1 -mercapto-l-undecanol, from here know as 
OH spacer, were dissolved in an appropriate solvent. Absolute ethanol was used as it 
dissolves most thiols and can be obtained at high purity in large quantities. The self- 
assembly o f the mixed thiols on gold ensures a non-lipolyzed support for the tethering of 
the biomimetic membrane vesicles. To ensure the biotin-thiol support matrix did not 
succumb to hydrolysis, the support system was exposed to PLA2, and the interaction was 
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Figure 4.28 (a) Monitoring the interaction between the biotin-thiol support matrix and 
phospholipase A2 enzyme, (b) Resonance minimum shift upon addition o f  PLA2 to the 
biotin-thiol support.
It can be observed that hydrolysis o f the biotin-thiol support matrix did not occur. 
Moreover, there was no adsorption o f the PLA2 to the membrane surface, as observed 
between PLA2 and the HLB (Figure 4.25). This was because the thiol molecules did not 
contain ester linkages, therefore, could not be hydrolyzed by the lipolytic peptides. This 
was confirmed by the shift in resonance minimum (Figure 4.28b). No shift was observed, 
therefore, the biotinylated support layer provided an inert support in terms of resistance to 









Figure 4.29 Schematic representation o f  the Biotin-Thiol: OH spacer SAM solid supported 
model cell membrane vesicles, (a) 50nm thin metal film-coated substrate, (b) 11- 
mercaptoundecanoic-(8-biotinoylamido-3,6-dioxaoctyl) amide and 11-mercapto-l- 
undecanol chemisorbed mixed-SAM, (c) Streptavidin, (d) 1 mol% DPPE-biotin 
incorporated into (DMPC artificial cell membranes.
4.5.2 Optimization o f  the Reactive Alkanethiol Concentration on Gold
The optimization o f the alkanethiol concentration was performed to ensure the maximal
binding o f the subsequent supramolecular layers. Various concentrations of the reactive
biotin-thiol (0.005 - 0.5mmol.dm‘3) were diluted with the lateral OH-spacer determinant
(0.995 -  0.5mmol.dm’3) and allowed to self-assemble on a clean gold substrate for over 16
hours to ensure a well packed and dense thiol monolayer. The SAM-gold substrate was
assembled into the flow-cell for further processing o f the multilayers. Streptavidin
(500nmol.dm'3) was added to the flow cell and allowed to bind to the biotin-thiol. Using
the biotin-streptavidin coupling chemistry, the biomimetic membrane vesicles were
attached to the solid support. These successive steps were monitored and the shift in
resonance minimum determined, as summarized for streptavidin (Figure 4.30a) and the
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Figure 4.30(a) Correlation between the mole fraction o f  Biotin-Thiol.OH-spacer and the 
change in the resonance minimum upon adsorption o f  500nmol.dm'3 streptavidin and (b) 
the correlation between the mole fraction o f  Biotin-Thiol.OH-spacer and the change in the 
resonance minimum upon adsorption o f  OAmg.mT1 biomimetic vesicles.
At low mole fractions of biotin-thiol (0.005-0.01 mmol.dm'3) there was little adsorption of 
streptavidin to the biotinylated-SAM, however, there was good subsequent vesicle 
adsorption. The optimum mole fraction o f biotin-thiol was 0.05mmol.dm'3 diluted in 
0.995mmol.dm '3 OH-spacer, which ensured maximal streptavidin adsorption and maximal 
vesicle attachment to the support matrix. At higher biotin-thiol mole fractions (0.1- 
0.5mmol.dm'3), a decrease in streptavidin binding was observed in comparison to the 
0.05mmol.dm'3 biotin-thiol SAM. Moreover, there was also a significant reduction in the 
adsorption o f the biomimetic vesicles to the support surface. The decreased tethering 
capacity was the result o f  an inaccessibility o f  the biotin groups caused by steric hindrance 
and over-crowding o f the SAM with the reactive species. High densities o f the biotin-thiol 
caused the vesicles to become too close to one another and vie for space. Tethered vesicles 
shielded some vacant streptavidin moieties and rendered them inaccessible to other 
vesicles. The adsorption o f the streptavidin and biomimetic membrane vesicles to varying 
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Figure 4.31 Comparing the resonance shift and equating adsorbed mass o f  streptavidin 
and biomimetic vesicle layers onto varying proportions o f  the biotin-thiol: OH-spacer self­
assembled monolayer.
The greatest increase in mass density was observed with the 0.05 mol% anchor molecule. 
A resonance shift o f  0.71° equated to an absorption o f 3.80ng.mm'2 streptavidin to the 
surface, and therefore equated to 3 .8x l0 19 streptavidin.mm '2 (3.80ng.mm'2/9.97 x 10'20). 
The resonance minimum shift o f 0.9° equated to an increase in mass o f 4.82ng.mm’2 for the 
adsorption o f the biomimetic vesicles. Therefore, there were 4.5x107 vesicles.mm '2 
attached to the support matrix (molecular weight o f  a single vesicle ~ 1.07x l0 '16g).
4.5.3 Gold Surface Oxidative Pre-treatment
The formation o f a SAM-gold substrate has advantages over other commonly used metals 
such as silver and copper, because gold possesses a high degree o f chemical inertness. 
Gold also resists oxidation under ambient conditions, unlike other metals including 
platinum, titanium and copper, where oxygen chemisorbs by forming O2' ions by electrons 
donated from the s and p  bands o f the metal [54], Gold contains unusually tightly bound s- 
valence electrons, therefore, does not readily donate electrons. However, organic 
molecules can chemisorb to the gold, causing a lowering o f the high surface energy 
characteristic o f the metal surface [55]. Moreover, it is consequently vital for the gold 
substrate to be o f high quality and thoroughly cleaned. Contamination o f the gold substrate 
results in poor film quality and may include defects and pinholes.
Common cleaning procedures include exposure to powerful oxidizing agents such as 
oxygen plasma [56], a mixture o f concentrated sulphuric acid and hydrogen peroxide [57], 
and UV/o-zone[58]. These cleaning procedures have been proven to be efficient in 
removing organic contaminants, however, they tend to oxidize the gold surface [59]. 
UV/o-zone cleaned gold films are hydrophilic, while freshly evaporated films tend to be
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hydrophobic [60]. Optimum UV/o-zone cleaning of the gold surface is limited to the first 
10 minutes o f exposure because extended exposure results in CH-, CO-, carbonyl and 
carboxyl groups contaminating the gold surface [61]. The oxidation o f the gold forms 
thermodynamically unstable compounds which decompose in ambient conditions. If the 
self-assembly o f alkanethiols is carried out on peroxidized gold, the SAM forms a densely 
packed monolayer which encapsulates the oxide underneath [62]. This gold oxide can be 
reduced by ethanol [63] prior to formation of the SAM.
The production o f a contaminant free gold surface for the self-assembly o f  alkanethiols 
occurs by:
2 Au + 3 H i O -  6e~ ->  A u iO i + 6 H +
(4.4)
The reduction o f the gold oxide to metallic gold by ethanol occurs by:
Au20 3 + CH3CH2OH —> 2 A w(0) + 3CH3CH0 + 3H20
(4.5)
Scanning Tunnel Microscopy has been used to examine the gold substrates before pre­
treatment and after pre-treatment with o-zone and ethanol. The freshly annealed gold 
exhibits atomically flat terraces approximately lOOnm in diameter. Exposure to the pre­
treatment regime, caused a high density o f small depressions on the gold surface [64], 
thereby effectively removing oxidized material from the surface.
The freshly evaporated gold film and the pre-treated gold (o-zone oxidation and ethanol 
reduction) were observed under the electron microscope (Figure 4.32).
Figure 4.32 (a) Scanning electron micrograph o f  the freshly evaporated gold film  on a 
clean glass substrate, and (b) an electron micrograph o f  the o-zone oxidized, ethanol 
reduced pre-treated gold substrate.
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From the electron micrographs, there were fewer contaminants, debris and pinholes in the 
pre-treated gold substrate (Figure 4.32b) compared to the freshly evaporated gold (Figure 
4.32a). The o-zone and ethanol treatment assisted in the removal o f contaminants, 
producing a more homogenous gold surface for subsequent self-assembly.
All subsequent experiments were carried out on 10 minute o-zone cleaned, 20 minute 
ethanol reduced metallic gold films, onto which a SAM consisting of 5% Biotin-Thiol 
anchor and 95% OH-spacer were chemisorbed.
4.6 Scanning Electron M icroscopy o f the SA M -Tethered Biom im etic 
M em brane Vesicles
The Biotin-ThiohOH spacer SAM solid supported bilayer vesicles were observed under 
the same condition as previously mentioned in section 4.2. The tethered vesicles were 
fixed with 2% glutaraldehyde, followed by staining with 1% osmium tetraoxide, and 
viewed under low vacuum.
Vesicles tethered to a 5% mole fraction biotin-thiol monolayer (0.05mmol.dm'3 biotin-thiol 
+ 0.995mmol.dm'3 OH-spacer) were examined using an electron microscope (Figure 4.33).
15kU X5.00I
Figure 4.33 Scanning electron micrograph o f  the 0.05mmol.dm biotin-thiol (low mole
fraction) tethered vesicles.
The vesicles showed a homogeneity in size and there was a reduction in vesicle-vesicle 
fusion and vesicle distortion. Maintaining a lower mole fraction o f the anchor molecule 
ensured the biomimetic vesicles did not come into close proximity to one another and 
reduce the probability o f vesicles fusing and/or rupturing. Therefore, a more homogenous 
population of biomimetic membrane vesicles were tethered for permeation studies.
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4.7 Optimization of the Biomimetic Vesicles: A View to Enhancing 
Encapsulated Dye Retention
The stability o f biomimetic lipid vesicles is governed by a number o f physical and 
chemical factors. The vesicular environment is critical to their overall longevity both in 
vivo and in vitro. Phospholipid vesicles have a limited shelf-life because o f their oxidation 
and their susceptibility to hydrolytic degradation. Unsaturated phospholipids are the 
primary target for oxidation, but saturated fatty acid vesicles are also susceptible to 
oxidation at high temperatures. Oxidation tends to occur via a free radical chain 
mechanism in the absence o f specific oxidants [65]. The use o f high grade phospholipids, 
storage at low temperatures, and protection from light and oxygen can minimize their 
degradation [66]. It has also been shown that the choice o f buffer is significant in the 
determination o f vesicle stability. HEPES has been found to be the most effective, and a 
lOmmol.dm'3 concentration provides 70% protection after 30 minutes sonication [67], 
because the buffer sequesters the hydroxyl radicals.
The physical stability o f lipid vesicles concerns their ability to retain their average vesicle 
size due to vesicle aggregation and fusion, and the loss o f encapsulated molecules due to 
leakage. Their physical stability characteristics are strongly influenced by the phospholipid 
composition, medium composition and pH [68]. Lipid vesicles which carry a charge tend 
to reduce the vesicles tendencies to aggregate and fuse. Leakage o f the encapsulated 
aqueous environment is also highly dependant o f the vesicle composition.
4.7.1 Modelling the Dye Diffusion through the Biomimetic Membrane Vesicles 
Membrane permeabilization is an important characteristic o f natural cell membranes, as it
is essential for the movement o f water, ions and small molecules into and out o f the cell.
The rate o f diffusion through a lipid bilayer is dependant o f the physical state o f the
membrane, and altering the membrane components can dramatically change the rate of
diffusion through the bilayer. The nature o f spontaneous leakage of the encapsulated
aqueous environment from the lipid vesicles is important for drug delivery [69], but in the
context o f this thesis, it is important for maintaining good fluorescence signal sensitivity.
Various models have been devised to simulate dye leakage through membranes, including 
the ‘sphere-of-action’ model and the ‘weak-association’ model [70, 71]. Described here, is
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a simple passive diffusion model derived from Fick’s law. The model has been adapted to 
take into account the physical dimensions o f the lipid vesicles and leads to the 
determination o f the dye flux through the lipid bilayer over time.
Fick’s first law states that, for steady-state diffusion: the diffusion flux is proportional to 
the concentration gradient, and this concentration gradient drives diffusion i.e. a high 




Where J  is the flux o f the dye through the membrane (mol. s '’.m'2), K  relates to the 
association o f the dye into the membrane (K = [dye]membrane/[dye]Vesicie), Cin is the 
concentration of dye encapsulated within the vesicle aqueous space, and L is the thickness 
o f the membrane which the dye must diffuse through (Figure 4.34).








Vesicle volume, V, dye concentration, Cfa; membrane thickness, L and vesicle surface area, A.
Figure 4.34 Schematic o f  the dye diffusion through the biomimetic membrane vesicles, 
governed by Fick’s first law.




Where A is the surface area of the vesicle, V is the volume of the vesicle and D  is the 
molecular diffusion coefficient
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Therefore, the rate o f diffusion o f the dye through the vesicle membrane is defined by:
D* = KD
(4.8)
Where, D*  is the apparent diffusion coefficient, which is dependant on the size o f the 
diffusing molecule and the viscosity through what it is moving.
The rate o f dye diffusion as a result of time (mol.s'1), can then be further simplified to give:
dC. AC. D *in   in
dt ~ VL
(4.9)
The diffusion through the membrane follows a first order kinetics pathway, as the reaction 
only depends on the concentration o f one reactant {i.e. the concentration o f the dye), 
therefore:
^ - k C .  
dt






Linearizing the dye diffusion through the membrane is defined by:
/wCW = lnCm,,=0~kt
(4.12)
Where Cin>t is the dye concentration at a particular time and Cjn,t=o is the dye concentration 
at time zero.
Therefore, plotting the log o f dye concentration (mol.m'3) against time (seconds) gives a 
linear plot, where the gradient o f the line is the first order rate constant, k (s'1). Then the 
apparent diffusion coefficient, D* (m2.s']), can be calculated using the first order rate 
constant, k, the vesicle surface area, A (m2), the vesicle volume, V (m3) and the membrane 
thickness, L (m), as follows:





This gives the apparent diffusion coefficient for the dye molecule through the lipid bilayer 
o f the membrane vesicles. A commonly used approach to evaluate membrane leakage 
and/or membrane fusion is to monitor the dye change o f the lipid vesicles after the 
properties o f the vesicles have been altered. The natural diffusion o f the dye can then be 
modelled and a quantitative analysis concerning the porosity o f the biomimetic membranes 
can be performed.
4.7.2 Altering the Phase Transition Temperature o f the Biomimetic Membrane Vesicles by 
Varying the Fatty Acid Chain Length
Phosphotidylcholines are the most abundant phospholipid class in mammalian membranes 
and are a major component in eukaryotic organisms. They are also the most widely used 
model membrane lipid in studies. However, the cellular membranes are highly diverse, and 
contain a huge range o f different phospholipid species found at different frequencies 
depending on the function o f the membrane in question. Phospholipids undergo a transition 
from the crystalline gel state through intermediates and into the liquid phase upon heating. 
The phase transition temperature is the temperature required to induce the change from the 
gel phase (hydrocarbon chains are closely packed and ordered), to a disordered liquid 
phase (hydrocarbons are randomly orientated and fluid). There are numerous factors that 
govern the phase transition temperature including hydrocarbon length, unsaturation, 
charge, and head-group species. It has been shown that the lipid alkyl chain length 
influences the encapsulation efficiency o f the dye/drug molecules and the release rate. 
Studies using ibuprofen, showed its incorporation efficiency increased with increasing 
lipid chain length, and was believed to be attributed to the increased hydrophobic area 
within the vesicle bilayer [72]. It was also demonstrated that increasing chain length also 
caused an increased capacity to retain the ibuprofen.
Production o f biomimetic membrane vesicles from phospholipids with varying chain 
length alters the physical properties of the vesicles, in particular, the temperature at which 
the vesicles transition from the ordered gel phase to the liquid disordered phase. DMPC 
(Figure 4.35 a), which contains two hydrocarbon chains o f 14 carbons in length, phase 
transitions at 23°C, DPPC (Figure 4.35b) contains two hydrocarbon chains o f 16 carbons in 
length, phase transitions at 41 °C, and DSPC (Figure 4.35c) contains two hydrocarbon 










Figure 4.35 (a) Structure o f l,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC), (b) 
Structure o f  l,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC) and (c) Structure o f  
l,2-Distearoyl-sn-Glycero-3-Phosphocholine (DSPC).
Tethered vesicles containing either DMPC, DPPC, or DSPC were produced and monitored 
using SPR/SPFS for changes in relative fluorescence over time due to the intrinsic porosity 
o f the vesicle bilayer. The natural leakage o f the fluorescent dye from the vesicle aqueous 
space into the bulk solution was monitored over 120 minutes (Figure 4.36).
DMPC (14 carbon chains) Tm = 23°C 
DPPC (16 carbon chains) Tm = 42°C 
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Figure 4.36 Monitoring the change in relative fluorescence o f  three phospholipid vesicle 
systems (DMPC, DPPC and DSPC), with various phase transition temperatures over a 
120 minute time period.
The retention o f the encapsulated BODIPY dye within the vesicle aqueous space was seen 
to be directly influenced by the lipid species comprising the bilayer. Over the observed 120 
minutes, the vesicles comprising the shorter hydrocarbon chain phospholipid (DMPC), 
showed the poorest retention capacity o f  the three systems tested. The two vesicle systems
134
comprising the longer hydrocarbon chain phospholipids (DPPC and DSPC), showed a 
marked improvement in their capacity to retain the encapsulated dye molecules. This 
retention capacity was the direct influence o f the hydrocarbon chain length.
A natural log plot o f the decrease in fluorophore concentration (pmol.m '3) as a function o f 
time (seconds) was plotted (Figure 4.37). It was assumed that at time= Ominutes, the 
fluorophore concentration was 5pmol.dm'3, which was the encapsulation concentration o f 
the dye at vesicle extrusion. Using the passive diffusion model detailed in section 4.7.1, the 
apparent diffusion coefficient for the three phospholipid vesicle systems was determined.
DM PC (14  c a rb o n  h y d ro ca rb o n s) 
D P P C  (16  c a rb o n  h y d ro ca rb o n s) 
D S P C  (18  c a rb o n  h y d ro ca rb o n s) 
L inear Fit ___________________
D PPC k = 7 . 7 x 1 0
D M PC k = 2 .35 x 10
Time (seconds)
Figure 4.37 Plot o f  the normalized In fluorescence concentration (jumol.m'3) as a function 
o f  time (seconds) fo r  the three vesicle systems containing either DMPC, DPPC or DSPC.
The monitoring o f the dye leakage through the membrane bilayer o f the DMPC tethered 
vesicles offered the lowest resistance to dye permeation. The calculate apparent diffusion 
coefficient (D*), was U b x lO '^ c m ^ s '1. The DMPC lipid was in the liquid phase at room 
temperature (23°C), therefore, the hydrocarbon chains were disordered and offer a weak 
barrier to the diffusion o f the dye into the bulk solution. Moreover, the lipids with longer 
hydrocarbon chains, DPPC and DSPC, which were in the gel phase at room temperature, 
42°C and 55°C respectively, ensured that their hydrocarbon chains were ordered and fully 
extended and offered a greater barrier to the diffusion o f the dye through the bilayer. DSPC 
had a calculated apparent diffusion coefficient of, D* =8.9xl0*15cm2.s'1, while DPPC had a 
calculated apparent diffusion coefficient of, D* = 5 .76xl0 '15cm2.s'1. Therefore, lipids in the
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gel phase offered a higher barrier to dye diffusion than phospholipids in the disordered 
liquid phase.
The increased barrier against porosity observed by increasing hydrocarbon length has been 
attributed to inter-chain bonding. A vesicles capacity to retain the entrapped aqueous 
environment was the result o f increasing van der Waals interactions between the 
neighbouring chains, because longer hydrocarbon chains induce stronger bonding. This in 
turn requires more energy to disrupt the ordered packing, therefore, the phase transition 
temperature increases [72]. Vesicles at or near their phase transition temperature show 
increased rates o f dye movement due to packing defects in the phase boundaries between 
the coexisting liquid phases and the gel phases [73].
4.7.3 The Effect o f  Sterols in the Bilayer o f  the Biomimetic Membrane Vesicles
Sterols comprise a major constituent o f the eukaryotic cell membranes, and cholesterol has
a flat, rigid fused ring structure, which is able to form stable stacked aggregates that other
lipid components tend not to form [74]. Human erythrocytes typically contain 20%
cholesterol but can be higher in certain membranes [75]. At 20-50% cholesterol content,
the sterol dissolves into the bilayer, where the hydroxyl group hydrogen bonds to water.
The sterol acts as a spacer between the hydrocarbon chains o f the phospholipids and
functions as a ‘cement’ to keep the assembly together and to fill in any voids between the
hydrocarbon chains.
4.7.3.1 The Effect o f  Cholesterol on Pure DMPC Bilayer Vesicles
Cholesterol-phospholipid interactions dramatically alter the integrity and functionality of 
the phospholipid bilayer. A substantial body o f work has determined the thermodynamic 
effects o f varying the proportion o f cholesterol within the phospholipid bilayer at a range 
of temperatures (Figure 4.38). From the phase diagram, the thermodynamics observed for a 
large proportion o f cholesterol in DMPC promotes the formation o f a liquid-ordered phase. 




Figure 4.38 Schematic phase diagram fo r  mixtures o f  DMPC and cholesterol. Tm = main 
phase transition temperature o f  pure DMPC, so = solid-ordered (gel phase), Id = liquid- 
disordered (fluid phase), and lo = liquid-ordered [76].
Cholesterol also has a pronounced effect on biomimetic lipid vesicles, and has been 
fundamental in the evolution o f drug-encapsulating liposomes for therapeutic uses. The in 
vivo and in vitro stability o f  the biomimetic vesicles is not only influenced by the 
environment which they come into contact, but also their structural characteristics and the 
characteristics o f the encapsulated aqueous environment. Inclusion o f cholesterol into the 
bilayer o f the biomimetic vesicles significantly affects the diffusion of the encapsulated 
aqueous material into the bulk solution.
Various mole percent (0-70 mol%) of cholesterol was included in DMPC vesicles, and 
monitored for dye leakage through the vesicle bilayer (Figure 4.39a). This allowed for the 
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-31Time (seconds)Figure 4.39 (a) Plot o f  the normalized In fluorescence concentration(jumol.m3)  as a 
function o f  time (seconds) fo r  each o f  the cholesterol/DMPC vesicle systems, (b) Plot o f  the 
apparent dye diffusion coefficient (cm2.s'1) as a function o f  cholesterol content o f  the 
DMPC vesicles.
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As mentioned in this section, natural biological membranes contain varying proportions o f 
sterols, and are typically found in the range 5-30%. As shown in Figure 4.39, the inclusion 
o f cholesterol in this range, substantially decreased the leakage o f encapsulated dye. The 
cholesterol altered the phase transition temperature o f the pure DMPC vesicles, changing 
its physical characteristics at room temperature from its typical disordered liquid phase into 
an intermediate condensed ordered gel phase. Moreover, the cholesterol reduced the 
mobility o f the fatty acyl chains [77], thereby altering the permeability o f the bilayer. A 
comparison o f the apparent dye diffusion coefficients o f the DMPC/cholesterol vesicle 
systems is summarized in Figure 4.40.
Mole Percentage of Cholesterol 
Included in Vesicles (%)
Apparent Dye Diffusion 
Coefficient (cm2.s_1)
0 8.9 x 1 0 14
10 2.63 x 10‘14
20 3.47 x 10'14
30 1.47 x 10'14
40 1.74 x 10'14
50 1.72 x 10 '4
60 7.78 x lO 15
70 7.93 x 10 '5
Figure 4.40 Summary o f  the apparent dye diffusion coefficients fo r  the various 
DMPC/cholesterol vesicle systems.
The inclusion o f sterols in the vesicle bilayer showed a decrease in the apparent dye 
diffusion coefficient compared to the pure DMPC vesicle system. At low cholesterol 
concentrations (10%) there was a >3-fold improvement in the ability o f the biomimetic 
vesicles to retain their fluorescent content compared to the system with no cholesterol 
present. At higher concentrations o f cholesterol (20-50%), there was around >5-fold 
improvement in fluorophore retention compared to the control system containing no 
sterols. Moreover, an >11-fold improvement in dye retention was observed at high 
cholesterol concentrations (60-70%).
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4.7.3.2 The Effect o f  Cholesterol on High Phase Transition Temperature Phospholipid 
Bilayer Vesicles
Sterols, such as cholesterol, stabilize phospholipid vesicles by broadening the main phase 
transition o f the phospholipid species. It has been shown that cholesterol causes the 
thermal fluctuations o f the phospholipids to decrease at the main phase transition but to 
increase in the wings o f the transition [78]. Thermal fluctuations o f lipids are the physical 
properties o f the system, such as thermodynamic stability, self-assembly, elasticity, 
interaction potentials, and phase transitions. Therefore, cholesterol acts to decrease the 
phase boundary between the liquid and gel phases, but also acts to broaden the ‘wings’ of 
the phase transition between the liquid and gel phases. Cholesterol has also been shown to 
cause larger fluctuations at the phase temperature o f phospholipids with longer chain 
lengths. High concentrations o f cholesterol has been shown to suppress the permeability of 
the phospholipid bilayer, and that relative permeability increases with decreasing chain 
length.
Inclusion o f cholesterol in the bilayer o f high phase transition temperature lipids, DPPC 
and DSPC, were tethered to the solid support system and the permeability was monitored 
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Figure 4.41 Plot o f  the permeability (ftmol.m )  o f  the high phase transition bilayer 
vesicles, DPPC and DSPC, compared to the lower phase transition vesicle system, DMPC, 
as a function o f  time (seconds).
Inclusion o f sterols in the bilayer o f the tethered vesicles significantly increased the 








permeability o f the vesicles allowed for the calculation of the first order rate constant, k, 
for each o f the vesicle systems. The apparent dye diffusion coefficients, D*, were 
calculated and summarized in Figure 4.42.
The pure-DMPC vesicles offered the lowest resistance to dye diffusion, D *  =1.20x10' 
15cm2.s_1, while 1:1 DSPCicholesterol vesicles offered the highest resistance to dye 
diffusion through the membrane, D*  =5.7xl0'17cm2.s'\ The three mixed vesicle systems all 
showed significantly higher permeability barriers against dye diffusion than their pure-lipid 
counterparts. The sterol:lipid vesicles offered a higher permeability barrier because the 
cholesterol caused a change in the physical properties o f the vesicles, placing them in the 
intermediate phase o f liquid-ordered state. There was around an 8-fold improvement in dye 
retention in both the sterol containing DMPC and DSPC systems compared to pure-lipid 
forms, and around a 4-fold improvement in the retention o f dye in the DPPC:sterol system 
compared to its pure lipid form. The highest barrier to dye permeability was offered by the 
phospholipids with the longer acyl chains, DSPC>DPPC>DMPC, and increasing chain 
length caused an increase in the temperature at which phase transition occurred. Therefore, 
the lipids with the higher phase transition temperature ensured the phospholipid 
membranes were ordered, and the acyl chains were fully extended and rigid. This helped to 
block the passage of the dye molecules though the bilayer. Cholesterol altered the phase 
transition properties o f the phospholipid vesicle systems by introducing conformational 
order and broadening the main phase transition [78]. This caused the phospholipids to 
increase their packing density [79] and filling in defects and gaps in the bilayer. The acyl 
chains o f the phospholipids showed reduced mobility when in the presence o f cholesterol, 
therefore, the vesicle systems demonstrate reduced permeability [77]. Higher levels of 
cholesterol in biological membranes imparts the membrane with mechanical coherence, 
resistance to mechanical fatigue, and stabilization o f the permeability barrier [80, 81]. The 
inclusion o f a small faction o f cholesterol in phospholipid bilayers resulted in the 
formation of lipid domains, which enhances the dynamic membrane heterogeneity. 
Moreover, this was because the low concentration o f cholesterol is unable to fully break 
the ordered structure when the lipids are in the gel-ordered phase and is unable to fully 
induce order o f the acyl chains in the fluid phase. Therefore, cholesterol at low 
concentrations produces a phase intermediate between the gel and fluid phases [82].
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Vesicle system Apparent dye diffusion coefficient (cm2.s'!)
Pure DMPC 1.20 x 10'15
1:1 DMPC: Cholesterol 1.50 x lO'16
Pure DPPC 3.38 x 10'16
1:1 DPPC:Cholesterol 8.45 x 10'17
Pure DSPC 4.94 x 10"'6
1:1 DSPC:Cholesterol 5.70 x 10'1'
Figure 4.42 Summary> o f  the apparent dye diffusion coefficient fo r  pure-DMPC vesicles 
(Tm = 23°C), pure-DPPC vesicles (Tm = 41°C) and pure-DSPC vesicles (Tm = 55°C), 
compared to the calculated apparent dye diffusion coefficients o f  the 1:1 
phospohlipid:cholesterol vesicle systems.
The inclusion o f the cholesterol into the vesicle bilayer stabilized the membrane vesicles 
by inducing conformational order in the phospholipid acyl chains and acting as a filler to 
seal defects in the bilayer. However, sterol content o f subsequent experiments was kept at 
30 mol% to ensure the cholesterol content mimic that o f biological membranes.
4.8 Monitoring the Permeation Processes using Phospholipase A2
As mentioned previously in this chapter, the production o f a stable cell mimic allows for
the real-time monitoring o f  permeation processes as a result o f toxin-membrane 
interactions. The adapted support system provides a reliable and simple support layer for 
the attachment o f biomimetic membrane vesicles, and can be prepared more efficiently 
compared to the laborious HLB support system used in section 4.1.
Vesicles were tethered to the biotin-thiol SAM, and 3.3 x 10'9mol.dm'3 PLA2 was injected 
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Figure 4.43 (a) Simultaneous measurement o f  SPR and SPFS fo r  the monitoring o f  the 
events during the injection o f  3.3 x 10 9mol. d m 3 PLA2 into the biotin-thiol tethered 
biomimetic vesicles, (b) Shift in resonance minimum upon vesicle hydrolysis with 3.3 x 10' 
9mol.dm'3 PLA2
The hydrolysis o f the biomimetic membranes occurred rapidly after injection o f the 
lipolytic enzyme at 30 seconds. The hydrolysis of the vesicles proceeded rapidly until 45 
seconds, when there was a reduction in the rate o f hydrolysis. The hydrolysis o f the 
vesicles caused a 0.35° resonance shift in the minimum (Figure 4.43b). This equated to the 
desorption o f 1.87ng.mm2 o f mass from the surface. Moreover, the vesicle adsorption to 
the surface caused a resonance minimum shift o f 1.0°, which equated to the adsorption o f 
5.35ng.mm'2 mass at the surface. Therefore, vesicle hydrolysis did not proceed to 
completion, and the reduction in hydrolysis rate was the time required to penetrate the 
densely packed vesicle.
The monitoring of the fluorescence during the hydrolysis o f the tethered vesicles showed 
an initial decrease in fluorescence as the vesicles were hydrolyzed, followed by a slower 
subsequent leakage o f the dye into solution. This suggests that the kinetics o f the lipolytic 
enzyme are reduced because o f the time needed to penetrate the optimized 
DMPC/cholesterol vesicles. The inclusion o f sterols into the vesicle bilayer renders them 
less prone to hydrolysis by the PLA2 , because the enzyme preferentially hydrolyzed 
defective bilayers as it improves their accessibility to the ester bond of the phospholipids.
The biotin-thiol support and the optimized biomimetic membrane vesicles provided a 
stable system with reduced natural permeability o f the bilayer for the study o f membrane- 
protein interactions.
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4.9 Inhibition o f L ipolysis in Relation to the Effects o f E icosadienoic acid
and M anoalide on Phospholipase A2
A means o f altering phospholipase A2 activity towards a biological system is an attractive 
route to modifying the inflammatory cascade and the associated medical conditions, such 
as arthritis, asthma, and venomous bites. Therefore, potential PLA2 inhibitors were 
monitored for their ability to prevent vesicle lysis.
The initiation of the inflammatory response is mediated by the biosynthesis o f eicosanoids 
from arachidonic acid (a product of the lipolysis o f phospholipids). Therefore, the actions 
o f lipolytic enzymes such as PLA2 and snake venoms cause the hydrolysis o f lipid to 
produce lysophospholipids and a free fatty acid. The liberation o f arachidonic acid from 
the sn-2 position provides the substrate for the biosynthesis o f eicosanoids. Hence, 
compounds that inhibit PLA2 activity are potential therapeutic agents for treatment of 
inflammation and the diseases with which they are associated.
4.9.1 Effect o f  Eicosadienoic acid on PLA2 Induced Lipolysis
7,7-Dimethyl-(5Z,8Z)-eicosadienoic acid (Figure 4.44), is an analogue o f arachidonic acid, 
and inhibits the biosynthesis o f  the Slow Reacting Substance o f Anaphylaxis (SRS-A) 
group o f leukotrienes, that are the mediators o f  bronchoconstriction, hypersensitivity and 
other allergic reactions [83]. 7,7-Dimethyl-(5Z,8Z)-eicosadienoic acid’s (DEDA) mode of 
action is to inhibit PLA2 via a non-selective mode o f action, as it is capable o f blocking the 
activities o f both cPLA2 and sPLA2 [84]. As DEDA is an analogue o f arachidonic acid, it is 
capable o f interfering with the biosynthesis o f the prostaglandins and leukotrienes, which 
in turn alters the steps in the inflammatory cascade or inhibit it altogether.
Figure 4.44 Structure o f  7,7-Dimethyl-(5Z,8Z)-eicosadienoic acid, a know PLA2 inhibitor.
DEDA is an unsaturated fatty acid and is an analogue o f a natural fatty acid (arachidonic 
acid). However, the analogue contains two cis-bonds, therefore, it cannot match the 
alignment and conformation o f other fatty acid hydrocarbons. This causes the DEDA to 
have a larger area/head-group at the membrane interface compared to the other 
phospholipids [85]. This increased surface area causes an increase its accessibility, thereby
•C O O H
143
making it a good competitive inhibitor. Little is known about the mechanism with which 
PLA2 is inhibited by DEDA, but the fatty acid analogue appears to act as a pseudo­
substrate.
The inclusion o f 0.3mmol.dm'3 DEDA in the circulating buffer did not prevent the 
permeation and lysis o f the tethered biomimetic membrane vesicles upon injection o f 
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Figure 4.45 Circulation o f 0.3 mmol.dm'3 DEDA around the tethered biomimetic 
membrane vesicles fo r  ~150 minutes before the addition o f  3.3x10~9mol.dm 3 PLA2 into the 
system.
DEDA did not sequester the PLA2 from the tethered vesicles, and inclusion o f the 
arachidonic acid analogue in solution did not prevent the lysis o f the biomimetic 
membrane vesicles. Direct injection o f the lipolytic enzyme into the circulating buffer 
containing the DEDA showed the enzyme binding to the tethered vesicles, which was 
subsequently followed by the hydrolysis o f the phospholipid aggregates.
The inclusion o f the DEDA into the bilayer o f the biomimetic membrane vesicles provided 
an effective means o f preventing the hydrolysis o f the phospholipids, and thereby 
maintaining the integrity of the vesicles (Figure 4.46a). A suspension o f DMPC, 
cholesterol and biotin was prepared in chloroform to which lmol%  DEDA was added. This 
suspension was mixed and the solvent removed. The lipid film was then processed 
according to the procedure outlined in section 3.6.1. This methodology ensured that the 
DEDA was incorporated into the phospholipid bilayer and not in the aqueous space or free 
in the bulk solution.
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Figure 4.46 (a) Simultaneous measurement o f  reflectivity (SPR) and Fluorescence (SPFS) 
upon the addition o f  3.3 x 10~9 mol.dm 3 PLA2 to the tethered vesicle system containing 
lm ol%  DEDA within the vesicle bilayer, (b) Resonance angle scans before and after the 
addition o f  PLA2 to the DEDA-containing vesicles.
The addition o f PLA2 to the DEDA-tethered vesicles showed an adsorption o f mass at the 
surface, and the increase in mass was confirmed by the shift in resonance minimum 
(Figure 4.46b). The 0.05° shift in resonance minimum equated to the adsorption of
0.27ng.mm'2 o f mass to the surface. The adsorption o f the enzyme to the surface was 
mediated by the increased head-group area o f the DEDA. Therefore, the PLA2 
preferentially bound to the arachidonic acid analogue. This attachment o f the enzyme to 
the analogue prevented the lysis o f the phospholipids and maintained the membranes 
structural integrity. This was because the analogue did not contain the sn-2 ester bond 
necessary for hydrolysis. The integrity of the vesicles was confirmed by the simultaneous 
monitoring o f the fluorescence, which demonstrated that there was no rapid efflux o f dye 
from the vesicle aqueous space.
The addition o f varying concentration o f the PLA2 to the DEDA-containing tethered 
vesicles allowed for the monitoring o f the binding o f the enzyme to the biomimetic 
membranes (Figure 4.47).
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Figure 4.47 Simultaneous monitoring o f the adsorption o f  mass at the surface (SPR) and 
change in fluorescence (SPFS) upon addition o f  varying concentrations ofPLA2.
Increasing the concentration o f PLA2 from 3.3x1 O'8 mol.dm'3 to 3.3x10'9 mol.dm*3 
followed a concentration dependant relationship. Plotting the change in reflectivity with 
increasing enzyme concentration produced a Langmuir isotherm (Figure 4.48) from which 
it was possible to directly determine the equilibrium dissociation constant, Kd.
•  Adsorption of PLAj to DEDA-contianing vesicles 
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Figure 4.48 Langmuir p lot o f  change in reflectivity with increasing PLA2 concentration 
from 3.3 x 10~9 mol.dm' to 3.3 x 1 O'8 mol.dm'3.
Using the Langmuir plot the KD was calculated to be 1.12xl0'8 mol.dm'3.
146
The incorporation o f DEDA into biomimetic membrane vesicles provided a protection 
against lipolysis by PLA2 , because the analogue prevented the hydrolysis o f the sn-2 ester 
bonds o f the phospholipids via a competitive inhibitory mechanism. The inclusion of the 
DEDA allowed for the determination o f the equilibrium constants between the membrane 
vesicles and the lipolytic enzyme. Preventing the lysis o f the phospholipids is a major step 
in understanding the mechanisms and improved therapeutic agents against disorders 
associated with the introduction o f high levels o f PLA2 , including arthritis, asthma, chronic 
inflammatory diseases and venomous bites.
4.9.2 Effect o f  Manoalide on PIA 2 Induced Lipolysis
Secondary metabolites, such as antibiotics, are organic compounds produced by a living 
organism, which are involved in the long-term survival o f the producer. These compounds 
are not directly involved in the normal growth, development or reproduction o f the 
organism. The secondary metabolites have been exploited for a variety o f purposes 
including in the food, fragrance, pigment, insecticidal and medicinal industries. Around 
40% of today’s pharmaceutical sales are derived from terrestrial microbial and plant 
products, however, the diversity o f the marine environment, which remains largely 
untapped, exceeds their terrestrial counterparts. The marine environment is a reservoir for 
bioactive natural products, many o f which exhibit structural features and chemical 
properties not found in terrestrial natural products [86]. Various groups of marine 
organisms produce secondary metabolites including bacteria, algae, seaweeds and 
molluscs. The marine sponges are the simplest multicellular organisms, which contain no 
true tissues or organs. These organisms synthesize a variety of natural products, and have 
been found to be a rich source o f anti-PLA2 compounds. Many of these anti-PLA2 
molecules show a high degree o f selectivity for secretory-PLA2 S compared to cytosolic- 
P L A 2s .
The non-steroidal sesterterpenoid, manoalide (Figure 4.49), was first isolated from the 
Luffariella variabilis sea sponge in 1980 [87], and shows antibacterial properties. The 
molecule was shown not to inhibit arachidonic acid induced inflammation, but inhibited 
the inflammatory cascade prior to the release o f the arachidonic acid [88]. Manoalide has 
been shown to irreversibly inactivate both bee and cobra venom P L A 2 , with an IC 50 of 0.05 
and 2.0pmol.dm'3 respectively [89-91]. The inhibitor is believed to cause the covalent 
modification o f the lysine residues o f the P L A 2  enzyme mediated by a neucleophilic attack.
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Manoalide shows analgesic activity and inhibition o f non-arachidonic acid induced 
inflammation. It has been shown to inhibit the hydrolysis o f phosphatidylcholine but fails 
to inhibit the hydrolysis of phosphatidylethanolamine [92], suggesting it does not cause the 
modification o f the PLA2 at the catalytic site o f the enzyme, but interferes with the binding 
o f the enzyme to the phospholipid interface.
Figure 4.49 Structure o f  manoalide, isolated from the Laffariella variabilis sea sponge.
As manoalide is an antagonist o f PLA2 and not an analogue o f the enzymes substrate, like 
DEDA, manoalide was not incorporated into the membrane bilayer, but was added to the 
PLA2 5 minutes prior to injection into the tethered vesicle system. Various concentrations 
o f manoalide were added to 3.3 x 10'9mol.dm'3 PLA2, which was subsequently injected 
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Figure 4.50 Change in reflectivity as a result o f  adding various concentrations o f
manoalide to 3.3 x 10~9mol.dm~J PLA2.- 3
From the results, it can be seen that by increasing the concentration o f manoalide there was 
a decrease in the change in reflectivity upon addition o f the PLA2. Therefore, it was 
possible to observe the inhibitory effects o f manoalide on PLA2. The addition o f 4.8x1 O'11
4.8 x 10 "  mol.dm J Manoalide 
3.6 x 10'" mol.dm3 Manoalide 
2.4 x 10'" mol.dm3 Manoalide
1.2 x 10'" mol.dm3 Manoalide
7.2 x 10'" mol.dm3 Manoalide
4.8 x 10 '" mol.dm-3 Manoalide
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mol.dm '3 manoalide into the tethered vesicle system significantly decreased the desorption 
o f mass from the surface upon addition o f PLA2.
Increasing the concentration o f manoalide from 4 .8x l0‘12 mol.dm'3 to 4 .8 x l0 'n mol.dm'3 
followed a concentration dependant relationship. Plotting the shift in resonance minimum 
with increasing inhibitor concentration produced a dosage dependant plot (Figure 4.51).
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Figure 4.52 Addition o f  various concentration o f  manoalide, 4 .8x1072 m ol.dm 3- 4.8xl0~u 
mol.dm'3, with 3.3 xlO'9mol.dm 3 PLA2 to the tethered vesicles.
The addition o f manoalide to the tethered biomimetic membrane system significantly 
reduced the desorption o f mass from the surface, showing its ability to prevent the 
hydrolysis o f the phospholipids caused by PLA2. The inactivation o f PLA2 by manoalide 
caused the membrane vesicles to remain intact, signifying prevention of the production of 
eicosanoids and thereby inhibiting the steps o f the inflammatory cascade. Prevention o f the 
actions o f PLA2 by manoalide has been reported to inhibit the catabolism o f cartilage in the 
arthritic joints o f rabbits [93].
However, DEDA prevented the hydrolysis o f the tethered membrane vesicles by PLA2 to a 
greater extent compared to manoalide. DEDA did not prevent the adsorption o f the PLA2 
to the membrane surface but prevented the hydrolysis o f  the sn-2 ester bonds o f the 
phospholipids. Moreover, manoalide reduced the effects o f PLA2 on the membrane 
vesicles but did not completely inhibit the hydrolysis o f the phospholipids.
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4.10 Conclusions
The functionalization o f a substrate was employed to tether intact biomimetic lipid vesicles 
to a surface. The phospholipid vesicles act as a cell membrane mimic, and are designed to 
control the physical properties o f the permeability barrier. The modification o f the 
phospholipid bilayer properties allowed the control over the intrinsic porosity and 
leakiness o f the membrane, thereby allowing for the encapsulation and retention o f  
hydrophilic molecules within the aqueous space o f the phospholipid vesicles. The natural 
permeability o f the phospholipid barrier was modelled upon Fick’s law to determine the 
apparent diffusion coefficient o f the encapsulated reporter molecules during its diffusion 
from the aqueous space of the vesicles into the bulk solution. Using the basic diffusion 
model it was possible to maximize the retention capacity o f the tethered membrane 
mimics, ensuring an optimum sensitivity for the detection o f membrane permeation events.
The generation o f a fiinctionalized surface was achieved by the constructing a biotinylated- 
HLB, to which intact phospholipid vesicles were tethered using biotin-streptavidin 
coupling chemistry. The fiinctionalized surface evolved to a simpler, more reliable and less 
time-consuming support system, by substituting the HLB for a thiol SAM. Maximal 
binding o f the phospholipid vesicles was achieved using a surface with % = 0.05 density o f  
the biotin-thiol molecule in a mixed SAM with an hydroxyl-terminated lateral spacer. The 
lower surface density o f the reactive thiol ensured spatial separation between the 
biomimetic lipid membranes, preventing their fusion with one another and reducing the 
steric interaction between the lipid vesicles on the solid substrate.
Surface Plasmon Resonance (SPR) and Surface Plasmon field enhanced Fluorescence 
Spectroscopy (SPFS) were employed to monitor and quantify the construction o f the 
tethered vesicle system. The techniques were also employed to monitor the effects of 
membrane hydrolysis as a result o f lipolytic toxins from Crotalus adamanteus venom and 
purified phospholipase A2 . Direct membrane hydrolysis was observed for both whole 
snake venom and purified PLA2 peptide.
The manipulation of the membrane hydrolysis was achieved by the inhibition o f the 
lipolytic peptides and venom. Eicosadienoic acid, an analogue o f arachidonic acid, was 
incorporated into the bilayer o f the biomimetic membrane vesicles. This analogue o f AA 
had a larger surface area compared to the phospholipids, therefore, acted as a competitive 
inhibitor. Manoalide, a natural compound isolated from a marine sponge, was shown to
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reduce the hydrolysis o f the biomimetic lipid vesicles in a dose dependant manner. The 
inhibitor acted by covalently bond to the lysine residues within the phospholipase A2 , 
thereby preventing the hydrolysis o f the phospholipid ester bonds.
A study o f the affinity binding constants o f the enzymes to the biomimetic membrane 
vesicles was performed. The equilibrium titration method was used to observe the effects 
o f the lytic peptides, which followed a Langmuir isotherm. This allowed the determination 
o f the equilibrium affinity constants between the toxins and the model membranes.
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5.0 Solid Supported Lipid Bilayer Vesicles: Method to 
Study Membrane-Bacterial Toxin Interactions
Pathogenic bacteria have acquired the ability to produce a range o f toxins that act as an 
offensive mechanism against host organisms. These toxins must be secreted from the 
producing organism to cause their detrimental effects, however, they must also circumvent 
the host defences and gain access to the intracellular environment for purposes of 
multiplication, transmission and to sequester nutrients. The cell membrane acts as a barrier 
to block the passage and the actions o f these toxins. The interaction between the toxins and 
the cell membrane provides an insight into the mechanism of toxin action and into possible 
therapeutic areas to combat these diseases. Using a biotin-thiol supramolecular architecture 
to tether the biomimetic membrane vesicles to the solid substrate, it is possible to observe 
the interaction between bacterial toxins and the model membranes.
Chapter Synopsis
Cholera is particularly prevalent in areas with poor sanitation, and causes significant loses 
of life each year. The history of cholera disease, and the associated microbe will be 
reviewed. Preliminary measurements concerning the interaction between the whole toxin 
with DMPC-GM1 -cholesterol vesicles and between P-subunit toxin with DMPC-GM1- 
cholesterol vesicles will then be detailed. The influence GM1 and cholesterol on toxin 
binding will also be discussed. Additional measurements showing the relationship between 
the toxin concentration and the amount o f toxin binding will be detailed and binding 
constants determined. Finally, a novel therapeutic for the inhibition o f cholera toxin 
binding to GM1 receptors will be detailed, and potential applications o f the compound will 
be discussed.
5.1 Vibrio cholerae, its toxin and the associated disease
The Gram-negative bacterium, Vibrio cholerae (Figure 5.1), is a facultative aerobic curved
rod. The Vibrio group are typically polarly flagellated, which aids the movement o f the 
bacterium. Most vibrios are aquatic microbes, either in freshwater or marine habitats. One 
species, Vibrio cholerae, is pathogenic to humans, and it does not usually infect other host 




Figure 5.1 Electron micrograph o f  a Vibrio cholerae bacterium
V.cholerae causes cholera disease, which is an acute intestinal infection, with an 
incubation period from less than one day to five days. Infections begin with the ingestion 
o f contaminated food or water containing the bacteria. After passage through the acid 
barrier o f the stomach, the organism colonizes the epithelium o f the small intestine. 
Cholera enterotoxin produced by the adherent bacteria causes the disease-associated 
symptoms (Figure 5.2). Secretory diarrhoea is abruptly induced following the incubation 
period. The loss o f several litres o f water as a result o f the watery diarrhoea may lead to 
hypovolemic shock and severe dehydration. Vomiting tends to accompany the diarrhoeal 
episodes leading to further dehydration. Muscle cramps are common when water and 
electrolytes are lost from the body tissue, also causing a loss in skin turgor and a drop in 
heart rate. The disease tends to run its course within 2 to 7 days, and the outcome depends 
on the extent o f fluid and electrolyte loss and the method o f treatment. Death can result 














Watery stool enriched for sodium, 
potassium, chloride and bicarbonate ions
Figure 5.2 Schematic representations o f  the mechanism involved in diarrhoea production 
by Vibrio cholerae [I].
Treatment o f cholera typically consists o f replacing the essential fluid and electrolytes 
which are lost as a result o f the watery diarrhoea and vomiting. This is the standard 
treatment procedure, but may be supplemented with antibiotics, such as tetracycline, to 
shorten the period o f infection. The oral rehydration solution contains various salts to 
restore the fluid and electrolyte balance and sugars as an energy source. The addition o f  
rice powder into the solution can reduce stool output and the duration o f diarrhoea [2, 3]. 
Without proper treatment, the case-fatality rate for severe cholera is around 50%, however, 
treatment is typically effective (mortality rate reduced to <1% with proper treatment) [4, 
5]. V.cholerae is transmitted via the faecal-oral route, therefore, the disease is especially 
prevalent in areas where sanitation is poor, drinking water is contaminated and areas which 
experience man-made and natural disasters. These outbreaks tend to occur sporadically. 
The disease can spread very quickly, and the rate o f transmission is intensified by close 
confined conditions, such as those found in refuge camps.
Historically, cholera was originally endemic to the Indian subcontinent in the early 1800s, 
and the Ganges River was believed to serve as the contaminated reservoir which harboured 
the disease. Prior to this, little was known about cholera. However, it soon spread across 
many parts o f Asia, and the first documented case in England occurring in 1848 when a 
sailor arrived from Hamburg where the disease was prevalent. He left the ship and sought a 
room to rent, where he died a few hours later. The next case was a man who subsequently 
rented the same room after the sailors death [6]. There have been seven sporadic 
pandemics o f cholera between 1800 and 1970. But it was in 1854 that cholera was first 
described, and was later isolated in pure culture by Robert Koch in 1884. However, a 
milestone in cholera research was the work by John Snow, who determined that the disease 
was water-bome rather than spread via the aerosol route as originally thought. Moreover, 
during the 1854 cholera epidemic in London, Snow isolated the source o f contamination as 
the Broad Street water pump that had become contaminated with sewage, and all the 
people who had contracted the disease had used that pump to collect their water [6, 7].
Cholera is still particularly prevalent in areas o f Africa and Asia (Figure 5.3). The last 
cholera outbreak occurred in Angola, on the western coast o f Africa between February 
2006 and May 2007 (correct at time o f submission). The country reported over 82000 
cases, resulting in around 3100 deaths. The peak o f the outbreak was reached at the end o f  
April 2006 where a daily incidence o f 950 cases were reported [8]. There has been a sharp
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increase in the number o f cholera cases reported to the World Health Organization, and in 
2005, a total o f 131 943 cases o f the disease were reported, including 2272 deaths, notified 
from 52 countries. This was an increase of 30% compared to numbers reported from the 
previous year [9]. Outbreaks still pose a considerable public health risk, causing soci- 
economic disruption as well as loss o f life. These disruptions are also believed to result in 
the under-reporting o f cholera cases for fear o f further trouble in the economy, unjustified 
travel restrictions and trade-related sanctions. Epidemiological studies show that cholera 
tends to follow a pronounced seasonality, and peaks in the warm seasons aiding the growth 
o f the vibrios [4].
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Figure 5.3 Countries reporting cases o f  cholera in 2005 [9].
The prevalence o f cholera ensures continued interest in its mode o f action, physiology, and 
therapeutic possibilities.
5.1.1 Cholera toxin
Vibrio cholerae has been well characterized biochemically and genetically, however, this 
species is not homogeneous in terms of pathogenicity. There is variation in the production 
o f its enterotoxin, serogroup and its ability to spread epidemically. Two serogroups are 
associated with epidemic spread, Vibrio cholerae O l and 0139. However, there are strains 
of these serogroups which do not have the capacity to produce the enterotoxin and 
therefore, do not produce cholera epidemics (Figure 5.3).
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Serotype Toxin production (% ) Epidemic spread
O l >95% positive Yes
0139 >95% positive Yes
02 -0138 >95% negative No
Figure 5.3 Classification o f  the major Vibrio cholerae serotypes, and their capacity to 
produce the enterotoxin and ability to cause epidemics.
Bacterial virulence factors such as toxins, adhesion factors and the ability to assimilate 
unusual substrates, are often encoded on accessory genetic element (bacteriophages, 
plasmids, pathogenicity islands and transposons). Pathogenic strains o f V.cholerae differ in 
their expression o f virulence factors, and possess two gene clusters that provide normally 
aquatic bacteria with the ability to colonize the human intestine and secrete potent toxins. 
The gene encoding the cholera toxin was acquired from a filamentous bacteriophage 
(CTXO), where it replicates as a plasmid [10]. The core o f the CTX element carries six 
known gene, including ctxAB (encoding the a  and P subunits o f cholera toxin), ace 
(accessory cholera enterotoxin) and cep (core-encoded pilin). The V.cholerae virulence 
cluster also contains the tcp gene cluster, which regulates the pilus structure essential for 
colonization and also acts as a receptor for CTXO transposition [11].
The toxin produced by pathogenic V.cholerae is a secreted hexameric AB5 enterotoxin 
(choleragen), composed o f structurally independent a  (enzymatic) and p (targeting) 
subunits (Figure 5.4). The crystalline structure of the toxin closely resembles that described 
for the heat-labile enterotoxin from Escherichia coli (LT) with which it shares 80% 
sequence homology. The wedge-shaped a  subunit (molecular weight 27,500 Da) is loosely 
held high above the plane o f the pentameric p subunits (molecular weight 11,800 Da each) 
by the tethering A2 chain [12]. The enzymatic activity o f the toxin is solely located in the 
Ai peptide o f the a-subunit, however, the A\ peptide has little effect on its own, and it is 
proposed the remaining toxin components are needed to aid with the insertion o f the 
enzymatic peptide though the membrane [13]. The toxin arranges into a toroidal ring o f 
five p subunits to which the a-subunit associates. All the subunits associate non-covalently 
[12], with the adjacent p subunits interacting directly via multiple hydrogen bonds. The p 
subunits form a pore, 30A long, with a diameter ranging from ~ 1 1A near the surface at 
which the a-subunit is positioned ~15A on the lower surface [5], The p subunits are lectins 
capable o f binding carbohydrates which are highly specific for their sugar moieties. The p
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subunits are able to form the pentamer in the absence o f the a-subunit, however, for a toxic 
effect to ensure, the whole a(3 toxin is required.
(Picture source www.bmsc.washington.edu)
Figure 5.4 Crystal structure o f  the cholera heterohexameric (AB5) protein toxin secreted 
by pathogenic strains o f  Vibrio cholerae.
Cholera toxin (Ctx) exerts its diarrheagenic action by subverting the normal physiological 
processes o f gut epithelial cells, here, it must bind to and enter the cells o f the gut 
epithelium.
5.1.2 Toxin-Membrane Interactions
To induce the symptoms associated with the disease, Ctx released into the intestinal lumen 
must enter the intestinal epithelial cells. V.cholerae does not invade the intestinal mucosa 
but it directly assists the delivery o f the toxin into the cytosol o f the cell. Therefore, the 
ability to enter the cells cytoplasm is entirely within the structure o f the fully assembled 
and folded protein toxin.
For the toxin to gain entry into the cytosol o f the sensitized cell, it must first circumvent 
the cell membrane that acts as a barrier to the toxin. The p subunits must bind to cell 
surface receptors to ensure the translocation o f the toxin from the extracellular 
environment into the cytosol. The principal receptor for Ctx is the GM1 ganglioside 
(Figure 5.5). The primary event is the tight and rapid binding o f the toxin to the receptors 
on the cell surface. There is a high affinity shown by the Ctx for the cell surface receptors 
and the equilibrium association constant has been shown to be approximately KA = 1 x 109 
mol' 1 [14]. It is possible for a single toxin molecule to bind up to five GM1 molecules [15],
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which was confirmed by in vitro fixation studies showing each p subunit binds to one 
GM1 molecule. The interaction between the GM1 receptor and the cholera toxin shows 
both specificity and stability, and this dictates toxin function because it affects the toxin 
trafficking into the cell. The initial binding of the p-subunit to the cell surface receptors is 
reversible. The GM1 receptor contains two long hydrophobic acyl chains, which partition 
into the lipid bilayer, and a hydrophilic pentasaccharide head group, which is responsible 
for the recognition o f the Ctx. The toxin binds to the cell surface to ensure that the Aj chain 
o f the a-subunit is facing away from the membrane [16]. This ensures that the whole toxin 
is internalized [17] rather than if  the A] subunit faced towards the membrane which 










Figure 5.5 GM1 ganglioside, a glycosphingolipid found ubiquitously on the surface o f  
eukaryotic cells. Cholera toxin exploits the receptors exclusivity to gain access into the 
cells cytosol.
The toxin hijacks the cells trafficking machinery to directly enter the cell using a 
retrograde trafficking pathway from the cell membrane into the cell. The tethered toxin 
associates with lipid rafts in the plasma membrane, which are rich in cholesterol. The sterol 
has been shown to play an important role in the assembly o f the toxin oligomer [19]. The 
toxin is internalized by clatherin-dependant and -independent mechanisms [2 0 ], causing 
the endocytosis o f the toxin from the extracellular environment into the cell cytosol within 
an endosome. Upon endocytosis, the encapsulated toxin is transported retrogradly to the 
Golgi apparatus. The acidic conditions found within the aqueous space o f the endosome 
causes a conformational change within the Ctx. This causes the dissociation o f the a -  from 
the p-subunits. The P subunits form a pore in the endosome to allow the translocation of 
the a-subunit into the Golgi. The a-subunit continues on to the endoplasmic reticulum 
(ER), which is mediated by the KDEL m otif (an ER-targeting motif) present in the a - 
subunit [21]. The released p subunit can then recycle from the Golgi into late endosomes 
and lysosomes [22]. In the ER, the a-subunit commandeers the machinery necessary for
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retro-translocation o f misfolded proteins to enter the cytosol. It has been proposed that the 
enzymatically active part o f the toxin disguise themselves as misfolded proteins to ensure 
that they enter the ER-associated protein degradation (ERAD) pathway [23], The toxin 
enters the ERAD pathway by exposing hydrophobic regions upon dissociation o f their a -  
and p-subunit, and as mentioned previously, defectively folded proteins are earmarked for 
degradation. However, the enzymantically active subunit o f the toxin must evade 
degradation. The a-subunit o f many a p  protein toxins have been found to possess few 
lysine residues within their sequence [24], and it is this that is believed to ensure the 
enzymatically active subunit escapes the ubiquitin-mediated protein degradation pathways 
during translocation from the ER into the cytosol. Moreover, this low lysine residue 
content o f the a-subunit is necessary because ubiquitination o f a defective protein requires 
lysine residues. Therefore, the camouflaged a-subunit is retrotranslocated from the ER into 
the cytosol using the host cell protein degradation transport machinery, where it can elicit 
its actions (Figure 5.6) [23].
Figure 5.6 Schematic o f  the transport o f  cholera toxin from the plasma membrane into the 
cytosol o f  the cell. The /3-subunits bind to the GM1 receptor on the cell surface, causing 
the endocytosis o f  the whole Ctx. The toxin is translocated to the Golgi apparatus, where 
the a/3 subunits dissociate. The /3-subunits form a pore in the endosome fo r  the 
translocation o f  the a-subunit, it is further transported to the endoplasmic reticulum and 
released into the cells cytoplasm. Within the cytosol, the a-subunit activates the G-protein 
to continually stimulate the production o f  cAMP. This causes the symptoms associated with 
cholera disease [25]. A is the a-subunit, B is the /3-subunit and R is the GM1 receptor.
Exotoxins (AB)
(Picture source.www. thepoint. Iww. comj
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The a-subunit o f the Ctx is composed of two polypeptide chains, Ai and Kj. The enzymatic 
activation o f the a-subunit requires the reduction o f the disulfide bond which links the two 
subunits. The liberated Ai polypeptide chain has been shown to exhibit both NAD+- 
glycohydrolase and ADP-ribosyltransferase activities in vitro [26]. Cholera toxin exerts its 
effects on the small intestines through activation o f adenylate cyclase, a transmembrane 
protein found on the inner surface o f the cell membrane. The activation process is 
dependent on the presence o f the a-subunit o f the toxin, NAD+, cellular cytosolic factors 
and ATP. The toxin causes the covalent modification o f the GTP-binding protein [27], in 
the presence o f NAD+ as followed:
G T P -binding protein  + NAD+ <choleratoxm >A D P -ribsoyl-G T P -binding protein
(5.1)
Cholera toxin catalyzes the transfer o f ADP-ribose from NAD to a GTP-binding protein in 
the plasma membrane, which subsequently causes the activation o f adenylate cyclase. GTP 
binds adenylate cyclase to catalyze the conversion o f ATP to 3’,5’-cylic AMP (cAMP). 
Qx-induced cAMP causes the blockage of Na+/H+ and C I /H C O 3 "  exchanger ion channels. 
This leads to the cAMP-dependent net secretion o f electrolytes and water from the 
cytoplasmic to the mucosal side o f the epithelium. This is reliant on the active secretion o f 
the chloride ions and the simultaneous inhibition o f absorption o f sodium and chloride ions 
in the epithelium [28]. This causes the efflux of water, increased chloride secretion and 
decreased sodium absorption, which affects the ion balance and osmolarity o f the cells in 
the small intestine. The secretory transport processes are stimulated to such an extent that 
the reabsorptive capacity is exceeded [29]. This manifests itself as the characteristic 
symptoms o f cholera, namely, rice water diarrhea and vomiting.
5.2 Preliminary Measurements of the Interaction between Tethered 
Vesicles and Cholera Toxin By Surface Plasmon Resonance
As demonstrated by the actions o f lipolytic enzymes on tethered biomimetic membrane
vesicles, it is possible to monitor the actions o f a range o f toxins that act at the membrane 
surface in real-time using SPR. This technique allows for the observable binding o f the 
cholera toxin to the biomimetic model membrane surface and subsequently any changes in 
the membrane structure or integrity. Biomimetic membrane vesicles composing 67% 
DMPC, 1% biotin, 30% cholesterol, and 2% GM1 were prepared and tethered to the 
supramolecular surface. Cholera toxin was added to the system at the appropriate 
concentration.
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It has previously been reported that cholera toxin is capable o f inducing channels in lipid 
bilayers [30], and in doing so, causes the leakage o f glucose entrapped within bilayer 
vesicles [31]. The toxin binds to and oligomerizes in target membranes generating small 
transmembrane pores. As demonstrated by osmotic protection experiments, pores formed 
in erythrocytes were approximately 0.7nm in size [32]. Therefore, any actions induced by 
the enterotoxin to the biomimetic membrane will be observed.
5.2.1 Monitoring the Interaction between Whole a-su bun it Cholera Toxin and Biomimetic 
Membrane Vesicles
The biomimetic membrane vesicles used in chapter 4 were adapted to ensure Ctx- 
membrane interactions were observable. The inclusion o f 2mol% GM1 ganglioside was 
incorporated into the bilayer o f the biomimetic membrane vesicles. This ensured that the 
natural receptor o f the Ctx was present within the model system. The addition of 
0.6pmol.dm '3 whole Ctx to the tethered vesicle system (Figure 5.7) was followed as a 
change in reflectivity at the surface o f the vesicles.
- « — S PR  addition of 0.6nm ol.dm  3 whole ap  subunit Ctx
1.00
0 .9 8 -
0 .9 6 -
^  0.94 -
cr
> ,0 .9 2 -
R inse
0 .9 0 -
■O  0 .8 6 -
m 0.84 -
O 0.82 -
0 .8 0 -
0 .7 8 - Addition of whole Ctx
0  1 0 0  2 0 0  3 0 0  4 0 0  5 0 0  6 0 0  7 0 0  8 0 0  9 0 0  1 0 0 0  1 1 0 0  1 2 0 0
Time (minutes)
Figure 5.7 Measurement o f  change in mass density at the vesicle surface (SPR) over time 
upon the addition o f  whole Ctx.
The injection o f the toxin into the tethered vesicle system showed an increase in 
reflectivity. The increase in mass density at the surface was the result o f the p-subunits o f 
the Ctx specifically binding to the GM1 receptors incorporated within the phospholipid
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bilayer o f the tethered vesicles. Maximal toxin binding was reached at around 1200 
minutes. The initial binding o f the toxin to the GM1 receptors was rapid, and was followed 
by a slower phase o f toxin binding (time<20minutes). The slower phase o f binding resulted 
from the decreased availability o f  the binding sites, therefore, toxin-receptor interactions 
decreased in frequency until equilibrium was reached. The approach o f equilibrium at 
around 20hours coincides with the incubation period o f the bacterium, therefore, this 
would suggest that cytotoxicity results as the analyte-ligand reaches equilibrium.
Analysis o f the resonance angle scan curves before and after the addition o f the whole Ctx 
(Figure 5.8), showed an increase in resonance minimum angle at the surface o f 0.4°. This 
increase in reflectivity equated to the adsorption o f 2.14ng.mm'2 mass at the tethered 
membrane surface, mediated by the GM1 receptors.
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Figure 5.8 Resonance angle scan curves o f  the tethered vesicle system before and after the 
injection o f  0.6/jmol.dm3 whole Ctx.
The initial results showed that the tethered biomimetic membrane system was a novel 
method for studying bacterial toxin-membrane interactions, and the measurement of 
change in reflectivity allowed for the quantitative analysis o f adsorption o f the protein 
toxin to the membrane surface. The incorporation o f bacterial toxin receptors, such as 
G M 1, allowed for the development o f surfaces for the monitoring and analysis o f  specific 
interactions between bacterial toxins and cell surface receptors.
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5.2.2 Monitoring the Interaction between p-subunit Cholera Toxin and Biomimetic 
Membrane Vesicles
The binding o f the (3-subunit o f the cholera toxin to the GM1 receptors within the 
biomimetic membrane vesicles was monitored as a change in reflectivity (Figure 5.9).
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Figure 5.9 Measurement o f change in mass density at the vesicle surface (SPR) over time 
upon the addition o f  P-subunit Ctx only.
The initial binding o f the (3-subunits o f the Ctx was rapid, and reached an equilibrium faster 
than the whole toxin (Figure 5.8). There was no subsequent slower binding phase, as 
observed with the whole Ctx, suggesting that the a-subunit affects the binding kinetics. The 
kinetics plot derived from the interactions between the P-subunit and the G M 1-containing 
membrane allowed for the determination of the equilibrium dissociation constant, which 
was determined to be Kd = 7 .2x l0 '9mol.dm'3. The KD observed for the interaction between 
the P-subunit and the membrane was shown to be a high affinity interaction, this was 
because it was a receptor mediated interaction compared to a non-specific or non-receptor 
mediated interaction which tend to show lower affinity.
From the resonance scan curves, it can be shown that there was an increase in reflectivity 
upon addition o f the p-subunit Ctx to the tethered vesicle system. A resonance minimum 
shift o f 0.2° was observed as a result o f p-subunit Ctx adsorbing to the surface (Figure 
5.10). The minimum shift equated to the adsorption o f 1.07ng.mnT2 mass to the surface. 
This was a smaller adsorption o f mass to the surface compared to the adsorption o f whole 
toxin (2.14ng.m m 2 whole Ctx adsorption), because the molecular weight o f the whole 
toxin was significantly greater than that o f the P-subunits only.
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Figure 5.10 Resonance angle scan curves o f  the tethered vesicle system before and after 
the injection o f  0.6jumol.dm'3 P-subunit Ctx only.
The use o f the P-subunit in binding studies, gave the opportunity to determine affinity 
constants and binding not influenced by the a-subunit. Therefore, it gave a true equilibrium 
binding constant for the p-subunit and the G M 1 -containing membrane. It can be observed 
that the a-subunit does affect the binding between the toxin and the membrane surface, and 
that the binding o f the whole toxin to the biomimetic membrane surface is reduced by the 
presence o f the a-subunit.
5.2.3 Measurement o f  Dose-Response o f  Cholera Toxin on Biomimetic Membrane Vesicles 
Cholera toxin has been shown to adsorb to the surface of biomimetic membrane vesicles
(section 5.2.1 and 5.2.2). This adsorption was mediated by the protein-carbohydrate
interaction between the p-subunits o f the cholera toxin and the GM 1 ganglioside present
exclusively in mammalian cell membranes. This receptor-analyte interaction was
concentration dependant, and varying the concentration o f cholera toxin caused a dose
dependant shift in the reflectivity (Figure 5.11).
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Figure 5.11 Langmuir isotherm fo r  the normalized equilibrium for the resultant adsorption 
o f  mass from the surface as a function o f  cholera toxin concentration.
The multivalent interaction between the cholera toxin and the biomimetic membrane 
vesicles followed a standard Langmuir isotherm. From the Langmuir plot it was possible to 
determine the Langmuir equilibrium dissociation constant, Kd, for the adsorption of the 
cholera toxin to the biomimetic membrane vesicles. The Kd was determined directly from 
the plot at the point where Req=Rmax/2 (Figure 5.11). The calculated Kd equilibrium 
dissociation constant for the interaction between the biomimetic membrane vesicles and 
cholera toxin was 6.3x10 '7mol.dm‘3, which was in good agreement with other reported KD 
values [33].
The calculated dissociation equilibrium constant was o f lower affinity compared to that 
determined between the p-subunit and the biomimetic membrane vesicles (7.2x1 O'9 
mol.dm"3), (Figure 5.9). The difference in affinity resulted from the influence o f  the a- 
subunit had on the interaction between the toxin and the membrane surface. Therefore, the 
whole toxin was used as the analyte to ensure a closer comparison to the real biological 
toxin system.
It is apparent that increasing the concentration o f cholera toxin added to the tethered 
biomimetic membrane vesicles caused a concentration dependant interaction between the 
















Figure 5.12 Summary o f  the change in resonance minimum (°) and the change in mass at 
the surface upon the addition o f  varying concentrations o f  cholera toxin to the biomimetic 
membrane vesicles.
Below a concentration o f 0.6pmol.dm‘3 the limit o f detection for cholera toxin was 
approached, and at a concentration o f 0.3pmol.dm‘3 there was no observable change in 
reflectivity. From the resonance angle scans o f the tethered biomimetic membrane vesicles 
before and after the addition o f Ctx below 0.6pmol.dm '3, there was no observable change 
in the resonance minima (Figure 5.13).
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Figure 5.13 Resonance angle scans for the tethered biomimetic membrane vesicles before 
and after the addition o f  varying concentrations o f  cholera toxin (6 x 1 O'5 to 0.6jumol.dm'3). 
No shift in the resonance minimum is observed.
Ctx concentrations below 0.06pmol.dm'3, showed no change in the resonance minima. This 
would suggest that a too small change in reflectivity at the surface occurred or too few 
receptor-analyte interactions took place to see a change because the toxin was at a low
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concentration. Therefore, the optimum concentration o f cholera toxin to study receptor- 
analyte interactions is above 0.06|imol.dm'3.
5.2.4 Monitoring the Interaction between Whole afi-subunit Cholera Toxin and Biomimetic 
Membrane Vesicles Containing No GM1
Using immunohistochemical techniques, it has been determined that the tissue receptor for 
cholera toxin was the sialidase-resistant monosialosylganglioside [34], The identity o f the 
monosialosylganglioside was established to be GM1 [35], It was shown to be an effective 
receptor for the bacterial toxin in final concentrations as low as lng.ml'1 [36]. Other 
gangliosides have been shown to bind the toxin with a lower capacity, including the 
disialoganglioside, GDib, which demonstrates a considerable binding capacity to cholera 
toxin [37]. The affinity of the P-subunit for the GM1 receptor on the cell surface is 
believed to be one o f the highest affinity protein-carbohydrate interactions known, with an 
equilibrium dissociation constant o f Kd = 4.3x10‘8mol.dm'3 [38], which is similar to the 
equilibrium dissociation constant determine in section 5.2.2. Therefore, it suggests that the 
interaction between p-subunit and the GM1 receptor has a higher affinity compared to the 
ap-cholera toxin with the GM1 receptors. The high affinity binding is the result o f a 
positive cooperativity between the toxin subunits [39] and through the multivalent 
interaction o f the pentameric toxin with up to five GM1 receptors at the cell surface [40].
GM1 has now been well reported to have the highest affinity and capacity to bind cholera 
toxin. Using combined SPR and SPFS, the interaction o f Ctx with tethered biomimetic 
membrane vesicles containing no GM1 ganglioside was monitored (Figure 5.14 Red and 
Blue plots), and was compared to the addition o f Ctx to GM1-containing biomimetic 
vesicles (Figure 5.14 Fuchsia and Green plots).
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5.14 Simultaneous measurement o f  change in reflectivity at the vesicle surface (SPR) and 
change in florescence (SPFS) upon the addition o f  whole Ctx to biomimetic membrane 
vesicles containing no GM1 ganglioside(Red and Blue plot), compared to when GM1 is 
present within the vesicle bilayer (Gn and Fuchsia plot)
The addition o f 0.6|amol.dm'3 Ctx to the tethered vesicle system containing no GM1 
showed a marked difference to that when GM1 ganglioside was present within the vesicle 
system. Upon the addition of the Ctx to the surface there was non-specific binding of the 
toxin to the membrane, therefore, Ctx has some intrinsic binding capacity to other 
membrane constituents. The non-specific binding may result from the presence o f sterols 
in the vesicle bilayer, as cholesterol has been shown to be a target molecule for many 
bacterial pore-forming toxins. Therefore, the toxin may have a certain intrinsic binding 
capacity towards sterols or membrane phospholipids. It has been shown that pore-forming 
toxins, such as Streptolysin O from Streptococcus pyogenes, requires cholesterol for the 
initial events during membrane binding [41]. Cholesterol has been shown to be necessary 
for the oligomerization o f the Ctx monomers [42, 43], therefore, there may be a certain 
degree o f affinity between the Ctx and the GM 1-deficient biomimetic vesicles as a result of 
cholesterol. This is supported by a report that suggests that in the absence of any ceramides 
or glycolipids, Ctx are still highly active when the concentration o f the membrane 
cholesterol is raised above 35mol% [44]. The Ctx can be seen to be active within the 
membrane because there was a change in the fluorescence signal upon addition of the Ctx 
to the GM l-deficient vesicles (Figure 5.14 Blue plot). The diffusion o f the dye 
encapsulated within the aqueous space o f the tethered vesicle was increased, suggesting the 
toxin had oligomerized and formed pore-like structures within the phospholipid bilayer.
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The pores subsequently provided an additional means o f dye diffusion, causing an 
increased porosity o f the membrane. The apparent dye diffusion coefficient for the leakage 
o f BODIPY from GM 1-deficient membrane vesicles was calculated to be D*  =5.8x10' 
14cm2.s‘1. However, the inclusion of GM1 in the vesicle bilayer allowed for specific toxin 
binding, and the calculated apparent dye diffusion coefficient was D* =1.1 l x l0 '13cm2.s'1. 
Therefore, the omission o f the GM1 receptor from the biomimetic membrane vesicles 
caused a reduction in the diffusion of the encapsulated dye into the bulk solution compared 
to when GM1 was present within the bilayer.
The change in reflectivity was greater between Ctx and the membrane surface containing 
GM1 (Figure 5.15a) compared to Ctx and membranes deficient in GM1 (Figure 5.15b). 
There was a 0.35° shift in resonance minimum when GM1 was present within the vesicle 
bilayer upon addition of Ctx, which equated to the adsorption o f 1.87ng.mm‘2 mass at the 
membrane surface. This was a significant increase in mass compared to when no GM1 was 
present, which exhibited a 0.05° shift in the resonance minimum. This equated to the 
adsorption o f 0.268ng.mm"2 mass at the membrane surface.
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Figure 5.15 (a) Resonance and fluorescence angle scan curves o f  the tethered vesicle 
system before and after the injection o f  0.6/jmol.dm'3 Ctx to GM1-containing vesicles and 
(b) Scan curves before and after the injection o f  Ctx to GMl-deficient vesicles.
The inclusion o f the GM1 glycoprotein mediated the attachment o f cholera toxin to the 
biomimetic membrane surface. The ganglioside significantly increased the binding 
capacity o f the toxin to the membranes. However, the toxins capacity to bind did occur via 
a non-specific interaction when the receptor was absent. This would suggest that the 
presence o f a high sterol content within the tethered vesicle bilayer mediates non-specific 
toxin binding to the receptors. The omission of GM1 from the vesicle bilayers ensured a 
reduction in the permeability o f the biomimetic membrane vesicles, as calculated from the
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apparent dye diffusion coefficient. Therefore, the expression of GM1 within biological 
membranes ensures specific binding to Ctx, however, non-specific binding may also occur.
5.2.5 Monitoring the Interaction between Whole a -su bun it Cholera Toxin and Biomimetic 
Membrane Vesicles Containing No Sterol
Sterols have been shown to affect the oligomerization o f cholera toxin monomers [42, 45]. 
Cholesterol is inclined to form lipid rafts within biological membranes, and this acts to 
concentrate receptors and glycoproteins into the cholesterol domains. Therefore, 
cholesterol would tend to cause the concentration o f the P-subunit monomers in the 
biomimetic membrane, which ensures oligomerization can take place. As mentioned in 
section 5.2.3, Ctx is highly active in membranes containing a high proportion o f sterol, and 
Ctx tends to non-specifically adsorb to the vesicle surface when GM1 is absent.
Using combined SPR and SPFS, the interaction o f Ctx with tethered biomimetic membrane 
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Figure 5.16 Simultaneous measurement o f  change in reflectivity at the vesicle surface 
(SPR) and change in florescence (SPFS) upon the addition o f Ctx to biomimetic membrane 
vesicles containing no cholesterol (red and blue plot) compared to vesicles containing 
cholesterol (grt < and fuchsia plot).
Biomimetic membrane vesicles deficient in cholesterol showed a smaller change in 
reflectivity upon Ctx addition compared to cholesterol-containing vesicles. The smaller 
change in reflectivity suggests that cholesterol does affect Ctx binding, as well as affecting 
the oligomerization o f the Ctx monomers. The change in fluorescence observed upon toxin
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addition to the vesicles containing the sterol can not be readily compared to vesicles 
deficient in cholesterol, because sterols significantly alter the natural porosity and 
permeability o f phospholipid bilayers (see section 4.7.3.1).
The omission o f cholesterol from the biomimetic membrane vesicles showed reduced mass 
density adsorption to the surface (Figure 5.17). A resonance minimum shift o f 0.15° was 
calculated from the resonance scans before and after the addition o f Ctx to the cholesterol- 
free vesicles, which equated to the adsorption o f 0.80ng.mm'2 o f  mass to the vesicle 
surface. This adsorption was significantly lower than that observed when tethered vesicles 
contained cholesterol (1.87ng.mm'2 mass adsorption calculated from Figure 5.15a). This 
suggests that cholesterol plays a dual role in Ctx pathogenicity, and causes toxin monomer 
oligomerization and also synergistically improves the capacity o f  the toxin to bind to 
biomimetic membranes.
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Figure 5.17 Resonance and fluorescence angle scan curves o f  the tethered vesicle system 
before and after the injection o f  0.6/jmol.dm3 whole Ctx to cholesterol-deficient vesicles.
From the results present in this section, it is apparent that the tethered biomimetic 
membrane system provides a novel means o f studying bacterial toxins. The combined 
SPR/SPFS technique provides a sensitive means o f determining affinity constants and the 
change in mass density upon toxin addition. It is evident that toxin binding is mediated by 
the P-subunit and it shows high affinity towards the GM 1 ganglioside, which is exclusively 
expressed in mammalian cells. Moreover, cholera toxin shows a non-specific affinity 
towards ganglioside-deficient membranes as a result o f high sterol content. The expression 
o f GM1 causes increased permeability o f the membrane vesicles, as determined by the 
apparent dye diffusion coefficient, compared to vesicles not expressing the ganglioside
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receptor. The omission o f cholesterol causes a reduction in the binding capacity towards 
Ctx. Therefore, cholesterol has a dual role in Ctx pathogenicity, assisting toxin binding to 
the membrane and facilitating the oligomerization o f the toxin monomers into a pentameric 
pore within the phospholipid bilayer.
5.3 Lum inescence Spectrom etry A nalysis o f Fluorescence D iffusion upon 
C holera Toxin-M em brane Interactions
The BODIPY 650/665-X STP ester was used as the fluorescent dye in these experiments 
(Figure 5.18). It has been shown that BODIPY dyes have high photostability, narrow 
emission spectrum with large Stokes’ shift and give less overlap with certain other 
fluorophores compared with other commercially available fluorescent dyes. These dyes 
tend to be relatively non-polar and the chromophore is electrically neutral. They have been 
favourably used because o f their high extinction coefficients, good fluorescence quantum 
yields and relatively long excited-state lifetimes (>3nanoseconds) [46].
C H =C H OCH — C ~NH(CH_) — C -  O SO,
Figure 5.18 Chemical structure o f  6-(((4,4-difluoro- 5-(2-pyrrolyl) -4-bora-3a,4a- diaza-s- 
indacene- 3-yl)styryloxy) acetyl) aminohexanoic acid, sulfotetrafluorophenyl ester, sodium 
salt, BODIPY dye molecule, which excites at 650nm and emits at 665nm.
The addition o f whole- and P-subunit Ctx to tethered biomimetic membrane vesicles during 
kinetics experiments caused an unexpected phenomenon in the measured fluorescence 
response (as highlighted in Figure 5.19). Upon the addition o f the Ctx to the biomimetic 
membrane surface there was an initial increase in the measured fluorescence signal, 
followed by the decrease in fluorescence as the encapsulated dye diffused through the 
permeated membrane. The increase in fluorescence signal has not been reported previously 
in literature.
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Figure 5.19 Monitoring the change in fluorescence as a result o f  biomimetic membrane 
permeation due to the addition o f  0.6/jmol.dm3 /?-subunit Ctx. Unreported increase in 
fluorescence upon toxin pore formation in the membrane vesicles is highlighted.
The increase in fluorescence observed upon Ctx addition could result from the 
encapsulated dye self-quenching (section 2.2.2). The encapsulation o f the BODIPY dye 
within the aqueous space o f  the tethered vesicles concentrates the fluorophore, thereby 
increasing the potential for the dye molecules to come into contact with one another. This 
would cause the quenching o f the dyes within the encapsulated space and therefore cause 
an underreporting in detected fluorescence. Quenching o f fluorescent molecules requires 
molecular contact between the fluorescent molecule and the quencher, and encapsulation 
o f the dye molecules increases the probability o f molecular contact. The quencher may be 
another fluorescent molecule (self-quenching), therefore, the encapsulation o f the dye 
within the vesicles could induce self-quenching. The oligomerization o f the Ctx monomers 
into a transmembrane pore causes the permeation o f the biomimetic membrane vesicles, 
and provides channels for the quenched fluorophores to diffuse through into the bulk 
solution. Diffusion o f the BODIPY from the region o f high fluorophore concentration to 
low fluorophore concentration in the bulk solution reduces the probability o f molecular 
contact, and therefore reduces the probability o f the BODIPY self-quenching. Diffusion of 
the supposed quenched BODIPY dye into the bulk solution removes the quenched state of 
the fluorophore and therefore could cause the increase in fluorescence signal until the 
fluorescent molecules are carried away into the bulk solution.
A fluorescence upon addition of Ctx to 
tethered biomimetic vesicles_______
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Using a luminescence spectrometer, the ability o f BODIPY to self-quench was determined. 
BODIPY solutions ranging between 0.05-10pmol.dm'3 were prepared and analyzed in the 
spectrometer (Excitation = 633nm, Emission = 665nm, Scan speed = 200nm/minute). 
During SPFS kinetics experiments, the BODIPY dye is encapsulated at a 5pmol.dm '3 
concentration within the aqueous space o f the biomimetic membrane vesicles, therefore, 
BODIPY solutions within this range were analyzed. The maximum emission intensity was 
observed for all o f the fluorophore concentrations analyzed, and plotted as a function of 
BODIPY concentration (Figure 5.20).
















2 0 0 -
10 0 -
0 2 5 6 7 8 9 10 11 121 3 4
BODIPY cone (uM/mL)
Figure 5.20 Luminescence spectrometry plot, with linear fit, o f  the fluorescence intensity o f  
varying concentrations o f  BODIPY dye at emission at 665nm.
For each o f the BODIPY concentrations tested, there was no evidence o f fluorophore self- 
quenching, as intensity was directly proportional to dye concentration. Therefore, 
increasing the probability o f molecular contact between BODIPY fluorophores, by 
encapsulating high concentrations o f dye, did not cause quenching o f the BODIPY. Above 
the working concentration (5pmol.dm*3), the fluorescent dye did not self-quench and 
therefore, does not explain the increase in fluorescence seen upon addition of the Ctx pore- 
forming toxin to the biomimetic membranes (Figure 5.19).
The change in fluorescence intensity was not dependant on the age o f the fluorophore 
solution or was not a result o f fluorophore degradation (Figure 5.21). The intensity o f the 
various dye concentrations taken over a seven day period showed no change in the linear 
fit. The linear fit for the dye concentrations taken on day one, day two and day seven were 
calculated to be 65.6, 53.7, and 59.9 respectively. Therefore, the fluorophore does not
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5.21 Luminescence spectrometry plot, with linear fit, o f  the fluorescence intensity o f  
varying concentrations o f  BODIPY dye at emission at 665nm taken after 1 day, 2 days and 
7 days.
A wide variety o f substances act as quenchers, including amines, chloride and hydrogen 
peroxide. One of the most prominent quenchers is molecular oxygen, which quenches 
almost all known fluorophores. Oxygen quenches fluorescent molecules in a reversible 
manner, but the degree o f quenching is dependant on the oxygen pressure and 
concentration [47]. The mechanism of quenching by oxygen is believed to be caused by 
the fluorophore undergoing an intersystem crossing into the triplet state, and the long-lived 
triplets are completely quenched, so fluorescence is not observed [48]. It has been reported 
that BODIPY is quenched by oxygen around 5% o f the time [49]. Quenching by oxygen 
was minimized by removing dissolved oxygen in all buffers and samples by bubbling 
nitrogen through. However, this did not eliminate the increase in fluorescence observed 
upon toxin addition.
Another mechanism o f quenching may arise from polarity effects. Charge effects are 
observed with quenchers including iodine and chloride. The charge of proteins and 
phospholipids can also have a marked effect o f the intensity o f fluorescence and changes in 
fluorescence can be seen during protein folding if  a fluorophore moves from a hydrophobic 
to hydrophilic environment o f vice versa. The BODIPY dye forms hydrogen bonds with 
water molecules when in solution, and the hydration o f the dye may cause partial
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quenching o f the dye molecules, and the effect on the fluorescence signal may arise from 
this partial quenching caused by the hydration o f the BODIPY. The effect o f charge on 
fluorescence signal could be caused by the formation o f the Ctx pore in the biomimetic 
phospholipid bilayer vesicles. As mentioned previously in this chapter, the p-subunits form 
a pentamer doughnut shape, with five monomers arranged symmetrically around the 
central axis, leaving a pore in the middle. It has been detailed that a very polar central pore 
is formed, and the many charged residues are located within this central pore, giving the 
pentamer a very unsymmetrical distribution o f charges [50]. The P-subunits are stabilized 
when oligomarized by a variety o f interactions, including hydrogen bonding between the 
P-subunits [51]. The charged pore and the hydrogen bonds involved in its stabilization 
could cause the phenomenon seen in the fluorescence signal. The pore formed by the Ctx 
provides a direct route for the encapsulated dye to diffuse into the bulk solution, but the 
charged residues may cause the water molecules surrounding the hydrated BODIPY dye to 
be stripped away temporarily while the dye traverses the Ctx pore. The temporary removal 
o f the hydration state by the charged pore may cause the partial self-quenched dye to 
fluoresce more intensely while traversing the bacterial toxin pore. Upon emergence from 
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Figure 5.22 Schematic o f  the potential mechanism to explain the temporary increase in the 
fluorescence signal upon Ctx addition to biomimetic phospholipid vesicles. The hydrated 
BODIPY dye (partially quenched) diffuses towards the highly charged Ctx pore. The 
charged pore causes the water molecules hydrating the dye to be temporarily stripped, 
instigating the temporary un-quenching o f  the BODIPY as it traverses the Ctx pore. Upon 
emergence from the pore, the BODIPY dye becomes rehydrated, and therefore, returning it 
to its original partially quenched state.
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Another proposed mechanism may be the influence o f the substrate surface, as solid 
surfaces have been shown to cause distortions in the shape o f tethered vesicles [52]. The 
solid surface may influence the vesicles by distorting the typically spherical vesicles and 
cause the compression o f the biomimetic membrane vesicles. Therefore, this would bring 
the vesicles closer within the evanescent field, and subsequently cause an enhancement 
effect in the detected fluorescence, which may manifest as the rise in fluorescence upon 
pore formation. Therefore, J3-subunit Ctx and whole Ctx were respectively added to the 
biomimetic membrane vesicles containing the encapsulated BODIPY in the bulk solution 
(vesicles were not tethered to the solid substrate), and the increase in fluorescence was 
subsequently observed (Figure 5.23).
1.25 ->
. 1.2 0 -
,0,







Control experiment- No Ctx added to vesicles in bulk solution 
p-subunit Ctx added to vesicles in bulk solution 











Figure 5.23 Observing the fluorescence upon addition o f  Ctx to biomimetic membrane 
vesicles free in the bulk solution (vesicles were not tethered to the surface). Initial increase 
in fluorescence still observed.
It can be observed that addition of the P-subunit or the whole Ctx to vesicles in solution 
causes the increase in fluorescence observed upon pore formation. This suggests that the 
solid surface does not affect the shape o f the vesicles and is not caused by an enhancement 
effect in compressed vesicles. Therefore, biomimetic membrane vesicles in the bulk 
solution also show the increase in fluorescence observed upon toxin addition and is not 
caused by tethering to solid surfaces.
The initial increase in fluorescence signal observed upon addition o f Ctx to biomimetic 
membrane vesicles was not a result o f the encapsulated BODIPY dye self-quenching at 
high concentrations when confined to the aqueous space o f the vesicles. The increase in
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fluorescence was not an affect o f the solid surface, as biomimetic vesicles in the bulk 
solution also showed this effect. The increase was best explained by the physical properties 
of the pentamer pore formed within the biomimetic membranes and the hydration o f the 
BODIPY. The interior o f the Ctx pores are highly charged, therefore, the charge may 
temporarily remove the bound water molecules from the dye causing the fluorophore to 
fluoresce more intensely while within the Ctx pore. Upon emergence from the charged 
pore, the dye rehydrates and this reinstates the partial self-quenched state. After the initial 
increased rate o f diffusion caused at the time o f pore formation, the rate o f dye diffusion 
decreases aid the fluorescence signal begins to fall as the BODIPY is free in the bulk 
solution.
5.4 Inhibition of Cholera Toxin-Membrane Interactions by Blocking the 
Membrane Receptors
Various drug molecules have been developed to target and relieve the symptoms associated 
with cholera disease as well as trying to prevent the actions o f the toxins produced by 
pathogenic Vibrio cholerae. However, at present, the primary method for the treatment of 
patients suffering from cholera is to replace the electrolytes and water lost during episodes 
of diarrhoea and vomiting.
5.4.1 The Use o f  Oral Rehydration Therapy in the Treatment o f  Cholera
Oral rehydration therapy (ORT) is the main strategy recommended by the World Health
Organization to achieve a reduction in diarrhoea-related mortality and malnutrition
especially in children. Oral rehydration salts are balanced glucose-electrolyte mixtures first







Sodium chloride 2.6 12.7 Sodium 75
Glucose 13.5 65.9 Chloride 65
Potassium chloride 1.5 7.3 Glucose 75
Trisodium citrate 2.9 14.1 Potassium 20
Citrate 10
TOTAL 20.5 100.00 Total Osmolarity 245
Figure 5.24 The composition o f  the oral rehydration salts, which are dissolved in drinking 
water to the correct concentration, given to patients with acute diarrhoeal disease, 
including cholera [53].
It has been shown that glucose facilitates the adsorption o f sodium and water in the small 
intestine, sodium and potassium are used to restore the essential ions lost during the 
purging, and citrate is included to correct the acidosis that occurs as a result o f diarrhoea 
and dehydration, and also ensures the stability o f the ORS mixture during storage [53].
Few pharmacological approaches to treat cholera have been developed, and the current 
treatment relies on the ORT. The provision o f these oral rehydration fluids is a means of 
treating diarrhoeal diseases such as cholera, but does not prevent the actions o f the cholera 
toxin either from binding to the cell membrane, being internalized into the cytosol or 
eliciting its actions on cAMP levels. Prevention o f diarrhoea in cholera can be achieved by 
intervention at different stages of the mechanism by which the bacterium causes the 
imbalance in intestinal secretions.
5.4.2 The Use o f  Anti-Motility and Anti-Secretory Therapeutics in the Treatment o f  
Cholera
Effective drug therapy against Vibrio cholera is pivotal for the prevention o f outbreaks and 
for the rapid treatment during an outbreak. There are four major routes for cholera 
treatment, which include the supportive therapy using the oral rehydration salts. Anti- 
diarrhoeal drugs, which include the anti-motility and anti-secretory agents, were developed 
to reduce stool output and frequency. Anti-motility agents act by increasing the time taken 
for the occurrence of diarrhoea, thereby enhancing the potential for reabsorption o f  the 
fluids and electrolytes before excretion can occur. However, this class o f therapeutic agent, 
which includes loperamide, has proven to be ineffective against cholera [54].
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Anti-secretory agents, such as enkephalins, bind to the 8 opioid peptide receptor, which 
causes the activation o f inhibitory G proteins. This results in a reduction in the intracellular 
levels o f cAMP, and subsequently results in the deactivation o f the chloride and potassium 
ion channels which reduces the secretion of salts and fluid [55]. The anti-secretory agents 
directly inhibit the secretory processes by reducing stool volume in patients with high 
volume watery diarrhoea [56], These drugs target intracellular signalling mechanisms, such 
as calcium binding proteins, helping to reduce stool weight and bowel frequency. 
However, these classes o f therapeutic agent may have potential side effects including 
delayed onset o f action and the interference o f the absorption o f other medications [57].
5.4.3 The Use o f  Anti-Microbials and the Cholera Vaccine in the Treatment o f  Cholera 
Antimicrobial therapies has proven to be controversial, mainly due to the development o f
resistant strains o f pathogens, especially in endemic areas [58]. However, anti-microbial
agents have been shown to reduce the severity and duration o f some Vibrio infections, such
as multidose norfloxacin treatment, which significantly reduces stool output, duration of
diarrhoea and fluid requirement compared with the other regimens [59].
Cholera vaccines were developed over 100 years ago, and various types have been 
developed, with varying efficiencies. The two major cholera vaccines developed are the 
oral killed whole cell-cholera toxin recombinant p-subunit vaccine and the oral live 
attenuated Vibrio cholerae vaccine. These oral vaccines have been shown to be well 
tolerated in field trials, and provide 80%-85% protection against Vibrio cholerae 01 for at 
least 6 months [60]. However, these vaccines can show high variability dependant upon the 
age o f the patient [55].
5.4.4 Inhibition o f  Cholera Toxin-Receptor Binding in the Prevention and Treatment o f  
Cholera
The rapid and high affinity binding between the cholera toxin and the GM1 receptor 
provides an attractive target for the prevention and treatment o f cholera. The interaction 
between the bacterial toxin and the membrane receptor occurs almost instantaneously, is 
saturable and initially reversible [36, 61]. One strategy to prevent the analyte-receptor 
interaction between the cell membrane and the enterotoxin is to neutralize the toxin using a 
crude ganglioside mixture, because exogenous GM1 inactivates the cholera toxin in about
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equimolar proportions. Administration o f large amounts o f GM1 or a structural analogue 
has been observed to prevent the binding o f the toxin to the cell membrane receptors [14].
Another approach is to block the GM1 gangliosides with (3-subunit cholera toxin. The (3- 
subunit can not elicit toxicity towards cells itself, therefore the administration o f  the 0- 
subunit could impede the interaction between the toxin secreted by the invading pathogen 
and the ceil membrane. Therefore, blocking the binding sites prevents the microbial toxin 
from eliciting its toxic actions. In vitro studies have shown that pre-treatment o f the gut of 
rabbits with O.Spg.cm'1 (3-subunit completely protects from experimental infection with 
high doses o f active cholera toxin [62, 63].
Another approach to blocking the GM1 binding sites has been the development o f small 
molecule antagonist to toxin-membrane binding. The benefit o f developing these high 
affinity ligands that block the interaction between the bacterial toxin and the membrane 
receptors is that they do not have to pass any membranes to exert their effects, therefore 
they can potentially be any size and carry a charge [64]. Using competitive surface 
receptor binding assays, a series of bivalent ligands have been synthesized to inhibit the 
receptor binding processes of cholera toxin. Reports suggest that steric blocking at the 
receptor binding surface may account for the inhibitory properties o f these synthetic 
bivalent ligands [64]. Multivalency allows strong interactions to occur from many 
intrinsically weak ligand-receptor pairings. The energetics needed for monovalent 
interactions compared to multivalency is different, and the enthalpy o f binding is directly 
proportional to the number o f binding epitopes [65]. This effect o f multivalency causes an 
increase in the Ka values of the multivalent interactions relative to monovalent counterparts 
because there is a more positive entropy contribution to binding o f a multivalent interaction 
[66]. These multiple interactions also show strong geometrically specific interactions, 
because the spatial ordering on one multivalent interactant can induce complementary 
ordering o f the corresponding receptor sites on its partner [67]. These properties directly 
influence the design and application o f therapeutic molecules that impede receptor-analyte 
binding.
Preventing toxin binding using small therapeutic molecules is an attractive approach to 
preventing cholera because the binding inhibitors can be administered prophylactically in 
high risk areas or as a therapy after an infection has begun. This method o f preventing and
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treating cholera is still in its infancy, because even though initial studies show promise, the 
compounds synthesized to date remain in development and have not be demonstrated to be 
effective in vivo.
The lanthanoid group o f elements, which include lanthanum, cerium, europium and 
ytterbium, are chemically similar to each other and occur as stable trivalent cations in their 
natural state. Lanthanum and europium complexes have been shown to be effective at 
detecting neutral sugars, glycolipids and phospholipids. Europium complexes has been 
reported to detect sialic acid-containing gangliosides at physiological pH because there is a 
co-operative complexation o f the oligosaccharide and sialic acid residues to the metal 
centre [68]. The presence o f a sialic acid moiety confers a negative charge on a molecule, 
and this charge prompts a strong interaction with cations o f biological relevance (Figure 
5.25), such as calcium or lanthanides [69]. The sialic acid residues o f the GM1 binds to the 
europium ions via multiple coordination sites with high affinity. Molecular recognition 
between GM1 and lanthanides has been exploited for the detection o f cancer biomarkers. 
The development o f lanthanide anticancer agents have initially demonstrated broader 
spectrum anti-tumour activity compared to classical platinum anti-tumour agents [70].
H
Figure 5.25 Schematic o f  the coordination o f  GM1 ganglioside to Europium III [68].
A novel use o f lanthanide compounds as a toxin-receptor binding inhibitor is described, 
and its ability to bind to GM1 gangliosides reconstituted within tethered biomimetic 




5.4.4.1 Preliminary Measurements fo r  the Effects on Europium III chloride on Biomimetic 
Membrane Vesicles
A lOpmol.dm'3 solution o f Europium III (Eu3+) was added to the biomimetic membrane 
vesicles after Ctx was added. Eu3+ did not displace bound cholera toxin (Figure 5.26) from 
GM1 receptors on biomimetic membrane vesicles.
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Figure 5.26 Simultaneous measurement o f  change in reflectivity (SPR) and Fluorescence 
(SPFS) upon addition o f  whole Ctx, followed by addition o f  Europium III during Ctx 
binding to membrane receptors.
The addition o f cholera toxin to the tethered vesicle system caused the adsorption of the 
Ctx to the membrane surface, however, the subsequent addition o f Eu3+ during the Ctx 
binding process did not prevent the bound toxin from eliciting its effects on the tethered 
vesicles. Therefore, Eu3+ did not prevent the oligomerization o f the p-subunits and did not 
block the pore o f the pentamer p-subunits.
Prior to the addition o f cholera toxin, the injection o f Eu3+ into the tethered biomimetic 
membrane system was followed by an increase in reflectivity. There was cooperative 
complexation between the europium chloride and the tethered vesicles. This was because 
there was an electrostatic interaction between the GM1 sialic acid carboxylate in the 
vesicle bilayer and the Eu3+, and a secondary interaction with the oligosaccharide 
hydroxyls, resulted in a coordination shell [68]. The addition o f the Eu3+ to the vesicle 
surface resulted in a 0.2° shift in the resonance minimum (result not shown), which equated 
to the adsorption o f 1.07ng.mm'2 mass at the membrane surface. The coordination o f Eu3+ 
to the GM1 receptors resulted in an increase in reflectivity at the membrane surface (Figure 
5.27).
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Figure 5.27 Simultaneous measurement o f change in reflectivity and fluorescence upon 
addition o f  lOOpmol.dm3 Eu3+ to tethered biomimetic membrane vesicles containing GM1 
ganglioside.
From the non-linear curve fitting, the association rate constant was determined to be kon = 
3379 m ol^.Ls'1 while the dissociation rate constant was determined to be k0ff= 0.5s’1. From 
these rate constants the equilibrium dissociation constant was determined, Kd =  1.48X10"4 
mol.dm'3. The equilibrium dissociation constant was relatively weak compared to many 
biological interactions such as between streptavidin-biotin. This would support the notion 
that the sialic acid residues o f G M 1 bind Eu3+ via multiple coordination sites, and that each 
o f the monovalent interactions are relatively weak [40], and collectively provide a stronger 
cooperative interaction. The affinity between the lanthanide metal and the ganglioside was 
relatively weak compared to that observed between Ctx and GM1, Kd = 6 .3 3 x 1  0 '7mol.dm'3. 
The coordination o f Eu3+ to the ganglioside does not show any adverse effects on the 
stability or viability o f the tethered vesicles, as the fluorescence over time did not change 
significantly, suggesting the lanthanide did not cause a change in the membrane structure 
or alter the permeability barrier.
The addition o f 0.6pm ol.dnf3 Ctx to the Eu3+-GM1 coordinated tethered vesicles (Figure 
5.28a) did not follow the typical binding kinetics observed when the lanthanide was not 
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Figure 5.28 (a) Kinetics plot o f  the addition o f  0.6jumol.dm3 Ctx to Eus+-GM1 coordinated 
tethered biomimetic membrane vesicles, (b) Resonance angle scans before and after the 
addition o f  Ctx to the membrane surface.
There was little observable change in reflectivity upon addition o f  Ctx to the membrane 
surface coordinated with Eu3+, which demonstrates the ability o f Eu3+ to block the binding 
o f Ctx to G M 1, and subsequently prevent the oligomerization o f the P-subunits into a pore 
and altering the permeability barrier. The calculated apparent dye diffusion coefficient for 
the leakage o f the dye from Eu3+ coordinated vesicles was D* =2.75x10 '15cm2.s'1. This was 
a lower coefficient compared to the control vesicles with no lanthanide ions present (D* =
l . l lx lO 'I3cm2.s_1), therefore, the europium significantly reduced the diffusion o f the 
BODIPY and reduced the permeation o f the biomimetic membrane vesicles. This was 
confirmed by the change in fluorescence upon addition o f the bacterial toxin. The 
prevention o f pore formation in the phospholipid membrane mediated by the interaction 
between Eu3+ and GM1 caused the membrane vesicles to maintain their integrity and no 
increase in the dye diffusion from the encapsulated aqueous space to the bulk solution was 
observed. This action o f the lanthanide was verified by the resonance angle scans (Figure 
5.28b), which demonstrated that there was no change in the resonance minimum before 
and after the addition o f the toxin. Therefore, the lanthanide prevented the p-subunits from 
binding to the GM1 sites on the membranes.
5.4.4.2 Measurement o f  Dose-Response o f  Europium 111 chloride on Preventing Cholera 
Toxin Binding to Biomimetic Membrane Vesicles
Europium III chloride showed an inhibitory action on Ctx binding to GM1 receptors on 
biomimetic membrane vesicles, and this action was dependant upon the concentration of 
Eu 3+ coordinated to the gangliosides (Figure 5.29). The binding o f  various concentrations 
o f Eu 3+ to the cell surface receptors followed a Langmuir isotherm binding kinetics.
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Figure 5.29 Langmuir simulation o f  the adsorption o f  Eu3+ to the GM1 gangliosides 
presented within the phospholipid bilayer o f  tethered biomimetic membrane vesicles.
The Eu 3+ bound to the GM1 gangliosides in a concentration dependant manner, and the 
change in mass density at the surface o f the membrane vesicles increased with higher 
concentrations o f the lanthanide. However, because the metal ion has a small mass density, 
it was difficult to observe lower concentrations o f Eu3+ binding to the GM1 receptors.
5.4.5 Inhibition o f  Cholera Toxin-Receptor Binding Using Other Lanthanide Complexes 
There are fifteen metals comprising the lanthanide group, and all lanthanides closely
resemble each other. The similar properties of lanthanides make the trivalent ions useful
tools to study proteins and sugars. Lanthanide ions have been reported to activate a range
of biological systems, and have been used in fluorescent studies to examine the biological
function o f phospholipase A2 [71], a-amylase [72], the coagulant protein o f Russell’s viper
venom [73] and staphylococcal nuclease [74]. Lanthanide ions show greater binding
constants to biomolecules compared to calcium ions, therefore, lanthanides can act as
substitutes for calcium activated enzymes, proteins and ion channels [75]. Therefore, the
similarity in physical and chemical properties between the lanthanide group suggests they
may also act as sialic acid binding ions, and thereby effectively blocking the specific
binding and oligomerization of the Ctx J3-subunits.
Five other trivalent lanthanide ions were compared to europium in their capacity to bind to 
GM1-containing tethered biomimetic membrane vesicles and their ability to inhibit the
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formation o f Ctx pores within the phospholipid bilayer. Lanthanum III nitrate, terbium III 
chloride, erbium III chloride, gadolinium III chloride and ytterbium III chloride were all 
coordinated to the GM1 gangliosides on tethered biomimetic membrane vesicles(all at 
lOpmol.dm'3) and examined for their ability bind Ctx (Figure 5.30).
M ass density adsorption to Lanthanide-GM1 
coordinated lipid vesicles___________________
Lanthanum Terbium Erbium Gadalinium Ytterbium Europium
L an th an id e  III c o m p le x  (p m ol.d m '3)
Figure 5.30 Comparison o f  the adsorption o f  Ctx to lanthanide-GMl coordinated tethered 
biomimetic membrane vesicles compared to europium-GMl vesicles.
Four o f the five lanthanide ions tested showed improved resistance to Ctx binding 
compared to europium. Erbium III ions (Eb3+) showed a reduction in the inhibitory action 
o f preventing Ctx binding to the surface compared to Eu3+. Gadolinium III (Gd3+) showed 
the greatest inhibition in preventing the binding o f the Ctx to the GM1 receptors on the 
vesicle surface, followed by terbium III (Tb3+), ytterbium III (Yt3+), then lanthanum III 
(La3+). Therefore, all o f the lanthanide trivalent ions tested coordinated to the sialic acid 
residue o f GM1, which subsequently blocked the receptor from binding to other ligands. 
This blocking o f the GM1 binding site thereby inhibited the oligomerization o f the toxin 
monomers on the surface o f biomimetic membranes.
The reduction in binding capacity conferred on the biomimetic membranes by the 
lanthanide trivalent ions was confirmed by calculating the apparent dye diffusion 
coefficient upon addition o f the Ctx to the biomimetic membrane vesicles (Figure 5.31).
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Figure 5.31 Comparison o f  the apparent dye diffusion coefficients (cm2, s'1)  upon 
adsorption o f  Ctx to lanthanide-GMl coordinated tethered biomimetic membrane vesicles 
compared to the control vesicles (No lanthanide trivalent ions present).
All lanthanide compounds tested, were shown to significantly inhibit the increased 
permeation o f the tethered vesicles as a result o f cholera toxin binding. Terbium III was 
shown to cause the greatest inhibition of cholera induced permeation, with an apparent dye 
diffusion coefficient o f D* = 2 .1 5 x l0 15cm2. s 1. Moreover, the least inhibition to permeation 
was provided by Ytterbium III, with an apparent dye diffusion coefficient o f D* =1.45x10' 
14cm2.s’\  A summary o f the calculated dye diffusion coefficients are presented in Figure 
5.32. Therefore, lanthanide trivalent ions significantly inhibit the binding o f the cholera 
toxin to the GM1 receptors, and thereby inhibit the permeation o f the biomimetic 
membranes.
Lanthanide Trivalent Ion 
Species
Apparent Dye Diffusion 
Coefficient, D* (cm2.s'])
Control Test (No lanthanides) 1.11 x 1(TJ
Lanthanum III 6.6 x lO 15
Erbium III 1.42 x 10"14
Europium III 2.75 x 1 0 15
Ytterbium III 1.45 x 10'“*
Gadolinium III 8.37 x 1 0 b
Terbium III 2.15 x 10'n
Figure 5.32 Summary o f  the inhibitory effect on the permeation o f  biomimetic membrane 
vesicles, as calculated from the apparent dye diffusion coefficients fo r  each o f  the 
lanthanide trivalent ions.
This novel application o f lanthanide trivalent ions in preventing the binding and 
oligomerization o f the |3-subunits o f Ctx could have a therapeutic application in treating
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cholera. Lanthanides possess relatively low toxicity, particularly when complexed to 
ligands [76]. The toxicity of the lanthanides is dependant on the route of administration, 
their chemical form and the biological system to which they are administered. 
Intravenously and intraperitoneally administered lanthanide salts have a toxicity ranging 
between 50-500mg/kg bodyweight [77-79]. Toxicity is negligible when administered 
orally, because the lanthanides show very low absorption from the gastrointestinal tract 
[80]. Therefore, lanthanide salts, such as europium III chloride which has an LD50 of 5g/kg 
bodyweight [81], could be included in the recommended oral rehydration salt composition 
for administration during cholera outbreaks. The oral administration of a rehydration fluid 
containing a lanthanide salt would be tolerated by the body and would deliver the 
lanthanide trivalent ions directly to the gastrointestinal tract where it would bind to the 
GM1 receptors of the cells preventing further adsorption of the Ctx to the gastrointestinal 
cells. This novel application of lanthanides could potentially decrease the effects of the 
bacterial toxin and accelerate recovery.
5.5 Conclusions
The tethered biomimetic membrane system shows versatility for studying pore formation 
in biomimetic membranes. The tethered membrane system provides a simple and 
convenient method to study permeation processes and to determine the binding kinetics 
between the toxin and the receptor.
Cholera remains a prevalent disease, especially in areas with poor sanitation and where 
drinking water is contaminated, the disease is sporadic and accounts for many deaths each 
year especially among the vulnerable groups of the young, elderly and infirmed. The 
symptoms associated with the disease are the result of the enterotoxin produced by the 
pathogenic bacterium. The secreted toxin has been shown here to specifically bind to the 
GM1 ganglioside receptors expressed on the biomimetic membrane vesicles. However, 
sterols, such as cholesterol, also have an affect on the degree of toxin binding and the 
severity of the dye diffusion caused by the formation of pores in the biomimetic membrane 
vesicles. The toxin shows strong binding to the membrane receptors, and this was shown 
for both whole cholera toxin and the (3-subunit toxin.
The blocking of the biomimetic cell surface receptors by trivalent lanthanide ions provides 
a means of inhibiting the interaction between the P-subunits of the cholera toxin monomers
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and the GM1 ganglioside. This subsequently prevents the oligomerization of the toxin 
monomers from forming the cholera toxin pore in the membrane. Therefore, the 
permeability barrier of the biomimetic cells is maintained and the integrity of the 
biomimetic cell remains. This novel use of lanthanide ions could have an impact on the 
treatment of cholera disease. At present, the standard treatment of patients suffering from 
cholera is the administration of oral rehydration fluids to restore the electrolyte balance and 
replace the water lost during episodes of diarrhoea and vomiting. The inclusion of a 
trivalent lanthanide compound, such as europium III chloride, in the oral rehydration salt 
mixture could potentially advance the recovery of patient by preventing further toxin 
binding to the gut epithelial membranes. The administration of a trivalent lanthanide ion 
solution to patients not yet suffering from the disease in areas prone to or suffering an 
outbreak of cholera could minimize the probability of suffering toxin-associated 
symptoms.
This tethered biomimetic membrane system provides a means of evaluating potential 
therapeutic molecules which inhibit the interaction between the toxin and the cell surface 
receptors, and provides a good in vitro model to examine the interactions between the 
cholera toxin and cell surface, as well as between the huge range of pore forming and ion 
channel forming toxins and proteins.
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6.0 Solid Supported Lipid Bilayer Vesicles: Method to 
Study Amyloidosis
Tethered biomimetic membrane vesicles have also found a novel application in studying 
the effects of protein aggregation as a result of insoluble proteins and/or peptides. The 
accumulation of insoluble peptides tends to cause detrimental effects to a biological 
system, therefore, they are naturally kept soluble or are degraded quickly. In this chapter, 
the affect of j3-amyloid peptide aggregation is described in relation to their effects towards 
biomimetic membranes.
Chapter Synopsis
The formation of insoluble aggregate proteins, in particular (3-amyloid, and their 
involvement in amyloidosis disorders will be reviews with a focus on Alzheimer’s disease. 
Preliminary measurements concerning the interaction between the |3-amyloid peptide and 
simple DMPC-GM1 -cholesterol vesicles will then be detailed. The influence of GM1 and 
cholesterol on p-amyloid binding will also be discussed. Additional measurements 
showing the interaction between a more complex vesicle system (multiple phospholipid 
species-GMl-cholesterol) will be detailed and binding constants determined. The potential 
neurotoxicity mechanisms will be reviewed, and using kinetics data, a proposed hypothesis 
will be developed. Finally, a novel therapeutic for the inhibition of P-amyloid binding to 
biomimetic membrane vesicles will be detailed, with potential applications of the 
compound.
6.1 Amyloidosis and their Related Diseases
Amyloidosis is a disorder initiated by the formation of an insoluble form of a protein or 
peptide, which is caused by the alteration in the peptides secondary structure. The 
formation of these P-pleated sheet amyloids causes their deposition within the structure of 
an organ or a tissue. Amyloidosis disorders can either be systemic, whereby they affect 
many different organ systems, or localized whereby they are organ specific. The causes of 
amyloidosis are highly variable, and may result from an inherited mutation in the precursor 
protein, the abnormal production of a protein or result from physical or chemical damage.
Despite the heterogeneity of the precursor proteins which form amyloid deposits, they all 
share a common core structure, consisting an anti-parallel P-strand lying perpendicular to 
the long axis of the fibril [1] (Figure 6.1). The highly ordered core and conformation 
confers the distinctive physiochemical properties of amyloid fibrils, including their relative
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stability and resistance to proteolysis [2]. The amyloid deposits contain several common 
non-fibrillar components, including apolipoprotein E, type IV collagen and the normal 
plasma glycoprotein serum amyloid P component (SAP). The SAP component within the 
amyloid deposit confers the uncharacterized specific binding to its cellular ligand [3].
Figure 6.1 Molecular model o f  the generic common core o f  an amyloid fibril. [1-sheets 
(four illustrated here) form the protofilament structure, with the sheets running parallel to 
the axis o f  the protofilament, with their component f-strands perpendicular to the fibril 
axis. The [1-sheets twist around a common helical axis that coincides with the axis o f  the 
protofilament, giving a helical repeat containing 24 fl-strands (the repeated unit is 
indicated by the boxed region) [1].
6.1.1 Systemic Amyloidosis
Systemic amyloidoses disorders are either acquired or inherited, and tend to be rare. There 
are at least twenty known different proteins that form amyloid fibrils in vivo. Inherited 
systemic amyloidosis disorders are typically due to the inheritance o f a point mutation in 
the precursor protein, whose structure makes them amyloidogenic. The rare hereditary 
systemic amyloidoses are very difficult to treat and are usually fatal. The extracellular 
deposits can be present in any or all o f the connective tissues, intestines, and blood vessel 
walls. Mutations can occur in a variety o f genes, with the most common cause being a 
mutation in the TTR gene. This gene encodes the transthyretin blood protein, which 
normally transports thyroid hormone and vitamin A to the body tissues. The abnormal 
form o f transthyretin tends to accumulate in tissues such as the heart, kidneys, nerves, and 
intestine. Its presence interferes with the normal functions o f the organ, and as the deposits 




proteins that cause hereditary amyloidosis include apolipoproteins Al and All, fibrinogen 
A a-chain, and lysozyme [5].
6.1.2 Organ-specific Amyloidosis
The formation of amyloid deposits are a pathological hallmark of amyloidoses disorders, 
and these deposits occur in a range of specific organs and give rise to various common 
medical disorders. These conditions begin as asymptomatic diseases, because their 
progression tends to be slow, gradual and typically age related. Subsequently, they lead to 
the development of degenerative diseases. The disease becomes clinically significant when 
it affects organ function by replacing the normal cell structure.
Type II non-insulin dependant diabetes mellitus (NIDDM) is a metabolic disorder which 
affects more than 160 million individuals worldwide [6 ]. The disorder results from the 
body’s ineffective use of insulin, and is largely the result of excess body weight and 
physical inactivity. Over time, type II diabetes causes damage to the heart, blood vessels, 
eyes, kidneys and nerves. The overall risk of dying among people with this form of 
diabetes is at least double the risk of individuals without it [6 ]. A pathological hallmark of 
this disease is the presence of amyloid deposits in the islets of Langerhans. These deposits 
are composed of islet amyloid polypeptide (LAPP), which is a hormone stored with insulin 
in vesicles and secreted by the islet (3-cells. The disorder manifests itself as a reduction in 
the mass of insulin-producing P-cells [7], because of the formation of cytotoxic fibre 
intermediates, which have been shown in vitro to lead to P-cell failure [8 ].
The infiltration of amyloid fibrils into the heart often results in restrictive cardiomyopathy. 
This tends to manifest as heart failure and conduction abnormalities [9]. Increased 
thickness of the myocardial wall, caused by increased amyloidal deposition, leads to 
systolic and diastolic dysfunction, and cardiac arrhythmias [10]. Currently, cardiac 
ultrasound is considered the non-invasive test of choice to diagnose cardiac amyloidosis, 
because cardiac biopsy is hindered by procedural risks and uncertainties concerning 
sampling errors [11]. The therapeutic strategy depends on the characterization of the type 
of amyloid protein and extent of disease. Treatment may include chemotherapy, stem cell 
transplantation, and liver transplantation. Heart transplantation is controversial and is rarely 
performed.
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Neurological amyloidoses result in the manifestation of a range of diseases, including the 
dementia disorders such as Parkinson’s disease, Huntington’s disease and the transmissible 
spongiform encephalopathies. Of these neurological amyloidoses, only prion diseases are 
transmissible. Prion diseases cause fatal neurodegenerative disorders related to a 
conformational change in the cellular prion protein into a misfolded protein capable of 
aggregation [12]. The prion proteins self-associate into ordered, stable supramolecular 
structures composed of the misfolded proteins. Human forms of the prions, such as those 
which cause Creutzfeldt-Jakob disease (CJD), are misfolded self-replicating proteins which 
are infectious and neurotoxic [13]. The protein responsible for CJD is a 
glycosylphosphatidylinositol-anchored protein, which during post-translation, becomes 
misfolded into the P-sheet conformation. Conversion to the misfolded protein results in an 
increased exposure of hydrophobic residues, which leads to the aggregation of the protein 
molecules into aggregates, protofibrils, ordered rigid amyloid fibrils and plaques [14].
Parkinson’s disease is the second most common neurodegenerative disease, and is 
characterized by the progressive loss of dopamine neurons and the accumulation of Lewy 
bodies. The a-synuclein, a protein found in mammalian brain tissue and enriched in 
presynaptic nerve terminals, has been identified as a fibril forming protein in individuals 
suffering from Parkinson’s disease [15]. The N-terminus of the a-synuclein forms an 
amphipathic ar-helical domain that specifically associates with lipid rafts. This has been 
implicated in the regulation of dopamine transmission and synaptic vesicle. Mutations in 
the genes encoding the a-synuclein, have been reported to cause the formation of amyloid 
fibrils via a gain-of-fimction mechanism causing its deposition in Lewy Bodies [16]. The 
mutant protein has also been reported to display an increased tendency to self-aggregate in 
vitro compared to the wild-type a-synuclein [17].
The standard procedure for diagnosing amyloidoses is by histological examination of 
autopsied tissue. The highly ordered amyloid fibrils stain with Congo red, and are observed 
as an apple-green birefringence (double refraction) under polarized light. Immunoelectron 
microscopy is used to characterize the amyloid deposits, and is preferred to light 
microscopy immunohistochemical analysis, which can be misleading due to the low 
specificity of the technique [18, 19].
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The prevailing therapeutic approach towards amyloidoses is based on reducing the 
concentration of the amyloidogenic precursor. For amyloid A amyloidosis (a disorder 
initiated by chronic inflammatory diseases), hereditary periodic fevers and certain 
neoplasms, treatment of the underlying disorder is encouraged, which aims to suppress the 
inflammatory activities and thereby suppressing the circulating levels of the serum 
precursor protein. No specific drug treatment is presently available for hereditary 
amyloidosis, but one recommended strategy is a liver transplant, because the liver is the 
main organ synthesizing most of the amyloidogenic precursor proteins [19]. The fibrils 
cause functional and structural damage to organs and tissues in the body, and this causes 
huge therapeutic problems and massive economic burdens in research and treatment of the 
associated diseases.
6.2 Alzheimer’s disease
Dementia is generally defined as the "loss of intellectual abilities of sufficient severity to 
interfere with social or occupational functioning" [20], and involves the loss of functions 
such as memory, calculation, speech, and problem solving. According to the World Health 
Organization, there are around 100 known causes of dementia, which include multiple 
strokes, infections of the brain, severe thyroid deficiency and severe brain injury. However, 
the most common cause of dementia is Alzheimer’s disease, which accounts for between 
50-70% of all dementias worldwide. The disorder was first reported in 1906 by Dr Alois 
Alzheimer, who described a patient who had died of an unusual mental illness. The disease 
generally has three kinds of symptoms; impaired daily living, abnormal behaviour and loss 
of cognitive functions.
In the early stages of the disease, the most complicated functions, such as those leamt in a 
professional capacity, are the first lost. However, basic functions, such as toilet habits and 
recognition of immediate family members, are preserved. As the disease progresses, 
additional functions are lost (Figure 6.2). In the more advanced stages, the patient becomes 
almost completely dependent on others in terms of being fed, bathed, dressed and 
exercised. The rapid progression of this disease leads to premature death, often due to food 
going into the lungs or fracture due to a fall. Patients can, however, survive up to 15-20 
years after the onset of illness.
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Figure 6.2 Development cycle from birth to death, demonstrating the gradual decline in 
cognitive function o f  a typically aging individual (-— ) compared to a patient suffering 
from  Alzheimer’s disease (  ).
Alzheimer’s disease can affect people o f all ages, however, the prevalence o f the disease 
significantly increases with age. Around 5% o f individuals aged 65-74 suffer from 
Alzheimer’s disease, and the incidence exponentially increases to around 50% in 
individuals aged over 85 [21]. It is generally reported that Alzheimer’s disease does not 
discriminate on basis o f gender, soci-economic status or lifestyle. It is believed that men 
and women are equally at risk from developing the disorder, but in developed countries, it 
is more commonly observed in women because this is a reflection on the increased 
longevity o f women compared to men.
The early diagnosis o f Alzheimer’s disease is pivotal to ensure the correct provision of care 
and to minimize the impact the disorder forces upon the individual sufferer and those close 
to them. At present, the only definitive way to diagnose Alzheimer’s disease is to study the 
brain tissue for hallmarks o f neuronal loss and p-amyloid deposits within the tissue. 
However, this can only be done at the time o f autopsy, therefore, it is only possible to 
speculate from behavioural changes that an individual is suffering from Alzheimer’s 
disease while the person is still alive. Neuroimaging techniques are looking into detecting 
neuronal damage in areas o f the brain involved in memory before disease associated 
symptoms occur [22, 23]. The progression o f the disorder varies from person to person, 
and typically, an individual may live with Alzheimer’s disease for up to 8 to 10 years, 
though some may live with the disease for up to 20 years. At present there is no cure for 
Alzheimer’s disease, and therapeutic intervention is possible but is highly dependant on the 
advancement o f the disease. Some drugs, such as tacrine and galantamine, help to alleviate 
some symptoms in sufferers with early and mild Alzheimer’s for a limited time. These 
drugs act as cholinesterase inhibitors, thereby preventing the breakdown o f acetylcholine, 
which is important for memory and thinking [24, 25]. Limited treatment is available for
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severe/advanced Alzheimer’s disease, and tends to be an N -methyl D-aspartate antagonist, 
which regulates glutamate that leads to brain cell death when produced in excess [26].
6.3 p-amyloid, Amyloid Precursor Protein and the Neurological 
Hallmarks of Alzheimer’s Disease
The brains o f Alzheimer’s disease sufferers have been shown to contain an abundance of 
p-amyloid plaques and neurofibrillary tangles. Neuropathological changes include 
neuronal loss (Figure 6.3), whereby the cortex o f the brain shrinks and causes damage to 
areas involved in thinking, planning and memory. Shrinkage o f the hippocampus is also 
observed in people suffering from Alzheimer’s disease, causing the loss o f key areas 
involved in the formation o f new memories. The mechanisms causing neurodegeneration 
are uncertain, but reports show evidence that mutations in the amyloid precursor protein 
(APP) occur. The APP is an integral membrane protein concentrated in the synapses o f 
neurons, and its primary function has not been definitively elucidated. However, the APP 
has been implicated to act in regulating synapse formation. Using cultured hippocampal 
neurons lacking APP, it has been shown that excitatory synaptic transmission is enhanced 
[27]. APP knock-out mice show enhanced neuritic outgrowth and increased number of 
synapses, which is subsequently believed to lead to enhanced glutamate toxicity in the 
knock-out mice [28]. APP has also been implicated in cell adhesion and motility, because 
the integral membrane protein possesses several domains that promote binding to specific 
substrates such as heparin and collagen. Exposure o f experimental animals to an enriched 
environment which stimulates learning, has demonstrated that there is an up-regulation of 






Figure 6.3 Crosswise section through the middle o f  the brain between the ears, comparing 
a brain section o f a healthy individual (left section) and an advanced Alzheimer’s sufferer 
(right section).
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Normally, APP is processed to form a soluble amyloid precursor protein (sAPP), whereby 
it is cleaved by a-secretase. The enzyme causes the integral membrane protein to be 
‘shedded’ from its membrane location to form a soluble form o f the APP. a-secretase 
cleaves the integral membrane APP close to the membrane spanning domain (Figure 6.4), 
to form a soluble APP 612 amino acids in length. The sAPP is believed to be a growth 
regulatory molecule and provides neuroprotection. In vitro studies have shown that sAPP 
confers increased resistance to excitotoxicity and glucose deprivation-induced injury on 
neurons [30]. In support o f these studies, it has been demonstrated that sAPP protects 
neurons against P-amyloid toxicity and other oxidative stresses [31]. It is believed that the 
sAPP protective mechanism is based on its rapid effects on ion channel function. sAPP 
causes the activation o f potassium channels and suppresses the agonist NMD A 
neurotransmitter mimic [32], therefore reducing excitability and preventing injury caused 
by over excitation. The soluble protein has also demonstrated neuro-protectivity in vivo, 
where post-ischemic administration o f the sAPP protects neurons in the rat hippocampus 
against ischemic injury. Treatment with sAPP resulted in increased neuronal survival, and 
the surviving cells show a continued ability to synthesize protein [33].
Figure 6.4 Schematic o f  the membrane spanning and cleavage sites o f  APP770. Soluble 
APP is generated from the cleavage o f  the protein by a-secretase. The Afij^fo fragment, 
generated by /I and y cleavage, comprises residues 672-711 o f  APP 770 while the amyloid- 
131 - 4 2  fragment spans residues 672-713 [29],
The integral APP may also be cleaved by P- and y-secretase to produce the 40 or 42 amino 
acid amyloid p i -40 or amyloid p i -42 (Figure 6.4). Cleavage by these enzymes generates 
the p-amyloid associated with the formation o f aggregate amyloids, which subsequently 
leads to the formation o f senile plaques. The processing o f the APP led to the development
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of the amyloid cascade (Figure 6.5). The amyloid cascade describes the processing o f  the 
APP via two pathways, either cleavage to produce a soluble APP, which provides the 
neuroprotective protein, or the production o f the insoluble amyloid-|3 protein, which 
oligomerizes to form aggregates and shows neurotoxicity [34, 35]. Various factors 
influence whether a- or p-secretase cleavage o f the integral membrane APP occurs. 
Conditions that promote |3-secretase cleavage include glucose deprivation, increased Ca2+ 
levels and traumatic head injury [30]. Environmental factors may also contribute to 13- 
amyloid deposition, such as acidic conditions and the presence o f an oxidizing 
environment [36]. The presence o f various metal ions, including iron, zinc and aluminium 
can also promote aggregation o f P-amyloid [30]. However, p-amyloid has been shown to 
be a normal product during cell metabolism, and that low concentrations (pico- to nano­
molar) o f the peptide confer increased neuronal survival o f hippocampal cells in culture 
[37]. Moreover, other reports have demonstrated that low concentrations o f P-amyloid 
modulates a variety o f cellular responses relevant to neuronal plasticity and survival [38, 
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Figure 6.5 The amyloid cascade, whereby the processing o f  the integral membrane 
amyloid precursor protein (APP) may occur via two pathways: (i) Cleavage within the 
transmembrane region by a-secretase generates a soluble APP that provides 
neuroprotection against excitotoxicity or (ii) cleavage o f  the extracellular- and 
intracellular- domains o f  the APP, resulting in the formation o f  amyloid-fi that precipitates 
to forms the insoluble f-amyloid, and in turn causes cell death.
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As the precipitated p-amyloid peptide ages, it self-assembles into higher-ordered 
structures, and in vitro studies have shown that after several days the (3-amyloid peptide 
forms insoluble aggregates [40]. It is the aggregated (3-amyloid that induces toxicity [40, 
41]. The aggregated (3-amyloid peptide forms fibrils, which subsequently form senile 
plaques. These plaques are dense deposits o f the p-amyloid peptide and cellular material on 
the extracellular face o f neurons (Figure 6.6). The hydrophobic terminus o f the P-amyloid 
1 -42 peptide is believed to influence the solubility and state o f aggregation o f the peptide. 
High molecular weight P-amyloid peptide 1-42 shows reduced solubility compared to the 
P-amyloid peptides 1-39 and 1-40, therefore, the hydrophobic C-terminus appears to be the 
critical determinant o f solubility [42, 43]. The aggregation o f the p-amyloid on the cellular 
membrane acts as a seed and thereby initiates the aggregation o f p-amyloid [44]. The 
binding o f the p-amyloid to the cell membrane has not been definitely described, and 
contradictory reports have suggested that the interaction between the peptide and the 
membrane may be mediated by a cell surface receptor or may aggregate via a non-specific 




Figure 6.6 Comparison o f  healthy neurons and neurons containing the f-am yloid plaques.
The formation o f the amyloid plaques is believed to occur via a two step mechanism, 
whereby the initial formation of a seeding aggregate is followed by the long term 
deposition of the P-amyloid peptide [46, 47].
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6.4 The Mechanism of Toxicity
The mechanism with which p-amyloid induces neurotoxicity is not definitive. However, it 
has been suggested that damage is caused by the disruption of cellular Ca2+ homeostasis 
[48, 49], and that the p-amyloid peptide causes the influx of Ca2+ ions. However, this 
mechanism has now been modified because it appears that ion homeostasis is disrupted as 
a result of P-amyloid's involvement in inducing cellular oxidative stress and the formation 
of ion-conducting pores in the membrane [30]. The mechanism that P-amyloid causes 
oxidative stress is unclear, however, two hypotheses have been suggested. One possibility 
is that P-amyloid forms free radical moieties on certain amino acids that then propagate to 
the cell membrane [50], or P-amyloid binds to a specific cell surface receptor that 
subsequently induces oxidant stress [51]. P-amyloid has been shown to induce the 
accumulation of reactive oxygen species and hydrogen peroxide in neurons in vitro, and 
causes membrane lipid peroxidation in cultured neurons [52].
The neurotoxicity induced by p-amyloid has been reported to result from the indirect 
promotion of the inflammatory cascade. It has been suggested that inflammatory reactions 
occur in association with the amyloid plaques in Alzheimer’s disease and that 
inflammation contributes to neurodegeneration, because plaques contain a variety of 
cytokines and other inflammatory mediators [53, 54].
The self-assembly of the P-amyloid peptide into plaques has been observed to induce 
programmed cell death, and this may drive neuronal degeneration in individuals suffering 
from Alzheimer’s disease. The hallmarks of programmed cell death in non-demented cells 
include morphological and biochemical changes such as membrane blebbing, compaction 
of nuclear chromatin and intra-nucleosomal DNA fragmentation. Moreover, cultured 
neurons treated with p-amyloid trigger degeneration through activation of programmed cell 
death [55], as observed by the characteristics mentioned above.
However, it is still unclear whether P-amyloid aggregation is the cause of Alzheimer’s 
disease or a consequence of some other underlying mechanism. This is because it has also 
been shown that substantial numbers of amyloid plaques were found in the brains of non­
demented individuals [56], suggesting that P-amyloid deposition does not necessarily lead 
to Alzheimer’s disease.
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6.5 Preliminary Measurements of the Interaction between Tethered 
Biomimetic Membrane Vesicles and p-amyloid 1-42
The tethered biomimetic membrane vesicles have also found a novel application as a 
model membrane mimic to monitor the interaction between insoluble p-amyloid 
neurodegenerative peptides, as found in Alzheimer’s sufferers, and the cell membrane. The 
simultaneous measurements o f change in reflectivity and fluorescence allowed for the 
sensitive detection o f analyte-ligand events and the determination o f binding constants 
between the interactants. The interaction between p-amyloid 1-42 and DMPC-GM1- 
cholesterol vesicles was observed and compared to the interaction between p-amyloid 1 -42 
and negatively charged phospholipid-GMl-cholesterol vesicles. The influence GM1 and 
cholesterol offers to P-amyloid binding was subsequently established.
6.5.1 The Interaction Between DMPC-GM1 -cholesterol Membrane Vesicles and P-amyloid 
1-42
The initial biomimetic membrane model was composed o f 1% biotin, 2% GM1, 30% 
cholesterol and 67% DMPC attached to the solid substrate via biotin-streptavidin coupling 
(as detailed in section 3.3.4). The biomimetic membrane vesicles used were to determine 
the proof-of-principle that it was possible to monitor the interaction between P-amyloid 1- 
42 and a simple single phospholipid species membrane mimic. A lOpmol.dm'3 solution of 
P-amyloid 1-42 was prepared and injected into the tethered vesicle system, and a change in 
reflectivity was observed (Figure 6.7).
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Figure 6.7 Kinetics plot fo r  the addition o f  lOpmol.dm3 P-amyloid 1-42 peptide to the 
biomimetic membrane vesicle surface composed o f  DMPC phospholipids.
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From the kinetics plot (Figure 6.7), the interaction between the biomimetic membrane and 
the P-amyloid peptide was observed in real-time. Therefore, the biomimetic membrane 
system provided a novel method to study protein aggregation and amyloidosis in vitro. The 
addition o f the peptide to the system was observed as a change in the reflectivity. The 
adsorption o f the peptide occurred via a two step mechanisms. The amyloid bound to the 
surface and followed a typical Langmuir interaction between 0 minutes and -200  minutes. 
At the initial stage, the amyloid peptide specifically bound to the membrane surface and 
seeded. However, following the first step, the amyloid began to non-specifically adsorb to 
the membrane surface, suggesting that the amyloid peptide binds to a specific receptor 
and/or receptors, which seeds the peptide to the membrane surface, and further peptide 
binding occurs via non-receptor specific attachment.
The adsorption o f the amyloid peptide to the DMPC-GM1-cholesterol membrane surface 
was simultaneously monitored as a change in fluorescence (Figure 6.8). The addition o f the 
peptide caused a change in the properties o f the simple biomimetic membrane, and 
therefore caused a change in fluorescence.
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Figure 6.8 Monitoring the change in fluorescence o f the encapsulated BOD1PY dye within 
the tethered biomimetic DMPC-GM1 -cholesterol membrane vesicles upon addition o f  
lOpmol.dm3 /?-amyloid
Using the simple DMPC biomimetic model, it was possible to observe a change in 
fluorescence upon addition o f the P-amyloid peptide. Addition o f the Alzheimer’s peptide 
caused an increase in the BODIPY dye diffusion from the encapsulated space o f  the 
tethered phospholipid vesicles, through the lipid bilayer and into the bulk solution.
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Therefore, the tethered biomimetic membrane system provided an attractive model to study 
the affects o f amyloidosis and the associated peptide.
The adsorption o f the amyloid peptide to the biomimetic membrane surface was confirmed 
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Figure 6.9 Resonance angle scan fo r  the addition o f  /?-amyloid 1-42 to the DMPC-GM1- 
cholesterol model membrane system. The adsorption o f  the peptide to the surface resulted 
in a resonance minimum shift o f  0.3°.
The addition o f the P-amyloid 1-42 peptide to the tethered biomimetic membrane vesicle 
system resulted in a 0.3° shift in the resonance minimum. This shift equated to a 
1.61ng.mm'2 increase in mass density at the surface, therefore the tethered membrane 
system allowed for the quantitative determination o f the adsorption o f the 
neurodegenerative peptide to the biomimetic membrane surface.
6.5.2 The Interaction Between GM1 -deficient DMPC Membrane Vesicles and P-amyloid 1- 
42
Biomimetic membrane vesicles containing 1% biotin, 30% cholesterol and 69% DMPC 
were prepared and tethered to the solid support. The G M 1 ganglioside was excluded from 
the vesicle bilayer.
The membrane receptor for the adsorption o f p-amyloid has not been definitively 
determined, and various receptors have been reported to specifically associated with p- 
amyloid. These include NK-1 tachykinin receptor [57] and a range o f membrane 
phospholipids [58], such as phosphatidylinositol which was shown to be the most efficient
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inducer of p-amyloid aggregation [59]. However, the GM1 ganglioside predominates in 
reports to mediate the fibrillogenesis o f the p-amyloid on membrane surfaces. It has been 
shown that the P-amyloid peptide binds to membranes containing G M 1 and upon binding 
undergoes a conformational transition from a random coil to an ordered structure rich in p- 
sheets [60]. Therefore, the GM1 ganglioside would appear to be the membrane receptor for 
P-amyloid and its subsequent aggregation.
Biomimetic membranes deficient in GM1 were tethered to the solid substrate and 
lOpmol.dm'3 p-amyloid 1-42 was injected into the system to observe any interaction 
between the analyte and membrane (Figure 6.10).
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Figure 6.10 Kinetics p lot fo r  the addition o f  lOpmol.dm~3 (1-amyloid 1-42 peptide to the 
GMl-deficient DMPC biomimetic membrane vesicles.
The addition o f the P-amyloid to the GM1-deficient membrane system showed weak non- 
specific attachment to the surface. The p-amyloid was allowed to associate with the 
biomimetic membranes for 20 hours, and a change in reflectivity was observed. However, 
upon rinsing o f the system, the reflectivity returned to its initial value, suggesting that the 
peptide was very loosely and/or non-specifically associated to the DMPC-cholesterol 
vesicles and was not mediated by a specific receptor. Therefore, it would suggest that GM1 
is a receptor for p-amyloid binding. The change in fluorescence observed upon p-amyloid 
addition did not show the expected increase in dye diffusion from the encapsulated vesicle 
space to the bulk solution as monitored when GM1 was present in the vesicle bilayer 
(Figure 6.8). Therefore, it appears that GM1 is the specific membrane receptor for P- 
amyloid 1-42 neuropeptide, and that membranes deficient in the ganglioside do not
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mediate specific binding, but show a weak attraction maybe between the phospholipid 
head group or sterol with the p-amyloid peptide. This observation suggests that the 
interaction between p-amyloid and GM1 was ganglioside-specific, as it has been shown 
that p-amyloid (1-40) does not change conformation in the presence o f various 
phospholipid species, but does change conformation upon GM l-Pamyloid interaction [60]. 
The moiety responsible for binding p-amyloid is believed to be the sialic acid group, which 
in turn is stabilized by the terminal galactose residue o f the GM1 [61].
The confirmation that GM1 acts as the membrane receptor for p-amyloid was verified by 
monitoring the shift in resonance minimum upon P-amyloid addition to G M 1-deficient 
vesicles (Figure 6.11).
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Figure 6.11 Resonance angle scan fo r  the GM l -deficient DMPC tethered biomimetic 
membrane vesicles before and after the addition o f lOpmol.dm3 (1-amyloid. No shift in 
resonance minimum was observed (see inlaid graph).
The addition of the P-amyloid to the GM1 -deficient biomimetic membrane vesicles 
resulted in no shift in the resonance minimum. Therefore, no adsorption o f the peptide to 
the membrane surface was observed. Moreover, this suggests that GM1 is a membrane 
receptor for the p-amyloid peptide. GM1 would provide a reliable receptor for ligand 
binding because gangliosides show an almost constant concentration between 20 and 70 
years o f age [62], therefore, its continual expression in neuronal membranes provides an 
attractive receptor for any analyte to bind. The GM1 receptor is ubiquitously found in the 
eukaryotes, and acts as a natural receptor for many analytes including some bacterial toxins 
(section 5.1.2).
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6.5.3 The Interaction Between Multi-Species Phospholipid Biomimetic Membrane Vesicles 
and P-amyloid 1-42
Tethered biomimetic membranes containing a mixture o f phospholipid species were 
prepared to included 1% biotin, 2% GM1, 30% cholesterol, 50% DMPC, 13.5% 1,2- 
Dimyristoyl-SH-Glycero-3-Phosphoethanolamine (DMPE), 1.75% 1,2-Dimyristoyl-sn- 
Glycero-3-[Phospho-L-Serine] (DMPS) and 1.75% l,2-Dimyristoyl-s?7-Glycero-3- 
[Phospho-rao(l -glycerol)] (DMPG), and were subsequently attached to the solid substrate 
using biotin-streptavidin coupling. The mixed DMPC, DMPE, DMPS and DMPG vesicles 
will be called mixed-vesicles.
The composition o f biological membranes varies significantly depending on its cellular 
location, the functions the membrane performs and its age. The macromolecular 
composition o f neuronal membranes are considerably different to other membranes such as 
those composing the epithelia. The phospholipid content o f neuronal membranes have been 
shown to contain a higher proportion of negatively charged phospholipids and also 
contains a very high proportion o f long-chained polyunsaturated fatty acids [63, 64]. 
Therefore, the chemical composition of the tethered biomimetic membrane vesicles was 
altered to reflect the negative charge associated with neuronal membranes.
The addition o f lOpmol.dm'3 p-amyloid to the tethered mixed-vesicles was followed by 
simultaneous measurements o f change in reflectivity and fluorescence (Figure 6.12).
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Figure 6.12 Kinetics p lo t following the adsorption o f  10/m o l.d m 3 P-amyloid to mixed 
phospholipid-GMl -cholesterol biomimetic membrane vesicles.
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The increase in reflectivity observed upon addition o f P-amyloid 1 -42 to the mixed-vesicle 
surface equated to the adsorption o f the neuro-peptide to the membrane surface. The 
adsorption o f the analyte to its respective receptors followed a slow association binding, 
whereby the change in reflectivity showed a gradual increase over time, until equilibrium 
was reached at around 1100 minutes. The slow binding o f the peptide to the surface would 
reflect the slow progressive accumulation o f the P-amyloid peptide characteristic o f 
Alzheimer’s and other amyloidosis disorders.
The addition o f the neuro-peptide to the mixed-vesicle surface resulted in a shift in the 
angle at which resonance was achieved. The change in reflectivity and fluorescence as a 
function o f resonance angle was shown in Figure 6.13.
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Figure 6.13 Resonance angle scan fo r  the addition o f  /3-amyloid 1-42 neurodegenerative 
peptide to the mixed-vesicle biomimetic model membrane system. The adsorption o f  the 
peptide to the surface results in a resonance minimum shift o f  0.5°.
The addition o f the p-amyloid 1-42 peptide to the mixed-vesicle biomimetic membrane 
surface resulted in a 0.5° resonance shift, which equated to the adsorption o f 2.68ng.mm'2 
o f the peptide to the vesicle membrane. The analyte-ligand interaction resulted in a 40% 
increase in mass adsorption compared to the DMPC tethered vesicles (Figure 6.9). The 
increase in binding capacity observed for the mixed-vesicle system probably reflects the 
influence o f the negative charge conferred on the mixed-vesicle surface by the inclusion o f 
negatively charged phospholipid species in the membrane bilayer. The negative charge on 
the surface would result in an electrostatic interaction between the membrane and the 
insoluble P-amyloid peptide. This electrostatic interaction has been observed to occur
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between the C-terminus o f the p-amyloid peptide and the negatively charged phospholipid. 
Using circular dichroism and electron paramagnetic resonance, it has been reported that 
electrostatic and hydrophobic interactions contribute to peptide-receptor binding [65]. 
These additional non-specific forces resulted in an interaction between the basic peptide 
residues and the negatively charged lipids in the membrane, which works in synergy with 
the specific binding between the p-amyloid peptide and the GM1 ganglioside receptors 
present on the biomimetic membrane surface. The electrostatic and hydrophobic 
interactions have not been reported to occur between the P-amyloid peptide and neutral 
biomimetic membrane vesicles [66], such as membranes composed o f DMPC. Therefore, 
increased binding was observed between the negatively charged surface and the amyloid 
compared to the neutral surface and the peptide.
6.5.4 The Interaction Between GM1-Deficient Multi-Species Phospholipid Biomimetic 
Membrane Vesicles and p-amyloid 1-42
Mixed-vesicles were prepared (as discussed in section 3.3.5) with the exclusion o f GM1 
from the bilayer vesicles. The GM1-deficient mixed-vesicles were tethered to the solid 
support and monitored for their interaction with p-amyloid 1-42.
The influence o f electrostatic and hydrophobic forces on the adsorption o f p-amyloid to 
biomimetic membrane vesicles was investigated using tethered mixed-vesicles deficient in 
the GM1 receptor. The exclusion o f the ganglioside from the vesicle bilayer resulted in the 
removal o f the membrane receptor, therefore blocking the potential for specific receptor- 
analyte interactions. Therefore, any adsorption o f p-amyloid to the membrane surface 
would be the result o f non-specific binding. The addition o f the P-amyloid 1-42 peptide to 
the GM1-deficient mixed-vesicles was monitored simultaneously as a result o f change in 
reflectivity and fluorescence (Figure 6.14a) and compared to GM1-containing mixed- 
vesicles (Figure 6.14b).
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Figure 6.14(a) Kinetics p lot monitoring the addition o f  lOjumol.dm'3 /3-amyloid to GM1- 
deficient biomimetic mixed-vesicles, and, (b) the addition o f  lOjumol.dm'3 /3-amyloid to 
GM1-containing biomimetic mixed-vesicles.
The addition o f the P-amyloid to the G M 1-deficient mixed-vesicles (Figure 6.14a) resulted 
in a change in reflectivity until equilibrium was reached. The increase in reflectivity 
equated to the interaction between the peptide and the membrane surface. However, 
because the GM1 membrane receptor was absent from the tethered biomimetic 
membranes, the peptide-membrane interaction was not the result o f specific analyte- 
receptor interactions. Therefore, the increase in reflectivity was the result o f an 
electrostatic and/or hydrophobic association. The rinsing o f the tethered membrane system 
resulted in the dissociation o f the P-amyloid ligand from the membrane surface. Moreover, 
this dissociation suggests that the interaction was relatively weak and not a specific 
interaction resulting from the binding o f the neuro-peptide to its specific GM1 receptor 
(Figure 6.14b).
The weak association observed between the negatively charged GM1-deficient mixed- 
vesicle surface and the P-amyloid was confirmed by monitoring the shift in resonance 
minimum upon addition o f the peptide (Figure 6.15).
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Figure 6.15 Resonance angle scans fo r  the addition o f  lOjumol.dm'3 f-am yloid 1-42 to the 
biomimetic GM1 -deficient mixed-vesicle system. The addition o f  the peptide resulted in no 
overall shift in the resonance minimum.
The addition o f the peptide to the GM1-deficient mixed-vesicle surface resulted in a 0° 
shift in the resonance minimum. Therefore, this equated to no adsorption o f the P-amyloid 
peptide to the surface lacking the membrane receptors, compared to the adsorption of 
2.68ng.mm'2 P-amyloid to G M 1-containing mixed-vesicles (Figure 6.13). This suggests 
that additional forces play a significant role in the binding between the P-amyloid peptide 
and the membrane surface, and that these hydrophobic and electrostatic forces act to 
stabilize the p-amyloid peptide on the surface. Therefore, the specific binding resulting 
from the interaction between GM1 and the neuro-peptide acts to anchor the p-amyloid to 
the membrane surface and the negatively charged phospholipids and sterols act to stabilize 
the structure. The interaction between the GM1 and the P-amyloid resulted in the formation 
o f an amyloid ‘seed’, whereby the GM1-bound amyloid accelerates fibrillogenesis in a 
first-order kinetics model [67]. The pathway from the ‘seeding’ o f the peptide is believed 
to occur via:
1) The rapid commitment to form either stable monomer/dimer or an unstable 
intermediate.
2) The cooperative association o f intermediates into a multimeric ‘seed’.
3) The elongation o f the ‘seed’ into filaments via addition o f other amyloid 
intermediates.
4) The lateral aggregation o f filaments into fibrils, and
5) Fibril elongation via end-to-end association [68].




6.5.5 The Interaction Between Cholesterol-Deficient Multi-Species Phospholipid 
Biomimetic Membrane Vesicles and ^ -amyloid 1-42
Mixed-vesicles were prepared (as discussed in section 3.3.5) with the exclusion o f 
cholesterol from the bilayer vesicles. The cholesterol-deficient mixed-vesicles were 
tethered to the solid support and monitored for their interaction with p-amyloid 1-42.
Sterols, such as cholesterol, typically play a significant role in biological membrane 
dynamics. They are key in influencing the permeability and compartmentalization o f the 
membranes, and their abundance within eukaryotic membranes have made them attractive 
targets for certain bacterial toxins and toxic analytes to circumvent the membrane barrier. 
The brain contains the highest cholesterol content o f all the organs, and contains around 
20% o f the total body cholesterol [69]. Cholesterol has been reported to alter the affinity of 
the P-amyloid for phospholipid membranes, and both in vitro and in vivo studies have 
shown that inhibition o f cholesterol biosynthesis leads to a reduction in p-amyloid 
aggregation [70]. Therefore, biomimetic membrane mixed-vesicles deficient in cholesterol 
were prepared and tethered to the solid substrate. The biomimetic membranes were 
monitored for any change in reflectivity and/or fluorescence upon P-amyloid addition to 
the system (Figure 6.16a) and compared to cholesterol-containing mixed-vesicles (Figure 
6.14b).
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-3Figure 6.16(a) Kinetics p lot monitoring the addition o f  lOjumol.dm /?-amyloid to
cholesterol-deficient biomimetic mixed-vesicles, and, (b) the addition o f  lOjumol.dm 3 fl­
amy loid to cholesterol-containing biomimetic mixed-vesicles.
The addition o f p-amyloid 1-42 to the cholesterol-deficient mixed-vesicles resulted in an 
increase in reflectivity, until an equilibrium value was reached. Non-specifically bound 
peptide was subsequently removed by rinsing the system with fresh buffer. The
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cholesterol-deficient mixed-vesicles maintained an affinity towards the P-amyloid because 
the GM1 receptor was present within the vesicle bilayer. However, the non-specific 
binding associated with the electrostatic and hydrophobic interactions was reduced. 
Therefore, this suggests that the cholesterol influenced the non-specific binding o f the P- 
amyloid to the membrane surface. The binding between the cholesterol-deficient vesicles 
(Figure 6.16a) followed a different kinetics path compared to cholesterol-containing 
vesicles (Figure 6.16b). It has been reported that the membrane cholesterol to phospholipid 
ratio directly influences the extent o f high-affinity lipid binding, and that pure 
phospholipid biomimetic membranes show reduced binding compared to cholesterol 
containing vesicles [71]. The influence of sterols on the binding capacity o f the P-amyloid 
towards biomimetic membranes suggests that cholesterol affects the charge o f the 
membrane, thereby influencing the non-specific association between the membrane and the 
neuro-peptide, and causes the concentration o f GM1 receptors into lipid domains. 
Therefore, receptor clustering into lipid domains facilitates amyloid aggregation. 
Cholesterol also affects the diffusion o f the encapsulated BODIPY, and dye diffusion was 
significantly reduced upon the adsorption o f the P-amyloid to the cholesterol-deficient 
mixed-vesicles (Figure 6.16a) compared to the adsorption o f P-amyloid to the cholesterol- 
containing mixed-vesicles (Figure 6.16b).
Cholesterol may also act to influence P-amyloid binding to biological membranes by 
altering the fluidity o f the phospholipid bilayers. In vivo studies have shown that the 
fluidity and lipid composition o f the membranes changes with increasing age, and that 
aged membranes show reduced fluidity compared with the membranes o f younger 
eukaryotes [72], All regions o f the human brain are rich in cholesterol, but alterations in 
the amount o f the sterol are highly variable during aging, ranging from no change to a 40% 
decrease [73, 74]. p-amyloid and the APP have been shown to be located in membrane 
domains enriched in cholesterol [75], and that P-amyloid perturbs biological membranes, 
and this action is believed to be dependant on the cholesterol content of the membrane 
[76]. Reducing membrane cholesterol below normal membrane levels results in an 
increased sensitivity o f the cells to P-amyloid toxicity [77]. Therefore, the depletion o f  
membrane cholesterol may possibly stimulate p-amyloid cytotoxicity.
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The binding effects o f the P-amyloid 1-42 towards cholesterol-deficient biomimetic 
membranes was confirmed by observing the change in resonance shift upon addition o f the 
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Figure 6.17 Resonance angle scans form the addition o f  10/jmol.dm'3 f  -amyloid 1-42 
neuro-peptide to the biomimetic cholesterol-deficient mixed-vesicle system. The addition o f  
the peptide resulted in a 0.1° shift in the resonance minimum.
The addition o f the P-amyloid 1-42 peptide to the cholesterol-deficient mixed-vesicles 
resulted in a 0.1° shift in the resonance minimum, which equated to a 0.54ng.mm'2 increase 
in mass at the membrane surface, compared to the 2.68ng.mm' adsorbed to cholesterol- 
containing vesicles (Figure 6.13). Therefore, cholesterol significantly affected the binding 
capacity o f the biomimetic membranes towards p-amyloid.
There is a synergistic relationship between the membrane phospholipid species, cholesterol 
content and the presence o f GM1 receptors within the biomimetic membrane vesicles 
which regulates the degree o f p-amyloid binding. Phospholipids which confer an overall 
negative charge on the extracellular face o f the biomimetic membranes showed an 
increased capacity to bind p-amyloid 1-42 peptides compared to phospholipids which 
conferred a neutral charge. The presence o f GM1 within the phospholipid bilayer acted as 
a membrane surface receptor for the neuro-peptide, and the elimination o f the ganglioside 
from the vesicle composition removed the capacity to bind p-amyloid in a specific 
interaction. However, biomimetic membrane vesicles deficient in GM1 did show a 
capacity to non-specifically associate with the P-amyloid via electrostatic attraction and 
hydrophobic forces, but this association was weak and was disrupted easily. Sterols also 
regulated the interaction between the biomimetic membrane vesicles and the p-amyloid 1 -
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42 peptide. Removal of the cholesterol from the biomimetic membrane bilayer caused a 
significant reduction in the binding between the analyte and receptors on the membrane 
surface. This phenomenon is believed to result from either a change in the overall surface 
charge o f the vesicles or a change in the fluidity o f the membranes as a result o f altered 
membrane-associated cholesterol content. Therefore, the sterol content, phospholipid 
species and ganglioside content o f neuronal membranes significantly affects the binding o f  
the p-amyloid.
6.6 Dose Response of p-amyloid 1-42 Towards Biomimetic Membrane 
Vesicles
Amyloid fibrils are produced upon the formation o f P-sheet proteins which have a high 
propensity to aggregate and fibrillize. Oligomeric P-sheet intermediates form before the 
appearance o f fibrils, and disappear upon fibril formation [78]. It is the fibrils which show 
the greatest stability compared to the oligomeric intermediates and the monomeric P- 
amyloid peptides [79]. The conversion o f the P-amyloid peptides from the protofibril 
intermediates to the P-amyloid fibrils is concentration dependant, and upon reaching the 
critical concentration of the chain-like intermediates, they are rapidly converted into the 
amyloid fibrils. Moreover, the number and size o f the plaques/fibrils formed does not 
correlate with the severity o f the disease at the time o f death [80, 81]. However, the 
protofibrils and intermediate aggregated P-amyloid have been implicated in the alteration 
of membrane permeability and with the pathogenicity o f Alzheimer’s disease [82].
Various concentrations, ranging between 0.1-10pmol.dm'3, were added to the tethered 
mixed-vesicle biomimetic membrane system (GM1-mixed phospholipids-cholesterol), and 








ro o CD« tO-4' 
Q) 3  O) W 
c  ro
"o u; co -g
|  I 00
^  E
-0.2 H
0c  0.2 
CD
- 0 . 4 -
Change in mass density at vesicle 













a d [p-amyloid 1-42] (nmol.dm')
Figure 6.18 Langmuir simulation fo r  change in mass at the biomimetic membrane surface 
upon addition o f  f -amyloidpeptide. The equilibrium dissociation constant, K d, is marked.
The addition o f the P-amyloid 1-42 to the biomimetic membrane surface followed a 
concentration dependant Langmuir isotherm and allowed for the determination o f the 
affinity constants. The equilibrium dissociation constant for p-amyloid 1-42 and the 
biomimetic membrane vesicles was determined to be, KD = 1.09xl0'6mol.dm'3, which was 
in good agreement with other reported values o f 1.4xl0"6mol.dm'3 [61, 83]. The affinity 
between the P-amyloid and the membrane surface was mediated by the specific interaction 
between the G M 1 ganglioside receptor on the membrane surface and the C-terminus o f the 
P-amyloid peptide.
The addition o f p-amyloid 1-42 to the biomimetic membrane surface also showed a 
concentration dependant effect on the permeation o f the vesicle bilayer (Figure 6.19).
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Figure 6.19 Plot o f  the change in fluorescence upon /?-amyloid addition to the biomimetic 
membrane surface.
At lower concentrations o f P-amyloid (0.1-7.5pmol.dm'3), the diffusion o f the BODIPY 
dye from the aqueous vesicle space to the bulk solution was relatively constant, and similar 
changes in fluorescence were observed upon P-amyloid peptide addition. However, at the 
higher peptide concentration (lOpmol.dm'3), an greater change in fluorescence was 
observed. This suggests that P-amyloid caused a concentration dependant change in the 
permeability of the biomimetic membrane vesicles.
The addition o f varying concentration of p-amyloid caused a concentration dependant 
effect on the tethered biomimetic membrane vesicles. The adsorption o f the peptide to the 
membrane surface occurred via a dose-dependant mechanism, and followed a Langmuir 
isotherm. The concentration dependence o f the peptide allowed for the determination of 
the equilibrium dissociation constant, which was found to be in agreement with other 
reported values. The alteration in membrane permeability in the biomimetic membranes 
showed little variation in the change in fluorescence at lower concentration o f the P- 
amyloid 1-42 peptide, however, at the highest concentration tested, a greater change in 
fluorescence was observed. Therefore, it would suggest P-amyloid permeation o f the 
membrane was concentration dependant and relies on the accumulation o f the amyloid 
peptides on the membrane surface, until a critical concentration is achieved, whereby they 
cause a change in the membrane structure. This progressive accumulation o f the 
neurodegenerative peptide is expressed in vivo as the characteristic slow progression of 
Alzheimer’s disease.
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6.7 Comparison Between Juvenile p-amyloid 1-42 and Aged p-amyloid 1- 
42 and Their Effects Towards Biomimetic Membrane Vesicles
The conformation and state of aggregation o f the p-amyloid is o f importance to the degree
o f interaction with the tethered biomimetic membrane vesicles, and therefore, with the 
interaction with biological membranes. It has been readily observed that monomeric p- 
amyloid adsorbs to biomimetic lipid vesicles less readily compared to the aggregated 
intermediate fibril p-amyloid [84]. The self-assembly o f aggregated amyloid intermediates 
causes hydrophobic domains to become exposed, and these domains have not been 
detected in the monomeric p-amyloid peptides or the mature fibrils. Therefore, the 
formation o f intermediate fibrils allows for the aggregates to interact with the biomimetic 
membranes via hydrophobic forces, aiding the stabilization o f  the aggregate to the 
membrane. The loss o f these hydrophobic domains in the mature fibrils causes a decrease 
in the binding capacity and stabilization o f the fibrils compared to the intermediate fibril 
aggregates [85]. In another study, it was shown that biomimetic lipid vesicles became 
disrupted to a lesser extent as a result o f aged P-amyloid fibrils compared to the 
monomeric peptide and the intermediate p-amyloid fibrils [86]. Therefore, tethered 
biomimetic membrane vesicles were used to compare the extent o f binding to the 
membrane surface using juvenile p-amyloid and aged p-amyloid (Figure 6.20). Aged p- 
amyloid was formed from juvenile P-amyloid 1-42 which was vortexed slowly (500 RPM) 
for 7 days to ensure mature fibril formation.
M ass adsorp tion  upon addition
|  of lOpm ol.dm 3 p-amyloid 1-42
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Figure 6.20 Comparison o f  the mass adsorption o f  juvenile p-amyloid (day 0) and aged fl­
amy loid (day 7) on the tethered biomimetic membrane vesicles, and the overall mass 
adsorption observed when the juvenile P-amyloid ‘seeds ’ and binding occurs over a 7 day 
period.
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The extent o f juvenile p-amyloid adsorption (0.8ng.mnT over 20 hours) was significantly 
higher than that o f the aged p-amyloid (0.27ng.mm'2 over 20 hours). This suggested that 
aged p-amyloid has a lower binding capacity to the biomimetic membranes because the 
mature fibrils have fewer exposed binding sites, and the loss o f the hydrophobic domains 
contribute to the decreased mass adsorption compared to the juvenile p-amyloid. It has 
been reported that on incubation in solution, all P-amyloid peptides initially undergo a 
transformation from mixtures o f p-sheet, a-helix, and random coil conformations to 
eventually adopt to a complete p-sheet structure [86], therefore, the intermediate p-amyloid 
fibrils show a greater degree o f association with the biomimetic membranes. The report 
also demonstrated that the ability o f P-amyloid to induce aggregation decays progressively, 
and they loose the capacity to aggregate after 24 hours o f incubation. Therefore, the aged 
P-amyloid would show a reduction in adsorption to the biomimetic membranes compared 
to the juvenile peptide. The binding of the juvenile p-amyloid peptide was followed for an 
extended period o f time (over 7 days), and showed that P-amyloid adsorbs significantly 
more to the surface (3.2ng.mm*2 over 168 hours). Therefore, the bound juvenile peptide 
acts as a ‘seed’ for subsequent binding o f the peptide to the surface.
The extent o f P-amyloid aggregation significantly affects the adsorption o f the peptide to 
the biomimetic membrane surface. Juvenile amyloid showed more binding to the 
membrane surface because it transitions from the mixed conformations to an all P-sheet 
conformation. Therefore, the juvenile P-amyloid transitions through the conformations to 
the intermediate fibril formation, which have more exposed hydrophobic domains. The 
transition from the intermediate p-amyloid fibrils to the mature fibrils, which occurs within 
24 hours, caused a loss in the capacity to aggregate and thereby caused a reduction in the 
adsorption to the membrane surface. The addition of the mature fibrils to the tethered 
membrane system could not aggregate because they tend to loose the hydrophobic 
domains, which reduced the non-specific electrostatic and hydrophobic forces between the 
mature fibrils and the membrane surface. Therefore, mature amyloid fibrils can not adsorb 
to the membrane surface to an extent observed with juvenile p-amyloid peptides and 
intermediate aggregates. Therefore, the ‘seeding’ of the amyloid produces the 
characteristic slow progression of Alzheimer’s disease in vivo.
229
6.8 Discussion Concerning the Mechanism of p-amyloid Neurotoxicity 
Towards Biomimetic Membrane Vesicles
The means with which P-amyloid causes the cytotoxic effects on neurons has not been 
definitively identified because it is not possible to directly observe the pathogenic events, 
and various models have been proposed as to how P-amyloid causes Alzheimer’s disease. 
It is assumed that the amyloid results in a gain-of-function which induces 
pathophysiological cellular responses by altering the cell membrane composition and 
destabilizing the cellular homeostasis.
The original assumption made about the toxicity caused by P-amyloid was that the 
deposition of the amyloid was necessary for cell death to occur in Alzheimer’s disease. 
However, it is still presently unknown whether it is the deposited P-amyloid that causes 
neuronal death or whether it is an intermediate p-amyloid peptide that causes toxicity. 
Therefore, much research has focused on whether p-amyloid fibrillization is the cause of 
neuronal death or a result of another upstream process.
One o f the theories presented for p-amyloid toxicity is that the neuro-peptide causes 
membrane poration followed by non-specific membrane leakage or specific ionic transport 
through ion channels. The formation o f channels in the neuronal membrane would 
subsequently lead to the destruction o f the ionic gradients and membrane potential o f the 
neurons which maintains this balance in order to function correctly for their signalling role. 
In vitro studies have shown that P-amyloid peptides form cation selective channels within 
planar lipid bilayers [87]. It has been proposed that non-fibrillar p-amyloid peptides form 
calcium-permeable ion channels in the cell membranes, allowing excessive calcium influx 
which disrupts the ionic gradients of the neurons. The disruption o f neuronal homeostasis 
in cultured cells by nanomolar concentrations of P-amyloid, show morphological changes, 
such as beading, granulation and swelling o f neuronal bodies [88]. The transmembrane 
region o f the P-amyloid peptide has been reported to increase the permeability o f neurons 
to Ca2+, Na+, and K+ [89], and reduce the fluidity o f murine brain homogenate preparations 
[76]. Atomic force microscopic examination o f P-amyloid peptides reconstituted in 
membrane bilayers have been shown to form ‘disc-like’ shapes, with an outer diameter of 
8-12nm and a central pore-like cavity with a diameter o f l-2nm [90].
The presence o f ‘pore-like’ structures in neuronal membranes would therefore provide a 
realistic hypothesis for a contributing mechanism in neuronal degradation in Alzheimer’s
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disease. The formation o f pores within membranes in vitro and in vivo would cause the 
disruption of the permeability barrier and result in the flux o f ions and solutes. The tethered 
biomimetic membrane system and the dye diffusion model, therefore, provides a means to 
study any changes in the porosity o f the membrane caused by p-amyloid. Various tethered 
membrane systems comprising different membrane components were monitored for 
changes in fluorescence upon addition of lOpmol.dm'3 p-amyloid 1-42. DMPC-GM1- 
cholesterol biomimetic membrane vesicles (red fluorophore leakage), mixed phospholipid- 
GM1-cholesterol biomimetic membrane vesicles (green fluorophore leakage), Cholesterol- 
deficient mixed phospholipid-GM 1 biomimetic membrane vesicles (blue fluorophore 
leakage), and GM1-deficient mixed phospholipid-cholesterol biomimetic membrane 
vesicles (fuchsia fluorophore leakage) were produced (Figure 6.21).
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Figure 6.21 Plot o f  the normalized In fluorescence concentration (fanol.m3)  as a function 
o f  time (seconds), with linear f it  data, fo r  the four vesicle systems; 1) pure DMPC  
biomimetic membrane vesicles, 2) mixed-vesicles, 3) GMl-deficient mixed-vesicles, and 4) 
cholesterol-deficient mixed-vesicles upon addition o f  lOjumol.dm'3 (3-amyloid 1-42.
Monitoring the leakage of the encapsulated BODIPY within the tethered biomimetic 
membrane vesicles, as a result o f P-amyloid permeation, allowed for the determination of 
the apparent dye diffusion coefficient for each o f the systems. The pure DMPC vesicles 
containing cholesterol and GM1 showed the slowest diffusion o f the BODIPY dye from 
the encapsulated space to the bulk solution, with a calculated apparent dye diffusion 
coefficient o f D * = 1 .0 8 x l0 17cm2.s'1. The addition o f p-amyloid to cholesterol-deficient 
mixed-vesicles showed an apparent dye diffusion coefficient o f  D* = 1 .30x l0 '16cm2.s'1, 
whereas the addition o f p-amyloid to GM1-deficient mixed-vesicles showed an apparent
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dye diffusion coefficient o f D*  = 1.29x1 O'16cm2.s_1. The greatest diffusion o f BODIPY dye 
was observed in the mixed-vesicle system, with a calculated apparent dye diffusion 
coefficient o f D *=2.44xl015cm2.s'1. Therefore, biomimetic membrane vesicles comprising 
the GM1 ganglioside receptor, cholesterol, and a negatively charged surface provided the 
lowest barrier against dye diffusion as a result of p-amyloid addition. This suggests that the 
P-amyloid peptide causes a change in the porosity o f the tethered biomimetic membrane 
vesicles, and the pores formed in the bilayer provide non-specific channels for the flux o f 
the encapsulated molecules within the aqueous space o f the vesicles.
The DMPC vesicles offered the highest barrier against p-amyloid permeation because P- 
amyloid showed a preference for negatively charge lipids, therefore, the p-amyloid did not 
readily form the channels through the phospholipid bilayer. Moreover, the omission o f 
cholesterol from the vesicles showed an improved barrier against P-amyloid porosity 
because sterols form domains in membranes, and cause the concentration o f membrane 
surface receptors within these domains. Therefore, exclusion o f cholesterol from the 
vesicle bilayer prevented the concentration of the GM1 receptors within domains and 
thereby caused a reduction in fibrillization o f the bound monomeric and dimeric P-amyloid 
peptides. This reduction in aggregation and fibrillization would cause a decrease in the 
formation o f the ‘pore-like’ structures, and therefore show reduced porosity compared to 
the GM1-deficient and mixed-vesicle systems.
The omission o f GM1 from the mixed-vesicles showed decreased dye diffusion compared 
to the mixed-vesicle system, because there was no receptor for P-amyloid adsorption. The 
exclusion o f the GM1 from the vesicle bilayer prevented the specific adsorption o f the P- 
amyloid to the membrane surface, however, the P-amyloid still associated with the 
biomimetic membrane via non-specific hydrophobic and electrostatic forces, and were free 
to laterally diffuse and self-assemble.
The mixed-vesicle system, comprising the GM1 receptors, cholesterol and the negatively 
charged phospholipids conferred the lowest resistance to P-amyloid induced porosity. The 
increased permeation resulted from the inclusion o f the membrane receptor, which allowed 
for specific adsorption o f the p-amyloid to the surface, and the inclusion o f the sterol, 
which acted to concentrate the GM1 receptors into lipid domains and provided a greater 
opportunity for the P-amyloid peptides to aggregate. The mixed phospholipid species also
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enhanced the porosity o f the vesicles by providing a negative charge on the biomimetic 
membrane surface. This ensured the non-specific association o f  the peptide and the 
membrane. A summary o f the results are presented in Figure 6.22.
Vesicle System First order rate constant 
k (sec1)
Apparent dye diffusion coefficient 
D* (m2.sec_1)
DMPC vesicles
(67% DMPC, 2% GM1, 30% 
cholesterol, 1% Biotin)
1.45 x 10'7(± l . lx l0 '8) 1.08 x 10 '7
Sterol-deficient
mixed vesicles
(97% DMPC, 2% GM1, 1% 
Biotin)
1.74 x 10-6 (±1.27x10-*) 1.30 x 1 0 16
GM 1-deficient
mixed vesicles
(69% mixed phospholipids, 
30% cholesterol, 1 % Biotin)
1.72 x 10'tl(±3.83xl0'li) 1.29 x lO 16
Mixed vesicles
(67% mixed phospholipids, 
2% GM1, 30% cholesterol, 
1% Biotin)
3.26 x 1 O'5 (±2.25x10 s) 2.44 x 1 0 15
Figure 6.22 Summary o f  the resistance o f  the various biomimetic membrane systems to fl­
amy lo id induced porosity as a result offl-amyloidfibrillization and channel formation, and 
calculated from the apparent dye diffusion coefficient to quantify the diffusion o f  
encapsulated BODIPYfrom the entrapped vesicle aqueous space to the bulk solution.
The proposed mechanism o f toxicity induced by P-amyloid is as a result o f increased 
permeation o f the biomimetic membranes. The addition o f the P-amyloid peptide to the 
membrane systems allowed for the quantification o f the apparent dye diffusion coefficient, 
which describes the rate at which encapsulated fluorescent dye molecules diffused from the 
entrapped aqueous vesicle space and into the bulk solution. The p-amyloid caused an 
increase in the diffusion of the dye, therefore, it would suggest that the projected channel 
formation hypothesis would satisfy the observations made here. Therefore, from the 
increased apparent dye diffusion coefficient data it would seem that P-amyloid caused 
pores in the phospholipid bilayer, which subsequently allowed the non-specific flux o f the 
ions/solute. The increase in permeability of the biomimetic membrane vesicles would 
reflect the in vivo hypothesis o f neurotoxicity, whereby the increased flux causes neuronal 
damage, and subsequently neuronal death.
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6.9 Blocking the GM1 receptor with Lanthanide Trivalent Ions and its 
Effects on p-amyloid Binding
The therapeutic pathways which have been explored for the control or cure o f Alzheimer’s 
disease are varied, and include drugs that reduce the production o f the insoluble amyloid 
protein, drugs that increase the rate o f clearance o f the misfolded/aggregated proteins, and 
those that increase the native-state stability or increase the kinetic barrier to misfolding 
aggregation [91]. In vivo, proteins are assisted with their folding by the chaperone system. 
It also facilitates the refolding or retrotranslocation of misfolded proteins back into the 
cytoplasm, where they are degraded by the proteasomes [92]. Small molecule ligands 
which bind to the native state o f the mutated and/or misfolded proteins have been 
investigated. These ligands can stabilize the mutated native state proteins to compensate 
for the influence o f the misfolded protein [91]. Chemical chaperones are small molecules 
that bind to a protein, stabilize the folded peptide and thereby reduce protein misfolding. It 
has been reported that osmolytes, such a trimethylamine /V-oxide and glycerol, mimic the 
effect o f naturally occurring chaperone molecules, and correct folding defects by 
preferentially hydrating partially denatured proteins and stabilize the native conformation 
[93]. These chemical chaperones were found to force the P-amyloid peptide into transition 
from the intermediate fibrils to the mature fibrils, thereby preventing the accumulation o f  
the toxic intermediate p-amyloid fibrils. However, no in vivo studies or clinical trials using 
chemical chaperones have been performed, therefore, their actual therapeutic benefit to 
Alzheimer’s sufferers has not been established.
As mentioned in chapter 5, lanthanide complexes have been used to label GM1 
gangliosides for fluorescent studies [94], and it was also shown (section 5.6.4) that 
trivalent lanthanide ions prevent the actions o f cholera toxin by blocking the GM1 
receptor, and thereby preventing toxin binding to the cell surface. Therefore, it was 
hypothesized that the coordination o f trivalent ions to GM1 receptors within the 
biomimetic membrane mixed-vesicles would block the specific binding of the P-amyloid to 
the membrane surface, and thereby preventing aggregation and the subsequent 
cytotoxicity. Mixed phospholipid vesicles containing 2% GM1, 1% biotin, 30% cholesterol 
and 67% mixed phospholipids were tethered to the solid support. Trivalent lanthanide ions 
were coordinated to the GM1 receptors o f the biomimetic membrane vesicles, and was 
subsequently followed by the addition o f lOpmol.dm'3 p-amyloid 1-42 (Figure 6.23).
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Figure 6.23 Plot o f  the change in reflectivity upon addition o f lOjumol.dm'3 f-am yloid to 
Europium III chloride-labelled GM1 biomimetic membrane mixed-vesicles, at three 
concentrations o f  the lanthanide compound (0, 10 and 100 nm ol.dm 3).
The addition of varying concentrations o f europium III chloride caused an increase in 
reflectivity (Figure 6.23), which was dependent on the concentration o f the lanthanide ions. 
The addition o f lOpm ol.dm 3 and lOOpmol.dm'3 europium caused a shift in the resonance 
angle scan that equated to the adsorption of 2.68ng.mm' and 6.96ng.mm‘ europium to the 
GM1 receptors respectively. The subsequent addition o f 10p.mol.dm'3 p-amyloid 1-42 to 
the europium coordinated mixed-vesicle system caused a europium concentration 
dependant change in the reflectivity. In the control experiment, where no europium was 
adsorbed to the GM1 receptors, there was a significantly greater shift in the resonance 
minimum that equated to the adsorption o f 2.68ng.mm'2 (3-amyloid. However, the GM1 
receptors coordinated to lOpmol.dm'3 europium showed a smaller shift in the resonance 
minimum upon p-amyloid addition (2.14ng.mm 2). This suggests that the europium 
reduced the binding capacity o f the p-amyloid to the biomimetic membrane vesicles 
because the GM1 receptors were blocked by the europium. At the higher europium 
concentration o f lOOpmol.dm'3, there was no change in the resonance minimum upon 
addition o f p-amyloid to the system. Therefore, at the higher concentration o f europium, p- 
amyloid adsorption to the GM1 receptors was inhibited. A summary o f the results are 











Figure 6.24 Comparison o f  the adsorption o f  the three concentrations o f  trivalent 
lanthanide ions, and the subsequent adsorption o f  /?-amyloid (10jumol.dm-3) to the 
coordinated GM1:lanthanide biomimetic membrane mixed-vesicles.
The change in fluorescence upon lOpmol.dm'3 P-amyloid addition to the europium 
coordinated mixed vesicles showed that the lanthanide altered the porosity and dye 
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Figure 6.25 Plot o f  the normalized In fluorophore concentration (pmol.m 3) as a function 
o f  time (seconds), with linear f it  data, fo r  the porosity o f  mixed-vesicles upon addition o f  
lOpmol.dm3 P-amyloid to the three lanthanide concentrations co-ordinated to the GM1 
receptors; 1) No lanthanide, control, 2) lOpmol.dm3 europium III chloride, 3) 
lOOpmol.dm3 europium III chloride.
The coordination o f the lanthanide compounds to the GM1 receptors altered the 
permeation o f the biomimetic membrane vesicles caused by p-amyloid. It has been 
reported in this chapter that p-amyloid causes the formation o f channels in the biomimetic 
membrane bilayer, and the channels allow the diffusion o f encapsulated BODIPY dye from 
the aqueous entrapped space to the bulk solution. The change in fluorescence as a result of 
p-amyloid permeation allowed for the quantification o f the apparent dye diffusion
236
coefficient for each of the vesicle systems. The control system, where no lanthanide 
compounds were present, showed the highest porosity, with a calculated apparent dye 
diffusion coefficient of, D* = 2.41xl0'16cm2.s'1. The addition o f lOpmol.dm'3 europium III 
chloride prior to the addition o f P-amyloid to the system, resulted in a decrease in the 
porosity of the tethered biomimetic membrane vesicles. The apparent dye diffusion 
coefficient for the lOpmol.dm’3 europium coordinated biomimetic membrane vesicles was 
D* = 9.57xl0'17cm2.s'1. The lOOpmol.dm'3 europium coordinated vesicles resulted in a 
greater coefficient, and was calculated to be, D* = 6.61xl0'17cm2.s*1. Therefore, the 
addition o f europium caused the inhibition o f p-amyloid binding to the membrane surface 
by blocking the GM1 surface receptors. This subsequently prevented the oligomerization 
of the P-amyloid peptides and the formation o f the ‘pore-like’ channels in the biomimetic 
membranes. Therefore, the adsorption o f europium reduced the diffusion of the entrapped 
BODIPY dye within the vesicle aqueous space to the bulk solution.
As described in chapter 5, europium could be a potential therapeutic candidate because it is 
tolerated well in the body and can be administered orally without toxicity problems. 
Therefore, the administration o f a therapeutic drug containing a trivalent lanthanide 
compound, such as europium, could be administered to Alzheimer’s disease sufferers to 
prevent the binding of the P-amyloid to the neuronal surface and reduce the aggregation of 
the p-amyloid peptide, thereby inhibiting channel formation which leads to neuronal death. 
The compound must cross the blood-brain barrier to bind the GM1 receptors o f the 
neurons, therefore, it could be encapsulated into liposomes targeted to the neurons. 
Europium compounds administered to Alzheimer’s disease patients could potentially 
reduce neuronal loss and subsequently slow down the progression o f the amyloidosis 
disorder.
6.10 Conclusions
The tethered biomimetic membrane vesicles provide a novel method to study amyloidosis 
disorders. The system provides a technique to follow the kinetic events associated with the 
formation o f aggregated peptides in real-time. The tethered biomimetic membrane system 
provides a reliable method to determine the equilibrium association and dissociation 
constants, which have been shown to correlate well with other reported values.
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Alzheimer’s disease is a very distressing disorder for the sufferers and those close to them. 
The disorder is typically an age related disease, and the prevalence increases significantly 
over the age o f 65 years old. The life expectancy o f a person suffering from the disease can 
be variable, however, the disorder may progress very quickly. Alzheimer’s disease also 
attaches huge financial pressures to governments and individuals for the prevision o f an 
appropriate standard o f care, therefore, inexpensive and reliable treatments are continually 
being sourced. The hallmarks o f the disease include the formation o f p-amyloid aggregates, 
plaque and tangle formation and neuronal loss. The aggregation o f the insoluble P-amyloid 
peptide produces what is believed to be toxic intermediates, which subsequently mature 
into fibrils and plaques. The adsorption of p-amyloid to membranes shows a capacity to 
bind the GM1 receptors, however, the p-amyloid aggregates may associate with membrane 
sterols and negatively charged phospholipids. The stabilized adsorbed amyloids act as a 
seed to allow the accumulation o f the peptide to the membrane surface.
The cause o f neuronal loss has not been definitively determined, however, a potential 
mechanism is believed to involve the formation o f p-amyloid ‘pore-like’ structures in the 
membranes, which causes increased permeation o f the membranes. The increased porosity 
of biomimetic membrane vesicles was shown here, and it is believed that the flux of 
cations causes neuronal damage and their subsequent death. The increased porosity 
observed upon addition o f the P-amyloid peptide to the biomimetic membrane surface can 
be inhibited by the coordination of lanthanide trivalent ions to the GM1 receptors. The 
adsorption o f europium to the GM1 blocks the receptors, effectively inhibiting the binding 
of the p-amyloid to the membrane surface, and thereby preventing the formation o f the 
channels and reducing the associated permeation. Europium could have a potential novel 
application in the treatment o f people suffering from Alzheimer’s disease by slowing the 
progression o f the disorder and extending the life expectancy of the patients.
The tethered biomimetic membrane system provides a novel means o f determining affinity 
constants, which are reliable and comparable to other methods to determine the constants. 
It has also been demonstrated that the system may be used to evaluate potential therapeutic 
drug candidates, such as the lanthanide trivalent compounds. The system provides a good 
in vitro model o f neuronal membranes, which can be easily modified to precise 
experimental specifications to create a firmer understanding o f the underlying mechanisms 
involved behind the initiation, progression and prevention o f the deliberating disorder.
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